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CHAPTER 1.4. SUMMARY 
1.4. Summary 
     Tuberculosis (TB) is an old infectious disease which causes ill-health among millions of 
people each year. Effective anti-TB drugs are available since 1950’s, but still the global burden 
of TB remains enormous. The disease is very complex and there is a need to look for supportive 
treatment to the standard anti-TB drugs. Cognizant of this, the present doctoral study was 
undertaken by giving emphasis on nutrition and TB in Ethiopia. The aim of this doctoral 
dissertation thesis was to deal with the nutritional situation of people with and without TB and 
come-up with solutions that could support the effort of combatting TB. In this thesis, five 
papers (four published and one submitted) were included. 
 
     The first paper encompassed the study of dietary and nutritional assessment.  In this study, 
dietary inadequacy, poor nutritional quality and high risk of micronutrient deficiencies were 
identified. The main dietary pattern included cereals, vegetables and legumes. About one-third 
of the population consumed animal source food (ASF).  Malnutrition was the common problem 
in people with and without TB. This suggested that malnutrition may pave the way for TB. 
 
     The case-control study in the second paper revealed that more than one-half of TB patients 
had vitamin A and zinc deficiencies. More than three-fourth of TB patients had below half of 
the energy fulfilment. The protein intake was above the average fulfilment, but most TB 
patients relied on cereal-based diets. Patients with TB used a larger proportion of proteins from 
oral feeding for oxidation and hence for energy production. About half of the patients were 
undernourished. Thus, vitamin A and zinc deficiencies along with protein-energy malnutrition 
need to be addressed in the management programme of TB. 
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     The third paper included systematic review which explored the existence of vitamin D 
deficiency (VDD). Sunshine, which is very important for the synthesis of vitamin D under the 
skin, is widely available in Africa throughout the year. Surprisingly, more than three-fourth of 
TB patients in Africa had VDD and vitamin D insufficiency (VDI). Statistically significant 
variables such as use of sun protection (lack of sun-exposure), inadequate dietary intake, low 
body mass index (BMI), high skin pigmentation, use of drugs (anti-retroviral and /or anti-TB), 
low socioeconomic status, rainy season, covering body skin with clothes , old age and 
comorbidities were identified as the main predictor variables that hampered the status of 
vitamin D.   
 
     Vitamin D can be obtained from dietary intakes apart from endogenous synthesis after sun-
exposure. Mushroom as such, is a potential non-animal source of vitamin D. The experimental 
study in the fourth paper revealed that sun-exposure significantly increased the content of 
vitamin D2 in oyster mushroom. Increasing the surface area for sun-exposure enhanced the 
production of vitamin D2. Other factors such as duration of sun-exposure and moisture content 
determined the production of vitamin D2. Exposing slices of oyster mushroom to direct sun for 
brief period provided enough vitamin D2 that could satisfy the current recommended dietary 
allowance (RDA) of vitamin D without any visible changes in colour and texture. 
 
          The study in the fifth paper was a randomized controlled trial and demonstrated for the 
first time the role of mushroom-derived vitamin D2 on the treatment outcomes of TB. 
Intervention with vitamin D2 derived from sun-exposed oyster mushrooms brought significant  
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improvement in vitamin D status, clinical outcomes and immunological responses, but not in 
sputum smear and culture conversion. The intervention corrected VDD in more than one-third 
of TB patients. About one-third of the variability in TB score in the intervention group was 
accounted for by the change in the serum 25 hydroxy (OH) vitamin D level. There were also 
significant improvements in the serum IFN- and cathelicidin LL-37 peptide levels after 
intervention. The balance of cytokines was skewed to TH1 responses due to high level of IFN-
. Thus, mushroom-derived vitamin D2 could serve as potential, safe, easily available and cost-
effective adjunctive therapy for TB.  Taken collectively, foods enriched with vitamin D need 
to be included in the national TB control programme to support the first line anti-TB drugs, 
increase the cure rate and reduce the infectiousness of TB.  
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1.5. Zusammenfassung 
          Tuberkulose (TB) ist eine alte Infektionskrankheit, an der jedes Jahr Millionen von 
erkranken. Wirksame Medikamente gegen Tuberkulose sind seit den 1950er Jahren erhältlich, 
aber die enorme Bürde durch Tuberkulose ist weltweit immer noch groß. Die Krankheit ist sehr 
komplex und es besteht die Notwendigkeit, eine unterstützende Behandlung für die Standard-
Anti-TB-Medikamente zu suchen. In Anbetracht dessen legte die vorliegende Doktorarbeit 
ihren Fokus auf die Ernährung von Tuberkulosepatienten in Äthiopien. Ziel dieser Dissertation 
war es, sich mit der Ernährungssituation von Menschen mit und ohne Tuberkulose zu befassen 
und Lösungen zu finden, die den Kampf gegen Tuberkulose unterstützen können. Die 
Ergebnisse dieser Arbeit resultierten in fünf Artikel (vier veröffentlicht und einer eingereicht). 
 
     Das erste Artikl befasste sich mit der Bewertung der Ernährung und des Ernährungsstatuses. 
In dieser Studie wurden unzureichende Ernährung, eine schlechte Ernährungsqualität und ein 
hohes Risiko für Mikronährstoffmangel festgestellt. Das Hauptnahrungsmuster beinhaltete 
Getreide, Gemüse und Hülsenfrüchte. Etwa ein Drittel der Bevölkerung konsumierte tierische 
Nahrung (TN). Unterernährung war das häufigste Problem bei Menschen mit und ohne TB. 
Dies deutet darauf hin, dass Mangelernährung den Weg für TB ebnen könnte. 
 
     Die Fall-Kontroll-Studie in der zweiten Veröffentlichung ergab, dass mehr als die Hälfte 
der TB-Patienten einen Mangel an Vitamin A und Zink aufwies. Mehr als drei Viertel der TB-
Patienten nahmen weniger als die Hälfte der empfohlenen Energie zu sich. Die 
Proteinaufnahme lag über dem Durchschnitt, aber die meisten TB-Patienten wiesen ein 
getreidebasiertes Ernährungsmuster auf. Patienten mit TB verwendeten einen größeren Anteil 
an Nahrungsprotein zur Oxidation und damit zur Energiegewinnung. Etwa die Hälfte der  
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Patienten war unterernährt. Daher, müssen Vitamin A – und Zinkmängel zusammen mit 
Protein-Energie Mangelernährung im Behandlungs programm für TB angegangen werden.  
 
     Der dritte Artikel beinhaltete eine systematische Übersicht über die Prävalenz eines 
Vitamin-D-Mangel (VDD) bei TB-Patienten. Sonnenschein, der für die Synthese von Vitamin 
D in der Haut sehr wichtig ist, ist in Afrika das ganze Jahr verfügbar. Überraschenderweise 
hatten mehr als drei Viertel der TB-Patienten in Afrika eine VDD- und Vitamin-D-Insuffizienz 
(VDI). Statistisch signifikante Variablen wie Sonnenschutz (fehlende Sonnenexposition), 
unzureichende Nahrungsaufnahme, niedriger Body Mass Index (BMI), hohe 
Hautpigmentierung, Medikamenteneinnahme (antiretroviral und / oder anti-TB), geringer 
sozioökonomischer Status, Regenzeit, Bedeckung der Körperhaut durch Kleidung, Alter und 
Begleiterkrankungen wurden als HauptPrädiktorvariablen identifiziert, die den Status von 
Vitamin D beeinträchtigten. 
 
     Vitamin D kann neben der körpereigenen Synthese durch Sonnenexposition auch über die 
Nahrungs aufgenommen werden. Pilz stellen eine potenzielle nicht-tierische Vitamin-D-Quelle 
dar. Die experimentelle Studie in der vierten Veröffentlichung ergab, dass die 
Sonnenexposition den Vitamin-D2-Gehalt in Austernpilzen signifikant erhöht. Eine Steigerung 
der bestrahlten Oberfläche erhöhte die Produktion von Vitamin D2. Andere Faktoren wie die 
Dauer der Sonneneinstrahlung und der Feuchtigkeitsgehalt beeinflussen die Produktion von 
Vitamin D2 ebenfalls. Wenn Austernpilzscheiben für kurze Zeit direkter Sonneneinstrahlung 
ausgesetzt wurden, war der Vitamin D2 – Gehalt ausreichend um die derzeit empfohlene 
Tagesdosis (RDA) für Vitamin D ohne sichtbare Änderungen der Farbe und Textur zu 
erreichen. 
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     Die Studie in der fünften Veröffentlichung war eine randomisierte kontrollierte Studie und 
zeigte zum ersten Mal die Rolle von aus Pilzen stammendem Vitamin D2 für die 
Behandlungsergebnisse bei TB. Die Intervention mit Vitamin D2 aus sonnenexponierten 
Austernpilzen führte zu einer signifikanten Verbesserung des Vitamin D-Status, der klinischen 
Ergebnisse und der immunologischen Reaktionen, jedoch nicht zu einer Verbesserung des 
Sputumabstrichs und der bakteriellen Kulturumwandlung. Die Intervention korrigierte VDD 
bei mehr als einem Drittel der TB-Patienten. Etwa ein Drittel der Variabilität des TB-Scores in 
der Interventionsgruppe war auf die Veränderung des Serum-25-Hydroxy (OH) -Vitamin-D-
Spiegels zurückzuführen. Es gab auch signifikante Verbesserungen bei den Serum-IFN- und 
Cathelicidin-LL-37-Peptidspiegeln nach der Intervention. Das Gleichgewicht der Zytokine 
wurde aufgrund des hohen IFN--Spiegels auf TH1 – Antworten verzerrt. Somit könnte aus 
Pilzen gewonnenes Vitamin D2 als potenzielle, sichere, leicht verfügbare und kostengünstige 
Zusatztherapie für TB dienen. Zusammengenommen müssen mit Vitamin D angereicherte 
Lebensmittel in das nationale TB-Bekämpfungsprogramm aufgenommen werden, um die 
ersten Medikamente gegen TB zu unterstützen, die Heilungsrate zu erhöhen und die 
Infektiosität von TB zu verringern. 
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1.6. Abbreviations 
 
25(OH)D - 25-hydroxy vitamin D   
AFB - Acid Fast Bacilli 
AHRI - Armauer Hansen Research Institute  
ALERT - All Africa Leprosy Rehabilitation and Training Centre 
ASF – Animal Source Foods 
BMI - Body Mass Index 
CI - Confidence Interval 
CRP - C- Reactive Protein  
CYP27B1 – Cytochrome P 27 B1 
DDS – Diet Diversity Score 
DOTS - Directly Observed Treatment Short Course  
ELISA - Enzyme Linked Immunosorbent Assay  
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FAO – Food and Agriculture Organization 
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2.1. Introduction 
2.1.1. Epidemiology of tuberculosis 
      
     Tuberculosis (TB) is an old infectious disease which is caused by mycobacteria belonging 
to Mycobacterium tuberculosis complex 1 and has affected humans for thousands of years 
2. The global burden of TB remains enormous. About one-third of the global populations 
were infected with TB 3 and nearly 10 million people developed TB disease in 2017 4.  
Most cases of active TB occur in males 4, adults 1 and during economically productive 
years of people's lives (19-49 years) 5. Undernutrition, smoking and HIV infection linked to 
poverty are the factors that have considerable impact on TB incidence 1, 6. In addition, the 
emergence of drug resistant strains of M. tuberculosis complicates the management of TB 7. 
 
2.1.2. Burden of TB in Ethiopia 
     Of the thirty high TB burden countries in 2017, Ethiopia ranked 25th with the incidence rate 
of 164 per 100,000 population 4. According to the Ministry of Health reports, TB was the 
leading cause of hospital admissions and the third leading cause of hospital deaths 8. More 
than half of TB patients were males and young adults between the age of 15 and 34 years 9, 
10. The high proportion of TB in young adults seems to suggest the rapid rate of TB circulation 
in the community 11. Rural and pastoral communities were highly affected by TB 10. The 
occurrence of chronic undernutrition, widespread poverty, overcrowding, and HIV infection 
increased the risk of TB infection and disease progression 12. 
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2.1.3. Nutrition and TB interaction 
 
     Nutrition has an important role in preventing illness and reducing morbidity and mortality 
in people living with TB and other infectious diseases. A healthy diet can support to manage 
symptoms, maximize the benefits of medications, and enhance their quality of life 13. Little 
was known about the link between nutrition and infection during the 1950s. Until that time, it 
was believed that protein deficiency (kwashiorkor) was the predominant basis of nutrition 
problems more than total calorie deficiency (marasmus). Because severe protein deficiency 
bore a definite relationship to antibody formation and the development of the immune system. 
The focus then changed to energy, with the assumption that if a person consumed enough 
kilocalories of energy, all nutrient needs would be met 14. After 1959, the research on the 
interaction of nutrition, immunity, and infection was advanced 15 and showed extensive, 
synergistic, antagonistic, and cyclical interactions between malnutrition and infection 14. 
 
     The complex interaction between malnutrition and infection creates a hostile environment 
that perpetuates a vicious circle and leads to the two entities benefiting from each other. There 
are two effects that can occur in the presence of both malnutrition and infection. The first one 
is the synergistic effect, and it happens when an infection worsens the malnutrition or when the 
malnutrition contributes to decreasing the immune response to infection. The second effect is 
an antagonistic mechanism, which occurs less frequently than synergistic effect. The 
antagonistic mechanism happens when malnutrition decreases the multiplication of the 
infectious agent 13. 
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     TB and undernutrition are the major problems of public health in developing countries. They 
are linked in a complex relationship and have synergistic effects. TB may cause undernutrition 
through increased metabolic demands and decreased intake. Whereas, undernutrition may 
predispose people to clinical disease development or delay recovery by depressing important 
immune functions 16, 17. The reactivation of latent or previously subclinical TB infection 
perhaps related to deteriorated nutritional status 18.  
 
     Most of health facilities in Ethiopia frequently report TB and undernutrition in the list of 
top ten diseases. However, only few studies done in the past considered TB and undernutrition. 
A cross-sectional study conducted in Addis Abeba demonstrated that more than one-third of 
adult TB patients were undernourished 19. Another study conducted in Sidama, the southern 
region of the country, found a high prevalence of undernutrition in TB patients 20. A study 
done in Gondar, the northern region of the country, also reported a higher magnitude of 
undernutrition in patients with TB 21. 
 
2.1.4. Micronutrients and TB 
  
     Micronutrients have diverse metabolic characteristics and functions 18. For instance, zinc 
is essential for the activities of over 300 enzymes, carbohydrate and energy metabolism, protein 
synthesis and degradation, nucleic acid production, heme-biosynthesis, cell differentiation, and 
immune function 14, 22, 23. Vitamin A is involved in lymphocyte proliferation, macrophage 
activity, and maintenance of mucosal surfaces and epithelial function 24, 25. Previous studies  
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have suggested that active TB is associated with low serum levels of zinc 26, vitamin A and 
vitamin D 17, 27, 28. Scrimshaw et al. 15 underlined that no nutritional deficiency is more  
consistently synergistic with infectious disease than that of vitamin A. Zinc has essential roles 
in vitamin A metabolism and its deficiency impairs the synthesis of retinol binding proteins 
and reduces plasma retinol concentration 18, 29. 
 
2.1.5. Immune response to TB 
 
     The variety of genetic and other risk factors for developing active TB underscore the 
complex relationship between the host immune system and TB infection 30. The host 
protective immune mechanism depends critically on the interaction and cooperation between 
monocytes, macrophages and T-lymphocytes and their cytokines 31. Following TB exposure, 
healthy individuals mount cell-mediated immune response. The immune response initially 
involves the uptake of bacterium into macrophages as part of the non-specific innate immune 
response, and later recruitment of T-lymphocytes, the cellular immune response 6, 32.  
 
     The lifetime risk of conversion from latent to active TB is around 5% to 10% in healthy 
population 33, but this can rise to around 50% in immunocompromised population 34. 
Dietary deficiency causes thymic atrophy and impairs the generation and maturation of T-
lymphocytes 18. Undernutrition may selectively compromise portions of the cell-mediated 
immune response by reducing the expression of interferon gamma (IFN-) and tumor necrosis 
factor alpha (TNF-) 35. 
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2.1.6. Vitamin D and TB 
 
     A role of vitamin D in resistance to active TB has been known for more than 100 years 6. 
Vitamin D was used to treat TB in the pre-antibiotic era, when special sanatoria were built in 
sunny locations, such as the Swiss Alps 14. Vitamin D is required for macrophage activation 
and blocks M. tuberculosis proliferation 35, 36. Resistance to infection may be determined 
genetically through the ability of vitamin D to activate macrophages. Effects of vitamin D are 
mainly determined through a vitamin D receptor (VDR), which has common polymorphisms 
to influence VDR activity. Polymorphisms are potentially the means of genetic susceptibility 
to active TB 37. Genetic variations in the VDR were identified as a major determinant of the 
risk for TB 38. 
 
     Vitamin D can be formed mainly via exposure to sun. It can also be consumed as 
cholecalciferol (vitamin D3) in oily fish and vitamin D fortified foods 39 or ergocalciferol 
(vitamin D2) in ultraviolet B (UVB) treated mushroom 40. Both cholecalciferol and 
ergocalciferol are activated by the liver and kidney 6, 39 into 25-hydroxy (OH) vitamin D 
and 1,25(OH)2 vitamin D, respectively.  
 
     Vitamin D deficiency (VDD) occurs when there is a lack of sun-exposure combined with 
low dietary intake of vitamin D.  The deficiency of vitamin D contributes to the acquired 
susceptibility to TB infection and allows the disease to progress to the active form 6, 41. The 
combination of a specific genotype with VDD is suggested to strongly predispose a person 
with latent TB to active disease 30. Rifampin and isoniazid treatment may alter vitamin D 
metabolism and influence the polymorphisms during treatment as well 42. Thus,  
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supplementation with vitamin D may be necessary where sun-exposure and diets are 
insufficient. However, further research on the impact of vitamin D supplementation during TB 
treatment is needed 6.  
 
2.1.7. Mushrooms and vitamin D 
 
     Mushrooms are fungi and belong to the division of Basidiomycota 43. They have different 
biological entities compared to plants and animals, despite being considered a vegetable from 
a culinary perspective 44. Consumption of mushrooms is rapidly increasing worldwide. The 
most commonly consumed mushrooms are Agaricus bisporus, Pleurotus ostreatus and 
Lentinula edodes which together comprise approximately three-quarters of all mushroom 
consumed 45. In Ethiopia, wild mushrooms are harvested in forests during rainy season. 
However, cultivation of oyster mushroom is a new activity in the country in which it is used as 
a means of income 46. 
 
     The presence of both ergosterol and vitamin D2 in mushrooms was first reported in the early 
1930s 44, 47. Retail fresh mushrooms have negligible amount of vitamin D2 48. But when 
exposed to UVB radiation, ergosterol in the mushroom is transformed to pre-vitamin D2, which 
is then thermally isomerised in a temperature-dependent process to ergocalciferol, commonly 
known as vitamin D2 43, 44. Vitamin D2 from mushrooms is as effective as supplemental 
vitamin D2 44  as well as vitamin D3 49 in raising and maintaining the serum 25(OH)D 
concentration.  Vitamin D2 is relatively stable during storage and cooking processes 44.  
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2.2. Scope of the work 
     The emergence of drug resistant strains of M. tuberculosis, mainly due to poor adherence to 
lengthy treatment, complicated the control of TB even more. TB affects mainly males and 
young adults who are the productive power of economy and have major contribution for food 
and nutrition security particularly in developing countries. There is bidirectional interaction 
between nutrition and TB. Nutrition plays a big role in the immune system which is critical to 
combat TB. TB, in turn, leads to undernutrition by increasing nutritional requirements, 
changing metabolic processes, causing loss of appetite, and decreasing food intake. Protein-
energy undernutrition and micronutrient deficiencies increase the risk of TB. Despite such 
interaction, the current management program for TB has given less attention to nutrition. In the 
case of Ethiopia, there is a wide gap of research on nutritional problems of TB patients. Thus, 
understanding the underlying nutritional situation has immense value in designing appropriate 
interventional strategies that can support the treatment of TB.  To put in nutshell, this doctoral 
thesis has given due consideration on nutrition and TB where the scope of the work has been 
concisely described by formulating the following research questions. These questions were the 
bases for the general discussion and conclusion of the thesis.   
Research Questions 
Nutritional situation- What are the dietary patterns of the communities in the study area? 
Micronutrients- Which micronutrients are predominantly deficient among TB patients? 
VDD – Why do TB patients in Africa face the challenge of vitamin D deficiency albeit year-
round-sunshine?  
Mushroom – Could sun-exposed mushroom be used as an alternative nutritional resource of 
vitamin D? 
Vitamin D-TB – What are the roles of vitamin D on the treatment outcomes of TB? 
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2.3. Aims and outlines of the thesis 
 
     The aim of this doctoral thesis was to deal with the nutritional situation of the people with 
and without TB and come-up with solutions that could support the effort of fighting against 
TB. In order to understand the relationship between nutrition and TB, in fact there is a need to 
study the nutritional situation of patients with TB before and after infection. However, it is 
unethical to let the people, who are involved in the study, get the infection of TB. Rather we 
prefer to assess the dietary patterns of the people with and without TB and identify the risks of 
micronutrient deficiencies in the communities (Paper 1). We identified vitamin A and zinc 
deficiencies, protein-energy malnutrition and low nutritional status in TB patients (Paper 2). 
The problem of vitamin D provoked our attention. Sunshine, which is very important to 
synthesize vitamin D under the skin, is available in Africa through-out the year. But we wonder 
why TB patients in this continent suffer from VDD. For this reason, we systematically 
reviewed the extent of VDD together with the major risk factors among TB patients in the 
continent (Paper 3). To address the deficiency of vitamin D, we opt to look for locally available 
food resources. Having the potential for vitamin D content, cheap price and easily available in 
the local market of Ethiopia, we undertook a study on mushroom.  In this study, the impact of 
sun-exposure on the content of vitamin D2 in oyster mushroom was assessed (Paper 4). 
Moreover, a study on the effects of vitamin D2 on the treatment outcomes of TB was performed 
by providing sun-exposed oyster mushroom for patients with TB (Paper 5). 
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Abstract
Background: Dietary patterns are the quantities, proportions, variety or combinations of different foods and beverages in diets, and the frequency with which they are habitually consumed. In Ethiopia, information on the dietary patterns and association of the proxies of dietary adequacy and quality with nutritional outcomes is scarce. The aims of this paper were to assess the interactions between dietary patterns, nutritional 
adequacy, nutritional quality and the risk of micronutrient deficiencies, and to highlight their implications in nutritional interventions.   
Methods: A community based cross-sectional study was carried out in North Shewa zone of Amhara Regional State, central Ethiopia from December 2014 to February 2015. Multistage sampling techniques were employed to recruit participants and 640 subjects involved in the study. Data were collected using structured and seven-day recall questionnaires. Chi-Square test, Kruskal-Walis test, Spearman correlation, multiple linear and multinomial regression models were used for inferential analyses. 
Results: The main dietary patterns included cereals, vegetables and legumes. Animal Source Foods (ASF) was consumed by 35.4% of participants. The median (range) of Food Variety Score (FVS) and Diet Diversity Score (DDS) were 16 (8-25) and 3.43 (1.14-5.57), respectively. About 28 % of subjects were malnourished. FVS had a positive correlation with DDS (r=0.502, p<0.001) and Body Mass Index (BMI) (r=0.145, p<0.001). DDS had also a positive correlation with BMI (r= 0.19, p<0.001). Family size and educational status were identified as determinant factors for FVS, but the 
later had a significant influence on DDS. The risks of vitamin A and iron deficiencies were 60.3% and 86.3%, respectively. The consumption of food 
groups rich in vitamin A and haem iron were significantly different across FVS and DDS (p<0.05).
Conclusions: Dietary inadequacy, poor nutritional quality and high risk of micronutrient deficiencies were identified. These underlined the implications of nutritional interventions in central Ethiopia. 
Keywords: dietary patterns; micronutrients; FVS; DDS; BMI; Ethiopia
Abbreviations: ASF – Animal Source Foods; BMI – Body Mass Index; DDS – Diet Diversity Score; FVS – Food Variety Score; LL – Lower Limit; OR - Odds Ratio; UL – Upper Limit; UNICEF – United Nations Children’s Fund; WHO – World Health Organization. 
BackgroundDietary patterns are the quantities, proportions, variety or combinations of different foods and beverages in diets, and the frequency with which they are habitually consumed. The dietary patterns’ approach considers the inherent interactions between foods and nutrients in promoting either health or increasing disease risk [1]. Until quite recently, there has been extensive focus on the quantity of food produced and consumed in food security rhetoric and in policy and decision-making arenas and much less attention given to the nutritional quality of foods and diets [2].
Nutritional deficiencies are not only the result of inadequate food consumed, but also of poor dietary quality and diversity despite adequate calories in many cases [3]. The prevalence of diseases associated with a poor-quality diet is increasing in Ethiopia. Even though most people consume plant based foods, diets low in fruits and vegetables are found to be the most common risk factors contributing to a large portion of diet-related Non-Communicable Diseases (NCD) [4, 5, 6, 7]. In 2013, more than a third (35.1%) of all deaths in Ethiopia was caused by NCDs [7]. The emergence of NCDs imposes another burden on the country’s health system while it is still striving to address infectious diseases and under nutrition. 
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Implication for Nutritional Intervention in Ethiopia Copyright: © 2018 Keflie TS, et al.Understanding the dietary patterns and evaluating their qualities are essential for nutritional intervention. The quality of diet can be assessed using a simple score of foods variety and dietary diversity [8]. Food variety is expressed as the number of biologically distinct foods eaten over a designated period. It minimizes the adverse consequences of food on health; and 
reduces the risk of NCDs [9]. It is usually quantified by the number of food items compared with the number of nutritious food groups known as dietary diversity [10, 11]. Assessing Food Variety Score (FVS) is a quick, simple and low-cost method of determining the nutritional adequacy of a diet. It is believed that a nutritionally adequate diet is best achieved by consuming a diverse range of foods [12]. Likewise, individual Diet Diversity Score (DDS) is a simple proxy measure of the nutritional quality of individual’s diets, particularly that of 
micronutrient adequacy of a diet [13]. Both FVS and DDS reflect the quality of the diet. Scores of dietary diversities have been positively correlated with macro and micronutrient adequacy of the adolescents and adults [9, 14, 15]. Savy et, al. described the importance of studying the association between proxies of overall dietary quality and nutritional outcomes [8]. Workicho et, al. also highlighted the need of tracking dietary quality and progress in nutritional outcomes in a population to develop timely interventions [16]. Until recent time, very few studies have been conducted in 
Ethiopia in relation to balanced and diversified diets. Of these studies, none has attempted to point out the implication of dietary 
patterns and risks of micronutrient deficiencies on nutritional 
intervention. Therefore, the aims of the present study were: 
• to assess the dietary patterns, nutritional adequacy and nutritional quality of the populations; 
• to examine their relationship with nutritional status; and 
• to describe the implications of the outcomes in nutritional interventions in Ethiopia.
Materials and Methods
Study Area and SubjectsThis study was conducted as a community based cross-sectional study in North Shewa zone of Amhara Regional State, Central Ethiopia from December 2014 to February 2015. Based on the 2007 census, 928,694 men and 908,796 women with a total of 1,837,490 people inhabited in this area [17]. Multistage sampling techniques were used to recruit study subjects. First, all kebeles, which are the smallest administrative unit, were 
stratified into urban and rural settings. Second, four kebeles from urban and three kebeles from rural settings were selected by simple random sampling technique. Third, households were included from each kebele by systematic random sampling 
technique. The first household was selected by a lottery system and then, every third household was included in the study. Lastly, one study subject was randomly selected from each household.The criteria to include study subjects were age above 18 years, 
living in the house for at least 6 months and willing to participate in the study. Subjects who were absent during the survey, 
disabled, seriously ill or had some difficulty of communication were excluded.  Single population proportion formula was used to determine the sample size. Taking the assumptions of 50% 
dietary intake below average DDS with 95% confidence interval, 4% margin of error and 10% drop out rate, a sample size of 660 was obtained. However, we recruited 100 study subjects from each kebele with a total of 700 study subjects to participate in the study.  
Data collectionThe data were collected by seven health extension workers who have been graduated with diploma (2 to 3 years’ college training) in nursing. Questionnaires which comprised of different parts were translated into Amharic, the local language. In the structured questionnaire, there were socio-demographic and anthropometric parts, whereas; in the dietary diversity questionnaire, the dietary intake assessment part was included. All interviewers were given one-day training on the content of the questionnaires and on the techniques, how to ask the list of ingredients for composite dishes and how to probe for meals and snacks not indicated in the list of 7-day recall. Before instigating the interview, each of them practiced on the questionnaire to alleviate ambiguity and minimize errors as much as possible.
Dietary AssessmentSeven-day recall of dietary intake was carried out on the study subjects. The dietary diversity questionnaire, which was adapted from the guidelines for measuring household and individual dietary diversity, was employed for face-to-face interview [12]. 
Each subject was asked to describe what he or she ate and/or drank for breakfast, snack, lunch, snack and dinner whether at home or outside the home for the past seven days. The interviews included a detailed description of foods consumed, the ingredients used, the cooking method, and brand names (for packed foods). The food items were subsequently transformed into food groups and their frequencies of consumption were computed and used for further analyses Table 1. 
Food Variety Score (FVS)FVS was measured using simple count of individual food items consumed during the seven days. Food variety checklist developed by Savige et, al. was used to score the food items [12]. Each type of food consumed is scored once over a week time. The maximum score would be 57. Quantities smaller than 1-2 
tablespoons (except for fats and oils) do not represent a sufficient 
quantity to rate FVS. The results of FVS were categorized into five 
dietary adequacy groups: very poor (<10 FVS per week), poor (10-19 FVS per week), fair (20-24 FVS per week), good (25-30 FVS per week) and very good (>30 FVS per week) [12].
Diet diversity score Individual DDS was calculated as the number of food groups 
consumed during the first day recall. These food groups were 
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Table 1: Food groups used for dietary diversity score*
Number Food groups Subgroups
Scores (if consumption is: 
yes=1, otherwise: no=0)
1 Starchy staples
Cereals, grains, white roots and tubers 1 or 0
2 Dark green vegetables
Locally available vitamin A rich vegetables such as kale, lettuce, spinach and wild forms such as samma (stinging nettle) 1 or 0
3
Other vitamin A rich fruits and 
vegetables
vitamin A rich fruits (mango), vegetables (carrot) and tubers (vitamin A blended sweet potatoes) 1 or 0
4 Other fruits and vegetables
Fruits: such as avocados, banana, dates, etc. 1 or 0
Vegetables: such as cabbage, onion, garlic, green pepper, tomatoes, etc.
5 Organ meat
Red organ meats such as liver, kidney, heart and any processed organ meats 1 or 0
6 Meat and fish
Beef, lamb, goat meat, chicken and 
fresh fish
1 or 0
7 Eggs Chicken eggs, quail eggs 1 or 0
8 Legumes, nuts and seeds
Legumes/pulses: such as beans, peas, lentils, peanuts, etc. 1 or 0
Seeds: such as oil seeds and pumpkin seeds
9 Milk and milk products
Dairy products such as milk, butter, sour milk, butter milk, cheese and whey 1 or 0
*Adapted from the guidelines for measuring household and individual dietary diversity [13].based on the guidelines for measuring household and individual dietary diversity Table 1. The score for individual diet diversity goes from 0 to 9 [13]. The percentages of the consumption of food groups rich in micronutrients such as vitamin A or iron were calculated using the food groups of DDS
Anthropometric MeasurementsThe weights of the subjects were measured while they were dressed in light clothes to the nearest of 100g. SECA personal weighing scale (used by UNICEF) was employed for measurement. The heights of the subjects were measured using 
tape meter fixed on the wall without shoes to the nearest of 0.1 cm.  For the calculation of Body Mass Index (BMI), the weight of the subject (in kg) was divided by the height (in meter) squared 
of the subject.   BMI was described as underweight (<18.50 kg/m2), normal weight (18.50-24.99 kg/m2), overweight (25-30 kg/m2) and obese (>30 kg/m2) [18].
Statistical AnalysisStatistical analysis was carried out using IBM SPSS version 23 statistical program. Continuous data were checked for normality using Kolmogorov-Smirnov test. When data were not normally distributed (p>0.05), nonparametric tests were used. In descriptive summaries, median (range) and percentages were used to present the data. Inferential statistics were also employed. The difference between proportions of categorical variables was examined by Chi-Square test. Kruskal-Wallis test was used to determine the differences between socio demographic variables on FVS, DDS and BMI. Bivariate analyses were carried out to test the links between socio demographic variables and dietary scores. The socio 
demographic variables which were significantly linked to either dietary scores or BMI were selected as potential confounders (P < 0.15). Significant variables subsequently included into the 
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between variables (P < 0.05). Multiple linear regression model was employed to differentiate the independent predictors of FVS and DDS after adjusting for confounding factors.Spearman correlation was used to examine the association between FVS, DDS, BMI, age and average meal frequency. The relationships between the groups of FVS, DDS and BMI were analysed using a multinomial logistic regression model. Odds Ratio (OR) was used to report the strength of association between the proportions of vitamin A and haem iron rich foods 
consumption between urban and rural areas. Unless specified, p 
value < 0.05 was considered as statistically significant.
Results
Socio-demographic studyThe study was undertaken in seven kebeles in urban and rural areas of North Shewa zone of Amhara Regional State, Central Ethiopia. A total of 700 participants were recruited. But, 640 were involved in the study with a response rate of 91.4%. The remaining 8.6% were excluded because of their refusal and absence during the study period.  Table 2 presents the socio-demographic characteristics of the study participants. Most participants belonged to Amhara ethnic group (93.5%) and Orthodox Tewahido Christian (89.8%). The median age 
Table 2: Socio demographic characteristics
Variables Percent
Living place (n=640) Urban 54.8
Gender (n=640) Female 44.7
Age Median: 35, Range (18, 76)
Religion
(n=616)a
Orthodox Tewahido 89.8Muslim 3.7Protestants 4.4Others 2.1
Ethnicity
(n=631)b
Amhara 93.5Oromo 3.2Gurage 0.8Tigre 2.5
Occupations
(n=613)c
Farmers 34.6Government Employees 21.7Non-Government Employees 3.9Private 25House wife 10.6Retired 0.8Students 3.4
Education
(n=620)d
Illiterate 15Primary 37.9Secondary 17.9Tertiary 27.3Religious teaching 1.9
Marital Status 
(n=610)e
Single 23.1Married 68.7Divorced 5.4Widowed 2.8
Family size  
(n=640)
1 to 3 57.54 to 6 37.27 to 10 5.3
Missed participants: 24 (a), 9 (b), 27 (c), 20 (d) and 30 (e)
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Dietary patterns
About 130 food items were identified in the study areas 
(See additional file 1). The main dietary patterns were included cereals, vegetables and legumes. Almost all subjects consumed starchy staples (99.7%) and about 58% consumed legumes 
cooked with oils and fats (99.2%) for the whole week Table 3. In every day meal, 95.6% consumed the food group of other fruits and vegetables Table 4. Dairy products (62.4%), dark green vegetables (49.69%), meat (37.9%) and, other vitamin A rich fruits and vegetables (30.35%) were consumed at least once in a week Table 4, 5. On the other hand, organ meat (2.6%) and 
fish (3.6%) were seldom consumed by the subjects. The food 
consumption patterns were significantly different between urban and rural areas (P<0.05). 
Additional file 1: Food items identified in North Shewa, Ethiopia
Cereals and grains Legumes/ pulses
Ambasha, circular flat bread dough Kinche, boiled splitted barley served with butter Ashuk, roasted and boiled faba beanAnebabero, double injera covered with butter and chilli in the middle Kinche, boiled splitted wheat served with butter Bokolt, germinated faba beanAtmit, very thin barley porridge Kita, unleavened flat barley bread Endushdush, soaked and roasted faba beanAtmit, very thin wheat porridge Kita, unleavened flat teff bread Fool, pureed stewed faba beanBesso, roasted and milled 
barleyflour served with butter
Kita, unleavened flat wheat bread Nifro, boiled chickpeaBiscuit, homemade fried dough bread Kolo, roasted and mixed barley, chickpea and pea Nifro, boiled faba beanBonbolino, homemade fried dough bread containing sugar Kolo, roasted and mixed wheat, chickpea and sunflower Nifro, boiled faba bean and maizeBread, wheat Kolo, roasted barley Nifro, boiled faba bean and wheatCake Kolo, roasted chickpea Shorba, lentil, carrot, and macaroni soupChechebisa, pieces of barley bread mixed with butter Kolo, roasted pea Shorba, lentil, pea and carrot soupChechebisa, pieces of wheat bread mixed with butter Kolo, roasted wheat Siljo, fermented faba bean, sunflower and mustard slurryCukis Macaroni Wot, beyeayinet -varieties of stewsDabo-kolo, very small size roasted bread dough Nifro, boiled wheat Wot, faba bean, chili, onion and oil stew
Fetira, fried filo dough cooked with egg and covered with honey Pizza Wot, pea flour, onion, chili and oil stew
Firfir, pieces of barley injera with stew Porridge, barley served with butter and chili Wot, splitted lentil, chili, onion and oil stew
Firfir, pieces of bread with stew containing butter Porridge, wheat served with butter and chili Wot, splitted pea, onion, chili and oil stew
Firfir, pieces of teff injera with stew containing beef Sambusa Wot, splitted pea, onion, oil and turmeric stew
Firfir, pieces of teff injera with stew containing butter Sandwich, sliced bread with fried egg in the middle Wot, tegabino - pea flour, onion, chili, garlic and oil stew
Firfir, pieces of teff injera with stew containing dried beef Spaghetti, pasta Wot, whole lentil, onion and oil stew
Fitfit, pieces of teff injera mixed with beef broth Steamed rice
Fitfit, pieces of teff injera mixed with 
pea flour, onion and oil sauce
Tirosho, flat barley bread dough covered with butter
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Fitfit, pieces of teff injera mixed with 
sunflower sauce
Tirosho, flat wheat bread dough covered with butterInjera, barleyInjera, teffInjera, wild oatVegetables and tubers Meat Sugar / ConfectionaryAtkilt, mixed vegetables and fruits Beef with steamed rice SugarBula - false banana porridge served with butter Dulet, semi roasted organ meat (sheep and goat) with butter HoneyEthiopian kale Kikil, boiled beef Sugar caneFried potatoes Kikil, boiled egg Salts and spicesKariya, green pepper Kikil, boiled goat meet SaltKariya, sinig - green pepper stuffed with onion and oil Kikil, boiled mutton Bird’s eye chiliKikil, boiled potatoes Kitfo, raw or sautéed minced beef mixed with chili and 
clarified spicy butter
Bishop’s weedKikil, boiled sugar beet Milas na senber, roasted cow tongue and rumen Black cuminLettuce with onion, oil and aceto vinegar Raw beef CardamomRaw tomatoes with onion, green peppers and oil Roasted beef CinnamonSamma, Stinging nettle Roasted goat meat ClovesShorba, vegetables soup Roasted mutton Coriander seedsSils, roasted tomatoes with onion, oil and green pepper Shoriba, beef broth RueSwiss chard Wot, beef with kale Alcohol beveragesWot, beetroot, onion and oil stew Wot, minced beef and egg stew Tela, local beerWot, cabbage, onion and oil stew Wot, red beef stew Keribo, hops free local drinksWot, cabbage, potatoes, carrot, onion and oil stew Wot, red chicken stew Tej, mead honey or sugary wineWot, carrot, onion and oil stew Wot, red dried beef stew Areke, homemade hard liquourWot, kale, garlic, onion, and oil stew Wot, red mutton stew WineWot, potatoes, onion, chili and oil stew Eggs BeerWot, pumpkin, chili, onion and oil stew Chiken eggs
Wot, stinging nettle and barley flour stew Dairy productsWot, Swiss chard, onion and oil stew Aguat, wheyWot, tomatoes, chili, onion and oil stew Arera, butter milk
Fruits Ayib, CheeseAvocado Butter
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Banana MilkJuice, mixed YoghurtJuice, avocado FishJuice, mango Fresh fishMango Fats and oilOrange OilTemir, dates ButterTringo, citron
Table 3: Percentages of the consumption frequencies of starchy staples, legumes and others per week
Food groups Urban (n=347) Rural (n=289) Total (n=636) P-value
Starchy staples
1-3 days 0 0.7 0.3 0.206The whole week 100 99.3 99.7
Legumes, nuts and seeds
None 0.6 0 0.3 <0.001*1-3 days 6.1 1.4 3.94-6 days 50.1 23.2 37.9The whole week 43.2 75.4 57.9
Oils and fats
None 0.9 0 0.5 0.0861-3 days 0 0.7 0.3The whole week 99.1 99.3 99.2
Spices, condiments and 
beverages
None 0.3 0 0.2 0.2851-3days 0 0.7 0.34-6days 0.3 0.7 0.5The whole week 99.4 98.6 99.1
*Statistically significant
Table 4: Percentages of the consumption frequencies of fruits and vegetables per week
Food groups Urban (n=347) Rural (n=289) Total (n=636) P-value
Dark green vegetables
None 46.4 57.1 51.3 0.001*1-3 days 42.9 39.4 41.44-6 days 8.6 3.5 6.3The whole week 2 0 1.1
Other vitamin A rich fruits 
and vegetables
None 58.5 83 69.7 <0.001*1-3 days 35.2 15.9 26.44-6 days 4.6 0.7 2.8The whole week 1.7 0.3 1.1
Vegetables
None 0.6 0 0.3 <0.001*1-3 days 0.6 0.7 0.64-6 days 3.4 26 13.6The whole week 95.4 73.4 85.5
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Fruits
None 85.1 97.2 90.6 <0.001*1-3 days 13.4 2.8 8.64-6 days 0.9 0 0.5The whole week 0.6 0 0.3
*Statistically significant
Table 5: Percentages of the consumption frequencies of meat, organ meat, eggs and dairy per week
Food groups Urban (n=347) Rural (n=289) Total (n=636) P-value
Meat
None 47.6 79.6 62.1 <0.001*1-3 days 40.3 19.4 30.84-6 days 11 1 6.5The whole week 1.2 0 0.6
Organ meat
None 95.7 99.7 97.5 0.003*1-3 days 4 0 2.24-6 days 0.3 0 0.2The whole week 0 0.3 0.2
Eggs
None 73.2 93.8 82.5 <0.001*1-3 days 25.9 6.2 114-6 days 0.9 0 0.5
Dairy products
None 44.4 29.4 37.6 <0.001*1-3 days 34.3 43.6 38.54-6 days 19 26 22.2The whole week 2.3 1 1.7
*Statistically significant
Meal FrequencyThe median meal frequency was 3 (range= 1 to 5). Comparing its distribution, average meal frequency had statistically 
significant difference across urban and rural areas (P<0.001).
Food variety score The median FVS was 16 (range= 8 to 25) per week. Urban 
and rural dwellers had a significant difference in FVS (P<0.001) Table 6. More than 98% of participants had poor and fair FVS in 
the areas Figure 1. There was also a significant FVS difference between socio demographic variables such as occupation 
(P<0.001), educational status (P<0.001) and family size 
(P<0.001). Spearman’s rank correlation showed that FVS had a 
positive association with DDS (r= 0.502, P<0.001) and BMI (r= 
0.145, p < 0.001). However, it had a negative correlation with average meal frequency (r= -0.102, P = 0.01). The results of regression model revealed that educational status and family size 
had significant influences on FVS (P< 0.05) Table 7.
  Figure 1: Food variety scores in different locations
Diet diversity scoreThe median DDS was 3.43 score (range = 1.14 to 5.57). The 
DDS of urban and rural dwellers was significantly different (P=0.004) Table 6. Nearly, 41% of subjects had 2.50-3.50 scores 
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Table 6: FVS, DDS and BMI distribution across urban and rural settings
Variables Urban Rural P-valueN Mean SD N Mean SD
FVS 348 17.09 3.35 289 15.31 2.51 <0.001*
DDS 348 3.63 0.63 289 3.45 0.38 0.004*
BMI 340 22.96 3.86 250 22.31 3.2 0.028*
  *Statistically significant
Table 7: Prediction of the effect of explanatory variables on dietary scores and BMI using multiple linear regression model
Explanatory variables
FVS DDS BMI
β (standardized) P-value β (standardized) P-value β (standardized) P-value
Occupations 0.046 0.247 0.01 0.811 0.075 0.082
Educational status 0.198 <0.0001* 0.122 0.004* 0.054 0.230
Family size -0.171 <0.0001* -0.045 0.292 -0.009 0.836
R2 0.094 0.021 0.01
*Significant contribution
Table 8: Vitamin A rich food groups used in vitamin A analysis
Pro-vitamin A Pre-vitamin A
Food group Food item RAE (µg/100g)* Food group Food item RAE (µg/100g*
Vitamin A rich 
vegetables or tubers
Carrot, raw 835
Organ meat
Liver (cattle), raw 4968Carrot, cooked 852 Liver (cattle), cooked 9442Sweet potato (orange or dark yellow), raw 709 Liver (sheep), raw 7391Sweet potato (orange or dark yellow), cooked 1043 Liver (sheep), cooked 7491
Pumpkin, raw 426 Kidney (cattle), raw 419Pumpkin, cooked 288 Kidney (cattle), cooked 0
Dark green leafy 
vegetables
Kale, raw 500
Eggs
Kidney (sheep), raw 95Kale, cooked 681 Kidney (sheep), cooked 137Spinach, raw 469 Chicken eggs, raw 160Spinach, cooked 524 Chicken eggs, cooked, fried 219Lettuce, raw 370 Quail eggs 156
Vitamin A rich fruits
Apricots 96
Milk and milk 
products
Milk, low fat 71Mango 54 Butter 684Papaya 47 Sour milk, cultured 124Butter milk, whole 47Cheese, fat free 11
Whey, acid fluid 2
*USDA [42].
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Table 9: Haem iron rich food groups used in iron analysis
Food groups Food items Haem iron (mg/10)* Food groups Food items
Haem iron 
(mg/100g)*
Organ meat
Liver (cattle), raw 4.9
Flesh meat
Beef (meat and by products), raw 5.67Liver (cattle), cooked 6.54 Beef, chuck for stew, all grades, cooked 2.96Liver (sheep), raw 7.37 Goat, raw 2.83Liver (sheep), cooked 8.28 Goat roasted 3.73Kidney (cattle), raw 4.6 Lamb, ground, raw 1.55Kidney (cattle), cooked 5.8 Lamb, ground, cooked 1.79Kidney (sheep), raw 6.38 Chicken meat, stewed 1.17Kidney (sheep), cooked 12.4 Fish and seafood Catfish, raw 0.3Heart (cattle), raw 4.31 Catfish, cooked 1.43Heart (cattle), cooked 6.38 Tilapia, raw 0.56Heart (sheep), raw 4.6 Tilapia, cooked, dry heated 0.69Heart (sheep), cooked 5.52 Mixed species, raw 0.89Mixed species, cooked 1.14
*USDA [42].and 55% had 3.51-4.50 scores. Altogether, 96% of subjects had scores below average DDS (4.5 out of 9 DDS). The bivariate 
analysis showed that there was statistically significant mean DDS difference between age group (P= 0.028), occupation (P= 0.027), 
educational status (<0.001), marital status (P=0.018) and family size (0.004). DDS had also a positive correlation with BMI (r= 0.190, P< 0.001) and average meal frequency (r= 0.219, P< 0.001). After controlling for occupations and family size, educational 
status had a significant influence on DDS Table 7. 
Vitamin A and haem iron indicatorsTable 8 and 9 indicate the food groups that were used for the analyses of the consumption of vitamin A and haem iron rich foods. Vitamin A can be obtained from foods, either as preformed retinoids (with biological activity of retinol) in animal products 
or as pro-vitamin A Carotenoids, mainly β-carotene in plant products.  Vitamin A and haem iron intake are usually expressed 
as retinol activity equivalent (RAE) and mg/100g, respectively. The recently accepted conversion factor for pro-vitamin A such 
as β-carotene is 12, for β-cryptoxanthin and α-carotene is 24, 
meaning that 12µg β-carotene and 24 µg β-cryptoxanthin or 
α-carotene, respectively, supposedly exert the activity of 1µg vitamin A [19, 20].Percentages for consumption of vitamin A and haem iron 
rich food groups were estimated using the first day data. Of 640 participants, 39.7% consumed either plant or animal source 
of vitamin A and 13.7% consumed organ meat, flesh meat or 
fish source of haem iron. In other words, the risk of vitamin A 
deficiency was 60.3% and about 86% of the consumers did not 
obtain animal source of iron. The consumption of Animal Source Food (ASF) was 35.4%.The odds of consuming all types of vitamin A rich food groups in urban settings were 1.69 times higher than the odds of rural settings. Similarly, haem iron rich food groups were 9 times more likely to be consumed in urban settings than rural settings Table 10. As indicated in Table 11, the consumption of food groups rich 
in vitamin A and haem iron were significantly different across FVS and DDS (P<0.05).
Vitamin D rich foods and iodized salt consumptions
Vitamin D rich food sources such as fish, organ meat and sun treated mushroom were consumed by 3.6%, 2.6% and 4.0% of participants, respectively. This indicated that more than 95% 
of the study participants were at risk of vitamin D deficiencies. Salt iodization is basically a safe and effective strategy for the 
prevention and control of iodine deficiency disorders. Salt consumption rate was very high, however, only 69.5% of subjects used iodized salt in their diet. This was far below the target of WHO iodine coverage (90%) [21]. 
Food taboosAbout 20% of participants avoided one or more food items from their diet. Bread (3.1%), milk (2.8%), fermented injera (1.7%), raw beef (1.7%) and tomatoes (1.3%) were the major food items reported as food taboos. Table 12 shows the percentages of avoided food items from consumption.
Nutritional statusAnthropometric measurements showed that the median 
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Table10: Indicators for the consumption of vitamin A and haem-iron rich food groups
Urban vs Rural 95% CI
Food groups
Percent 
(n=640)
Urban Rural
Pearson             
Chi-Square P-value
Odds 
Ratio
LL UL
Plant Vitamin A  
(Pro-vitamin A)
Yes 15.8 81 20 30.78 <0.0001* 4.03 2.39 6.71No 84.2 270 269
Animal Vitamin A (Pre-vitamin A)
Yes 29.5 109 80 0.78 0.377 1.18 0.83 1.65No 70.5 242 209
All Vitamin A
Yes 39.7 159 95 9.84 0.002* 1.69 1.21 2.31No 60.3 192 194
Animal Source Food
Yes 35.5 142 85 8.13 0.004* 1.63 1.16 2.25No 64.5 209 204
Haem Iron
Yes 13.7 79 9 49.86 < 0.001* 9.04 3.61 18.2No 86.2 272 280
*Statistically significant
Table 11: Vitamin A and haem iron rich food groups consumption across FVS and DDS
Vitamin A consumption Haem iron consumption
Scores Categories
Yes 
n=251
No 
n=386
Chi-square 
test
P-value
Yes    
n=88
No 
n=549
Chi-square 
test
P-value
Food variety 
score
< 10 FVS/week 0.8 1.3 13.15 0.004* 0.0 1.3 16.01 0.001*
10-19FVS/week 75.3 85.5 68.2 83.6
20-24FVS/week 23.5 13.2 31.8 14.9
25-30FVS/week 0.4 0.0 0.0 0.2
Diet diversity 
score
< 2.50 DDS 0.8 0 44.09 < 0.001* 2.3 0 17.6 0.001*2.50-3.50 DDS 27.1 50.5 29.5 43.23.51-4.50 DDS 64.9 47.9 63.6 53.24.51-5.50 DDS 7.2 1.6 4.5 3.6
*Statistically significantbody weight, height and BMI were 60 (range= 37 to 89) kg, 1.65 
(range= 1.2 to 1.9) m and 22.05 (range= 13.49 to 40.21) kg/m2, respectively. Men and women had statistically significant difference in body weight and height measurements (P < 0.001). Our study revealed that 6.9% of subjects were underweight, 17.1% were overweight and 4.1% were obese. This implied that the proportion of malnutrition in the area was 28.1%. Unlike body 
weight and height, men and women did not have a significant difference in BMI (P= 0.164). But, there was a statistically 
significant difference in BMI across urban and rural settings (P=0.028) Table 6. The link between BMI and DDS was limited.
Discussion
Dietary Patterns
We identified about 130 food items. The major dietary patterns composed of cereals (teff, wheat and barley), vegetables (onion, green pepper, tomato and cabbage), legumes (peas, faba bean and lentils), oils (cooking oil) and spices (salt). All these food items are the ingredients of injera and thick stew made from 
flour of roasted legumes (‘shiro wot’). The trend of taking hot beverages (coffee and tea) with sweets (sugar) was habituated 
by almost all people. In line with this finding, other studies also reported cereals, vegetables, legumes and oils as the main staples in Ethiopia [16, 22]. 
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We also identified that the dietary patterns rarely entailed 
food groups containing fish (fresh fish) and organ meat (liver, 
kidney, heart and tripe). Despite abundant resources, fish consumption in Ethiopia is very limited. This is due to cultural factors and poor connections between production areas and markets. Fish is mostly consumed in large towns during periods of religious fasting [26]. There was also a limited access to organ meats. One of the reasons could be infection. Most of the time, livers from cattle and sheep are infected by internal parasites and as the result they are condemned from consumption. 
Our results showed that dietary patterns were significantly 
different in urban and rural settings (P < 0.05). The difference could be attributed to availability and accessibility of food groups. Urban people are very close to the market where much variety of foods could be available. Although all people could not have equal access to food varieties because of affordability, the case for rural people is even worse. Large numbers of rural people are living at subsistence level and far away from the market so that they have less access and economic power to purchase food varieties with high price.
Meal frequencyThe median meal frequency per day was 3 with a range of 1to 5. But, another study reported a range of 2 to 3 meal frequency per day [27]. This implied that the lowest consumption rate was 1 
and the highest was 5. The consumption rate significantly varied in urban and rural areas (P< 0.001). This could be justified by the difference in food groups availability and accessibility in urban and rural settings. 
Food varietiesThe median FVS was 16 per week but the range varied from 8 to 25 per week. Urban dwellers had a higher FVS as compared to 
rural dwellers. Based on the classification made by Savige, et al. 98% of people had FVS between poor and fair dietary adequacy 
[12].  This result is prone to seasonal fluctuation. The scenario could be even worse during low production season in rural settings as the present study was conducted during harvesting season. FVS had a positive correlation with DDS (r = 0.502, 
P<0.0001) and BMI (r = 0.145, P<0.0001). But, it had a negative correlation with average meal frequency (r = -0.102, P=0.01). This inverse association suggested a monotonous type of diet. Besides, Kant explained that consuming some food items more frequently means that other food items are being consumed less frequently [28].Socio demographic characteristics such as educational status and family size were linked to FVS, but their impacts 
were different. Educational status had a positive influence on FVS. This implied that educated persons better understand the 
health benefit of consuming nutritious foods and spend much budget on food varieties. This was corroborated by other studies done in Ethiopia and in Tanzania [16, 29]. On contrary, family 
size had a negative influence on FVS. Increasing the members of family without increasing income could deter the access to food varieties. Income and supply of foods had great impacts on the dietary diversity of food consumed [30]. 
Dietary diversityDietary diversity is a qualitative measure of food consumption which evaluates the dietary quality of the individuals. Based on the guideline for individual DDS nine food groups were used for assessment and the median DDS was 3.43 (range = 1.14 to 5.57). This was comparable with the mean DDS of 3.4 reported by Weldehaweria, et al.  among lactating women in Tigray, Ethiopia [13]. In the same region, another study reported a median of 5 DDS, but 14 food groups were used for evaluation [22]. Hence, 
it is very difficult to compare the three results owing to the difference in study subjects and number of food groups used for counting. The implication of the median 3.43 DDS was that half of the people at least included 3 food groups in their diet. Mostly, starchy staples, vegetables and legumes were involved in the dietary patterns. About 96% of people in the study areas had DDS below an average 4.5. A diet of at least 4 DDS was valid as nutritionally adequate, but below 4 DDS represented poor diversity [32, 33]. DDS was directly associated with BMI and average meal frequency. After controlling for age group, occupation, marital 
status and family size, the influence of educational status on 
DDS was significant.  This was supported by Workicho, et al. and Mbwana, et al. [16, 29]. However, there were reports that showed the inverse relationship between education and DDS [25, 34, 35]. The explanation given was that although some people particularly women were educated; their employment rate was very low and have less income as the result they relied on poor nutrition. 
Vitamin A and iron indicatorsDDS can be used as a proxy indicator to assess the likelihood of achieving micronutrient requirements [16].  Micronutrients can be obtained from vegetables, fruits and Animal Source Foods 
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rich food groups were assessed using the first day data of food consumption. The results showed that 39.7% of people consumed either plant or animal source of vitamin A and 13.7% consumed organ 
meat, flesh or fish as source of haem iron. This implied that the 
remaining 60.3% was at risk of vitamin A deficiency and 86.3% was unable to get haem iron sources of foods. According to WHO 
definition, when food groups with high vitamin A content are consumed less than three times in a week by three fourth or more of vulnerable groups, there is a high risk of inadequate vitamin 
A status [36]. Given this definition, the result of the present study revealed that there were high risks for vitamin A and iron 
deficiencies in Central Ethiopia.
haem iron rich food groups was significantly different across 
FVS and DDS (P < 0.05).  This suggested that people who are consuming less variety of food items and diversity of food groups are less likely to incorporate food groups rich in vitamin A and haem iron in their diet. 
Vitamin D and iodine indicatorsLow intake of vitamin D was realized in the study areas. Very 
few people consumed fish (3.6%), organ meat (2.6%) and sun treated mushrooms (4%). Although vitamin D rich foods are the 
second sources of vitamin D next to sunshine Keflie, et al. in their 
review paper reported the predictors of vitamin D deficiencies in tropical African countries. Taking the predictor factors into 
account, the risk of vitamin D deficiencies could be anticipated to be very high. Iodine consumption was also assessed, and the result revealed that 69.4% of people consumed iodized salt albeit high salt consumption rate. This implied that salt iodization coverage did not reach to at least three fourth of the communities. However, WHO suggested 90% coverage for the prevention and 
control of iodine deficiency disorders [21].  In other words, more 
than one fourth of the people are at risk of iodine deficiency disorders.  
Food taboos
Food taboos were another concern. One fifth of people avoided one or more food items from their diet. The major reasons ascribed to food taboos were culture and health related problems. Some people usually avoided consumptions of raw foods such as tomatoes, vegetables, beef and milk due to their fear for infectious diseases; fermented injera and bread for stomach ache; and eggs and goat meat for cultural reasons.   
Nutritional status
The results of BMI (median=22.05; range= 13.49-40.21kg/m2) illustrated that 28.1% of people were malnourished. Of whom, 6.9% were underweight, 17.1% were overweight and 4.1% were obese. The proportion of overweight people was larger than the proportions of underweight and obese. This suggested that overweight has become a serious public health concern followed by underweight and obesity.  There is a perception among many Ethiopian communities that overweight and being obese are indicators for wealth and health status. BMI had a 
statistically significant difference across urban and rural settings. The proportion of overweight and obesity were like the report of Amare, et al. in Gondar town of Ethiopia (21.3%) [25]. But, the proportion of overweight alone was higher than those reported among adolescent girls in rural Southern Ethiopia (13.8%) [27].This suggested in general that malnutrition is the major public health problem in Ethiopia.After the socio demographic characteristics were controlled, 
the link between BMI and DDS became insignificant. Savy, et al. described that the socio demographic and economic context could reduce the strength of the link between nutritional status and DDS [8]. This was explained that nutritional status was not 
Table 12: Food items avoided from the diet
Food group Food item Percent
Vegetables
Lettuce 0.94Kale 0.63Tomatoes 1.26Beetroot 0.47
Fruits Avocado juice 0.47
Cereals
Bread 3.14Porridge 1.1Roasted wheat 1.1Fermented injera 1.73
Legumes and seeds
Lentils 0.47Linseeds 0.47
Meat and Fish
Raw beef 1.73Goat meat 0.47
Eggs Fried egg 0.47
Dairy products
Milk 2.83Yogurt 0.63Cheese 0.47
Salts and sugar Salt 0.94Sugars 0.47We compared the consumption of vitamin A and haem iron rich food groups in urban and rural settings. The results showed that urban people were nearly 1.7 times and 9 times more likely to consume vitamin A and haem iron rich food groups than rural people, respectively. This, in turn, implied that the risks of vitamin 
A and iron deficiencies would be higher among rural communities than urban communities. This was corroborated by the report of 
Alaofe, et al. that vitamin A and iron deficiencies were high among rural communities particularly women and their childrenin Northern Benin [37]. The consumption of vitamin A and 
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Implication for Nutritional Intervention in Ethiopia Copyright: © 2018 Keflie TS, et al.only determined by the quality of food but also the quantity of the foods consumed.In several studies done elsewhere, height less than 1.45m was used as a cut-off point for determination of stunting in women [39-41]. Based on this threshold, the anthropometric results indicated that 4.6% of people were stunted, of whom three fourth were women. The proportion of stunted women was slightly comparable to the report of 2.2% from a study among lactating women in Tigray, Ethiopia [22]. Even though, the proportion of underweight women was higher than that of men, the nutritional 
status was not significantly different. This showed that both men and women were affected by malnutrition without any difference. And hence, the nutritional intervention measures should give emphasis on both genders.
LimitationsAlthough this study has the strength of dealing with dietary patterns, nutritional adequacy and nutritional quality, the dietary 
assessment instruments used to define the dietary patterns are 
based on self-report and may inflict some levels of report bias. This study does not contain data on seasonal variations of food consumption as it is a community based cross-sectional study.
ConclusionsIn conclusion, the people of North Shewa, Central Ethiopia have cereal and legume based dietary patterns. Almost all of them have poor dietary adequacy and nutritional quality, and 28.1% are malnourished. Overweight and obesity are the upcoming nutritional problems besides under nutrition. Family size and educational status determine FVS. But, the later determines DDS. Related with low frequency of consumptions, the risks for vitamin 
A, vitamin D, iron and iodine deficiencies are very high. All these nutritional problems underlined the implications of nutritional interventions. Therefore, by giving emphasis on the improvement of food and nutrition security, and considering the real situations 
of the area, the following recommendations are made:1. Improving meal frequency, food varieties and diet diversities;
2. Creating awareness of the nutritional benefits of consumption of locally available food items including edible wild plants like stinging nettle (Urticasimensis);3. Demonstrating the idea of balanced diet in the garden or kitchen garden;4. Developing food based dietary guidelines;5. Promoting nutrition sensitive agricultural practices; and6. Promoting micronutrient enriched staple food.
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Background: The link between tuberculosis (TB) and malnutrition has long been recognized. Vitamin A and zinc
deﬁciencies may reduce the host defenses and increase the risk for diseases.
Objective: The aim of the present study was to estimate the diﬀerence in vitamin A and zinc deﬁciencies together
with dietary intakes among pulmonary TB patients and controls.
Materials and methods: A case-control study design was employed to undertake this study in North Shewa,
Ethiopia. Sputum smear examination, high-performance liquid chromatography (HPLC), ﬂame atomic absorp-
tion spectrometry (FAAS), and enzyme-linked immunosorbent assay (ELISA) were used to analyse acid fast
bacilli (AFB), vitamin A, zinc, and C-reactive protein (CRP), respectively. Dietary intake was assessed using a 24-
h recall questionnaire. Mann–Whitney U test, Kruskal–Wallis test, Chi-square, odds ratio (OR), Spearman cor-
relation, and multinomial logistic regression model were computed for data analyses.
Results: In this study, 62 TB cases and 59 controls were included. The proportions of vitamin A deﬁciency among
TB cases and controls were 56.4% and 39.0%, respectively. All TB cases and 92.5% controls were zinc deﬁcient.
The odds of TB cases with deﬁciencies of vitamin A and zinc was 2.3 (95% CI: 1.1 to 4.8)times more likely as
compared to the controls. More than 80% of all participants had below average fulﬁlment of energy and vitamin
A intakes.
Conclusion: Vitamin A and zinc deﬁciencies are severe problems among TB patients. Moreover, undernutrition
determines the development of TB. Therefore, the management programs of TB need to address the problems of
vitamin A and zinc deﬁciencies together with protein-energy malnutrition.
Introduction
Tuberculosis (TB) is an ancient disease caused by Mycobacterium
tuberculosis. Despite the applied eﬀorts for its control, TB is still one of
the major public health challenges. According to the global TB report in
2017, 10.4 million TB cases and 1.67 million TB deaths occurred
worldwide in 2016. Of whom, about 70% of the new cases and more
than 85% of the deaths were reported from South East Asia and Africa
[1]. The report also showed that Ethiopia is one of the top 30 TB burden
countries globally with 182,000 new cases and 30,000 deaths in 2016
[1].
The link between TB and malnutrition has long been recognized;
malnutrition may predispose people to the development of clinical
disease, and TB can contribute to malnutrition [2]. Malnourished
people are also susceptible to a new infection since their immune sys-
tems are debilitated [3]. As key contributors to immune function and
cytokine kinetics, micronutrients such as vitamin A and zinc play a
major role in combating TB [4].
Vitamin A is a fat-soluble vitamin which is needed in small quan-
tities for several metabolic activities in the body [5]. Vitamin A and its
active metabolites are important for growth and diﬀerentiation of a
variety of cells, mainly in mucosa-associated epithelia [6], T and B
lymphocytes, macrophages, and generation of antibodies [7]. Zinc is
also an essential trace element with diverse physiologic and metabolic
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functions [8] such as maintaining immunological integrity, cellular
immunity, and antioxidant activity [9]. Because of the absence of
specialized zinc storage in the body, a daily intake is required to
achieve its steady-state [10]. In the prechemotherapeutic era, cod liver
oil rich in vitamin A was used regularly for the treatment of TB to
strengthen the host defense system [11].
Vitamin A and zinc deﬁciencies are common features of pulmonary
TB. Deﬁciencies of both micronutrients can reduce host defenses and
immune responses [12]. A study done in Rwanda revealed that 29% of
adult TB patients had serum vitamin A levels consistent with deﬁciency
(less than 0.7 µmol/L) [13]. Deﬁciency in zinc (below 10.7 µmol/L) is
thought to be one of the primary causes of morbidity in developing
countries and yet little is known about the status of the world [14].
Until recent time, many of the epidemiological studies conducted on
vitamin A and zinc deﬁciencies in Ethiopia were focusing on children
and pregnant women [5,15,16]. However, there is a paucity of in-
formation on the magnitude of the deﬁciencies of these micronutrients
in TB patients. The available studies were very few [17,18] and con-
ducted long years ago in some pocket areas of North West part of
Ethiopia. Therefore, the present study was designed to estimate the
diﬀerence in vitamin A and zinc deﬁciencies together with dietary in-
takes among pulmonary TB patients and non-TB controls.
Materials and methods
Study design, area and population
A facility-based case-control study was conducted in North Shewa
Zone of Amhara Regional State, Central Ethiopia. In this study, one
referral hospital and ﬁve health centers were involved. The study po-
pulation included TB patients and non -TB controls who were living in
the same geographic area. All TB cases who visited the health facilities
between March and August 2015 were recruited.
Selection of TB cases and controls
The diagnosis of TB was performed microbiologically and radi-
ologically as per the national standard diagnostic algorithm of Ethiopia
[19]. As per the diagnostic algorithm, smear positive pulmonary TB is
deﬁned by at least two initial sputum smear examinations positive for
acid fast bacilli (AFB) by direct microscopy, or a patient with one initial
smear examination positive for AFB by direct microscopy and culture
positive, or a patient with one initial smear examination positive for
AFB by direct microscopy and radiographic abnormalities consistent
with active TB as determined by a clinician.
Smear-negative pulmonary TB is also deﬁned by a patient having
symptoms suggestive of TB with at least three initial smear examina-
tions negative for AFB by direct microscopy, and no response to a
course of broad-spectrum antibiotics; radiological abnormalities con-
sistent with pulmonary TB; decision by a clinician to treat with a full
course of anti-TB; or a patient whose diagnosis is based on culture
positive for M. tuberculosis [19,20].
In this study, both smear positive and negative pulmonary TB cases
who were willing to participate in the study were included. All selected
TB cases were used as a point of contact to recruit controls. Individuals
who were apparently healthy, non-TB, living in the same geographic
areas with TB cases and interested in participating in the study were
selected as controls. As vitamin A and zinc concentrations in the serum
are aﬀected by many physiological and pathological states and drugs,
TB cases and controls with pregnancy, lactation, chronic or degen-
erative diseases, and who were taking vitamin A and zinc supplements,
corticosteroid drugs and oral contraceptives were excluded from the
study.
Duration of treatment
The treatment of TB lasts for a total of six months for newly diag-
nosed TB patients or for those who had taken previously the anti-TB
drugs for less than one month as per the standard treatment guidelines
for the general hospital in Ethiopia. The treatment regimen consists of 2
months treatment with Rifampicin (R), Isoniazid (H), Pyrazinamide (Z)
and Ethambutol (E) during the intensive phase, followed by four
months with Rifampicin and Isoniazid in the continuation phase
(2RHZE/4RH) [21].
Data collection
A structured questionnaire, comprised of socio-demographic char-
acteristics, health status and diet factors, was prepared, translated into
Amharic (the local language) and administered to each of the study
participant. Medical records were also used to collect clinical char-
acteristics.
Anthropometric measurements
Standardized procedures were employed to measure body weight,
height, and mid upper arm circumference (MUAC). All study partici-
pants were weighed while wearing light clothes using an electronic
platform weighing scale to the nearest 0.1 kg. Height was measured to
the nearest 0.1 cm by means of a seca stadiometer.
Body mass index (BMI) was calculated as body weight (kg) divided
by height (m) squared (kg/m2). BMI values of 18.5, 17.0, and 16.0 kg/
m2 were used as the cut-oﬀ values below which patients were classiﬁed
as having mild, moderate, or severe malnutrition [21]. MUAC was
measured half way between the olecranon and acromion processes of
the left arm using a ﬂexible non-stretch measuring tape to the nearest
0.1 cm while the arm is hanging relaxed, without compressing the tis-
sues. MUAC less than 23 cm for male and 22 cm for female is used to
deﬁne undernutrition as per FANTA III [22].
Dietary intake assessment
The dietary intake was assessed by means of a 24-h recall to esti-
mate the intake of energy, protein, vitamin A and zinc. Each 24-h recall
was performed using a standardized four-stage protocol [23,24]. First, a
complete list of all food and beverages consumed over the 24 h was
obtained. Second, detailed descriptions of the food and beverages
consumed, including the cooking methods and brand names were re-
corded, together with the time and place of consumption. Third, esti-
mates of the portion sizes of all consumed food items were determined
by referring to household measuring and serving utensils (e.g., spoons,
plates or cups), and food packages. Finally, the food recall was re-
viewed to ensure that all items had been recorded correctly. The
amount of nutrient intake from dietary recalls was calculated using
nutrisurvey software (Dr.Juergen Erhardt SEAMEO-TROPMED RCCN-
University of Indonesia copy right© 2007).
After the dietary intake assessment, the individual dietary diversity
score (DDS) was calculated as the number of food groups consumed
over the 24-h recall. These food groups were based on the guidelines for
measuring the household and individual dietary diversity. The score for
individual diet diversity goes from 0 to 9 [25,26]. Considering four food
groups as the minimum acceptable dietary diversity, the individual DDS
less than four was classiﬁed as having a poor dietary diversity [26,27].
Blood collection and serum separation
After overnight fasting, 10mL of venous blood was withdrawn from
antecubital fossa vein into a non-heparinized vacutainer tube between
8:00 and 10:00am at the selected health facilities. Blood samples were
allowed to clot for about 1 h in the dark and subjected to centrifugation
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at 4000 rpm for 10 min at room temperature. Samples with visible
haemolysis were discarded.
The sera were separated immediately into aliquots of sterile
Eppendorf tubes by means of sterile Pasteur pipettes and stored at
−20 °C in the laboratory of the health facility. The sera were later
transported in the ice box to Armauer Hansen Research Institute (AHRI)
where they were stored at −80 °C until analysis. Aliquots of the sera
were transferred to Ethiopian Public Health Institute (EPHI) for the
analysis of serum vitamin A concentration and to Natural Sciences
College of Addis Ababa University for the determination of the serum
zinc concentration.
Measurements of vitamin A, zinc and C-reactive protein (CRP)
Vitamin A
Serum vitamin A concentration was determined using high perfor-
mance liquid chromatography (HPLC) as explained in the method of
Arroyave et al. [28] with slight modiﬁcations. In brief, 100 µL of
ethanol and an equal volume of retinyl acetate (reconstituted in
ethanol) as internal standard were added into a 2mL Eppendorf tube
containing 100 µL of serum sample. The solution was then mixed for
1 min using vortex mixer. In the ﬁrst round, 750 µL of n-hexane was
added into the solution, vortex mixed for 1 min and centrifuged at
3000 rpm for 10 min. The supernatant was transferred into a new Ep-
pendorf tube. In second round, 750 µL of n-hexane was added and the
whole steps were repeated. The pooled supernatant was then evapo-
rated into dryness under a steam of nitrogen, reconstituted in 200 µL of
methanol, and transferred into the injection vial.
A Shimadzu HPLC system (Shimadzu, Tokoyo) which composed of a
reverse phase Supelco LC-18 column (250 × 4.6mm, 5 µm particle
size) and UV–vis detector was used to separate and detect the retinol at
325 nm with a column temperature set at 40 °C. Series of standards
(having a concentration of 60, 40, 20, 10 and 5 µg/dL) and samples
were loaded into the autosampler tray of the HPLC. Methanol was used
as a mobile phase with injection volume of 40 µL, ﬂow rate of 1mL/min
and retention time of 15 min.
Retinol was determined by comparing the retention times with the
external standard and quantiﬁed based on externally drawn calibration
curve using the series concentrations of standards. All extraction pro-
cedures were performed under dim light to avoid oxidation of the
compound. Vitamin A concentration below 0.7 µmol/L was considered
as deﬁcient.
Zinc
Serum zinc concentration was determined by means of ﬂame atomic
absorption spectrometry (FAAS) with a micro-sampling technique in
AA-7000 Atomic Absorption Spectrophotometer (Shimadzu, Japan)
using the method described in Sepehri et al. [29]. In brief, 10mL of
concentrated nitric acid was added to 1mL of serum in a beaker and
heated for 3 h, below boiling point, on a hot plate. When the volumes of
the samples reduced to about one-third, 5 mL of 30% hydrogen per-
oxide solution was added. The samples were further heated almost to
dryness at the same temperature. Finally, the residues were dissolved in
50mL of 1% nitric acid and ﬁltered. The prepared samples were
transferred into 50mL polyethylene tubes for zinc analysis. The con-
centration of 10.7 µmol/L was used as a cut-oﬀ value below which was
considered as zinc deﬁcient.
C-reactive protein (CRP)
CRP was measured at AHRI, Ethiopia using enzyme-linked im-
munosorbent assay (ELISA) (Human CRP ELISA Kit, HK 358, Hycult
biotech) method according to the manufacturer's instruction as in-
dicated in the manual of the kit. For each TB patient, CRP was measured
in duplicate. The mean value ≥10mg/L was considered as CRP posi-
tive.
Ethical consideration
This study is a part of our project entitled ‘’eﬀect of micronutrients
on the treatment outcome of TB’’, which has been ethically approved by
the ethical approval committee of AHRI- ALERT (All Africa Leprosy
Rehabilitation and Training) Centre. Supportive letters were also ob-
tained from the zonal and districts’ health bureau of Amhara Regional
State. This study was carried out in accordance with the principle of
Helsinki declaration. After explaining the purpose and objective of the
study, written informed consent was obtained from each of the study
participant.
Statistical analysis
Statistical analysis was conducted using IBM SPSS version 23 sta-
tistical program. All continuous data were checked for a normal dis-
tribution using a Shapiro-Wilk test. Descriptive statistics, including
frequency, proportion, and median (IQR-Inter Quartile Range) were
employed to summarize the study variables. Mean and standard de-
viation (SD) were used to describe concentrations of vitamin A and
zinc, BMI, and MUAC. Odds ratio (OR) together with 95% conﬁdence
interval (CI) was computed to assess the strength of association.
The signiﬁcance of the diﬀerence in continuous and categorical
variables between groups was compared using Mann–Whitney U test
and Chi-square test, respectively. Kruskal–Wallis test was used to assess
the diﬀerence in the serum vitamin A and zinc concentrations of TB
patients at diﬀerent duration of treatment. The association between
MUAC, BMI, and DDS was examined using Spearman correlation test.
Bivariate analysis was done to explore the crude association be-
tween diﬀerent predictor variables and TB. To control for possible
confounding factors and identify factors that are independently asso-
ciated with TB, multinomial logistic regression analysis was performed
for those variables with p-value of less than 0.2 in the bivariate ana-
lysis. The major assumptions of logistic regression model were multi-
collinearity and interaction among independent variables. The absence
of multicollinearity was checked using variance inﬂation factor (VIF)/
tolerance and the ﬁtness of logistic regression model was checked using
Hosmer-Lemeshow statistical test. Unless speciﬁed, p-value< 0.05 was
considered as statistically signiﬁcant.
Results
Socio-demographic characteristics
The present study was conducted on 62 TB patients and 59 controls.
The median (IQR) age was 26 (14) years with the minimum and max-
imum age of 14 and 77 years. Most of the participants were Orthodox
Tewahido Christians in religion (89.3%) and farmers in occupation
(31.1%) (Table 1).
There was statistically signiﬁcant diﬀerence in sex between TB pa-
tients and the controls (P< 0.05). The odds of males with TB was 2.2
(95% CI: 1.05 to 4.48) times more likely as compared to the odds of
females. The most (85%) TB aﬄicted age group was found between 19
and 50 years.
Clinical signs and symptoms of TB
TB patients showed various clinical signs and symptoms. The
identiﬁed clinical signs and symptoms at the time of diagnosis were
fatigue (100%), cough (83.3%), malaise (83.3%), night sweating
(83.3%), fever (75%), anorexia (75%), productive cough (75%), chest
pain (70.8%), dyspnoea (54.2%), haemoptysis (29.2%) and tachycardia
(25%).
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Vitamin A and zinc deﬁciencies
The proportions of vitamin A, zinc and the combination of the two
micronutrient deﬁciencies were 47.9%, 96.5% and 47.8%, respectively.
The mean serum retinol and zinc concentrations in females
(0.80 ± 0.47 µmol/L and 2.10 ± 1.20 µmol/L, respectively) were not
signiﬁcantly diﬀerent from that of males (0.77 ± 0.60 µmol/L and
2.50 ± 2.50 µmol/L, respectively) (p>0.05). The proportions of vi-
tamin A deﬁciencies among TB patients and the controls were 56.4%
and 39.0%, respectively.
All TB patients and 92.5% of the controls were identiﬁed as zinc
deﬁcient. There were statistically signiﬁcant diﬀerences in all propor-
tions of the deﬁciencies between TB patients and the controls at
p<0.1. The odds of TB patients who were vitamin A deﬁcient was 2.03
(90% CI: 1.1 to 3.7) times greater than the odds of the controls. In the
same line, TB patients had vitamin A and zinc deﬁciencies 2.3 (95% CI:
1.1 to 4.8) times more likely as compared to the controls.
Fig. 1 shows a wide-ranging of serum retinol levels. The proportions
of severe and, mild to moderate hyporetinolaemia were higher in TB
patients than the controls. About 19% of TB patients and 25% of the
controls had suboptimal retinol levels, whereas the optimal level in
both groups was below 5%.
CRP
About 62% of TB patients were CRP positive. The mean ± SD of
retinol and zinc concentration in CRP positive TB patients were
0.62 ± 0.50 µmol/L and 2.05 ± 0.74 µmol/L, respectively. Whereas,
these values in CRP negative TB patients were 0.75 ± 0.69 µmol/L and
2.48 ± 1.20 µmol/L, respectively. Excluding CRP positives, the pre-
valence of vitamin A deﬁciencies in CRP negative TB patients became
66.7%. Both CRP negative and positive TB patients did not have sta-
tistically signiﬁcant diﬀerences in serum retinol (p= 0.25) and zinc
(p= 0.09) concentrations.
Durations of TB treatment
Fig. 2 shows the mean serum retinol and zinc concentrations in
diﬀerent durations of TB treatment. During the ﬁrst month of TB
treatment, the retinol level was below the cut-oﬀ value of 0.70 µmol/L
but increased slightly afterward. Similarly, the zinc level increased
slightly up to 2months of treatment but its concentration throughout
the entire courses of the treatment was below the cut-oﬀ value of
10.70 µmol/L. Per the result of the analysis of variance, the retinol and
zinc concentrations were not signiﬁcantly diﬀerent in both within and
between the durations of the treatment.
Dietary intakes
The mean DDS was 3.56. Most (84%) of TB patients and the controls
(86%) had below average DDS (4.5 out of 9 food groups). DDS had
statistically signiﬁcant correlation with BMI (γ=−0.22; p=0.019).
There was also a signiﬁcant diﬀerence in DDS between males and fe-
males (p=0.031). While analysing the nutrients intake, about 87% of
TB patients and 80% of the controls had below 50% fulﬁlment of energy
intake. Almost all participants had below 50% fulﬁlment of vitamin A
intake. But, less than 30% of participants had protein and zinc intakes
below 50% fulﬁlments. In other words, many participants had above
the average fulﬁlments of protein and zinc intakes, albeit much cereal-
based diet.
Nutritional status
More than 29% of the participants had BMI below 18.50 kg/m2. The
mean BMI of female TB patients (18.80 ± 3.80 kg/m2) was
Table 1
Socio-demographic characteristics of TB patients and Controls.
Type Variables TB-cases
(n)
Control (n) P-value
Sex Female 26 36 0.036
Male 36 23
Residence Urban 24 22 0.391
Rural 29 37
Age (years) 14–18 9 9 0.805
19–30 37 32
31–50 12 15
51–70 3 3
More than 70 1 0
Marital status Single 31 26 0.807
Married 30 32
Widowed 1 1
Educational level Illiterate 8 8 0.644
Primary 20 16
Secondary 23 21
Tertiary 11 12
Religious Teaching 0 2
Religion Orthodox Tewahido
Christian
56 52 0.176
Muslim 1 5
Protestant 3 2
Catholic 2 0
Occupation Student 9 15 0.002
Private 12 19
Government employees 8 7
Non-Government
employees
0 1
Farmer 29 8
Housewife 2 8
Retired 1 0
Fig. 1. Percentages of vitamin A deﬁciencies in TB patients and controls. The categories of vitamin A deﬁciencies were indicated in WHO global report [30], Olang
et al. [31] and Kassaye et al. [32].
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signiﬁcantly lower than females in the controls (20.40 ± 2.92 kg/m2)
(p<0.05). There was a statistically signiﬁcant diﬀerence in the pro-
portions of undernutrition (BMI<18.50 kg/m2) between TB patients
(40.3%) and the controls (19.3%) (P< 0.05). Undernourished in-
dividuals had 2.8 times the odds of TB disease compared to the controls.
As deﬁned by MUAC, undernutrition for both male and female was
44.2%. The mean MUAC of females in TB patients (20.60 ± 2.20 cm)
was signiﬁcantly diﬀerent from those females in the controls
(21.80 ± 2.20 cm) at p< 0.10. MUAC was signiﬁcantly correlated
with BMI (γ=0.56, P<0.001).
Determinants of TB
The multinomial logistic regression model in Table 2 indicated that
sex and BMI had statistically signiﬁcant association with TB patients
(p< 0.05). Adjusting for BMI, serum retinol level, religion, and occu-
pation, females had 0.2 times less the odds of TB compared to males.
Similarly, undernourished individuals had 3.3 times the odds of TB
compared to well-nourished individuals holding sex, serum retinol
level, religion and occupation constant.
Discussion
In most countries, TB notiﬁcation is twice as high in men as in
women [33]. The study done in central part of Ethiopia also showed a
high rate of TB notiﬁcation in male (60.9%) and people with the age
group of 14 to 54 years (87.3%) [20]. In line with this, the odds of
males with TB in the present study was 2.2 times more likely as
compared to the odds of females. The most (85%) TB aﬄicted age
group was also found between 19 and 50 years. The reason why males
and the productive age groups are highly aﬄicted by TB could be as-
sociated with their sociocultural, behavioral and biological components
[33].
Micronutrient deﬁciencies are rampant in Ethiopia. More than 47%
of TB patients and controls were aﬀected by the deﬁciencies of either
vitamin A, zinc or their combination. This was corroborated by the
report of Keﬂie et al. [26] who identiﬁed the presence of a high risk of
micronutrient deﬁciency in central part of Ethiopia (>60%). According
to WHO and International Zinc Nutrition Consultative Group (IZiNCG),
the risks of vitamin A and zinc deﬁciencies are of public health concern
when the prevalence of low serum retinol and zinc concentrations are
greater than 20% [34]. This implied that the results of the present study
were more than twice of the indicator of the public health concern.
Comparing with the control, the odds of TB patients who were vi-
tamin A deﬁcient was 2 times higher. The proportion of vitamin A
deﬁciency in TB patients was 56.4% which was closer to the report of
nearly 60% among TB patients in Gondar, Northwest Ethiopia [18].
Severe and mild to moderate types of vitamin A deﬁciency was more
common in TB patients than the controls. The low concentration of
vitamin A in the serum of TB patients could be resulted from TB in-
duced anorexia that lead to low consumption of vitamin A rich food
items; reduced absorption of dietary vitamin A owing to parasites co-
infection; decreased mobilization of hepatic reserves of retinol; rapid
utilization of vitamin A by target tissues; and increased urinary losses of
vitamin A associated with fever [18,35]. This justiﬁcation was
strengthened by the occurrence of fever and anorexia together with
Fig. 2. Mean concentrations of serum retinol (μmol/L) and zinc (μmol/L) in diﬀerent duration of anti-TB treatment.
Table 2
Multinomial logistic regression model for diﬀerent variables in TB patients.
Variables β Wald DF P-value Odds Ratio 95% CI
Lower Limit Upper Limit
Sex Females −1.64 10 1 0.002* 0.19 0.07 0.53
Males
BMI < 18.50 kg/m2 1.2 5.06 1 0.024* 3.33 1.17 9.50
≥ 18.50 kg/m2
Retinol < 0.70 µmol/L 0.62 1.77 1 0.184 1.86 0.74 4.64
≥ 0.70 µmol/L
Religion Orthodox Tewahido 0.7 0.22 1 0.64 2.01 0.10 38.56
Muslim −0.48 0.07 1 0.796 0.62 0.02 23.34
Protestant
Occupations Students −0.92 2.01 1 0.16 0.40 0.11 1.42
Private workers −0.84 1.77 1 0.183 0.43 0.13 1.48
Government employees −0.97 1.59 1 0.207 0.38 0.09 1.71
Housewives 1.73 2.91 1 0.088 1.26 0.35 4.51
Farmers
NB: The reference category is the controls.
*Statistically signiﬁcant at p< 0.05.
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fatigue, cough, malaise, and night sweating in more than 74% of TB
patients in the present study.
Likewise, there was a signiﬁcant diﬀerence in the proportion of zinc
deﬁciency among TB patients and controls. All TB patients were iden-
tiﬁed as zinc deﬁcient. This result was much higher than the report of
the previous study done in Northwest Ethiopia (32.1%) [17]. Such a
proportional diﬀerence could be owing to variations in the dietary
patterns and seasons together with the availability and accessibility of
food items rich in zinc. In line with the present study, the low serum
zinc concentration in TB patients was also reported in Indonesia [24],
Ecuador [36], Malaysia [37], and Korea [38].
The lowered concentration of zinc among TB patients could prob-
ably be associated with reduction in hepatic production of a zinc carrier
protein (α2-macroglobulin); redistribution of zinc from blood circula-
tion to other tissues; and/or a rise in the production of metallothionein,
a protein that transports zinc to the liver [17,37,39]. The concomitant
deﬁciencies of vitamin A and zinc were very high in TB patients as
compared to the control. This could be due to the high magnitude of
zinc deﬁciency in TB patients. Vitamin A and zinc deﬁciencies are
usually occurred together, as zinc deﬁciency impairs the synthesis of
retinal binding proteins and reduces plasma retinal concentration [40].
Several studies indicated the essence of measuring CRP in TB pa-
tients to get a clear picture on the serum retinol and zinc concentrations
[18,36,41]. CRP is a tissue protein which is produced at the time of
acute phase response and its concentration changes rapidly as a result
of infection or inﬂammation. Visser et al. [41] showed the relationship
between the low retinol concentration in active TB and the acute phase
response. Likewise, Cuevas and Koyanagi [9] described the low con-
centration of zinc in TB patients with and without a raised CRP.
In the present study, we did not observe any diﬀerence in the
concentrations of vitamin A and zinc in the serum of TB patients with
and without CRP. In line with our ﬁnding, Karyadi, et al. [24] reported
that retinol concentration did not correlate signiﬁcantly with markers
of acute phase response. This suggested that CRP is not the best option
to control the change in the acute phase response in the concentrations
of vitamin A and zinc in the serum of TB patients.
We observed a ﬂuctuation of vitamin A and zinc concentrations in
TB patients at diﬀerent durations of anti-TB treatment. During the ﬁrst
month, the retinol concentration was below the cut-oﬀ value but later
increased slightly. The gradual increment of zinc concentration was
also observed up to the second month of the treatment, but such a
concentration was below the cut-oﬀ value throughout the whole course
of anti-TB treatment. The improvement of vitamin A was in accordance
with the reports of Mugusi et al. [7] in Tanzania and Kassu et al. [18] in
Ethiopia. It is believed generally as patients improve and fever subsides,
the loss of vitamin A declines, and its serum concentration resume to
the reference ranges [18].
Despite the low improvement, our observation on the changes of
zinc concentration was corroborated by the ﬁndings of Khanna et al.
[42] and Kassu et al. [17]. On the contrary, Edem and others [39] re-
vealed that trace elements and vitamins were lowest at 2 and 4 months
of anti-TB drug therapy. This may be due to drug-micronutrient inter-
actions or drug induced nutrient depletion. Further, the eﬀects of anti-
TB drugs on the absorption of zinc was presented by Karyadi et al. [11]
in their study done in Indonesia. Ethambutol was shown in rats to in-
crease not only zinc absorption but also urinary zinc losses, resulting in
reduced circulating zinc concentrations [43].
In the comparison made on nutritional status as measured by BMI
and MUAC, the results were signiﬁcantly lower in TB patients than the
controls. Undernourishment in TB patients was almost three times
higher than that of the controls. In agreement with our results, several
studies demonstrated undernutrition as a well-recognized clinical sign
of active TB [24,44,45]. Pakasi et al. [46] described undernutrition as a
reﬂection of two processes. One would be protein-energy malnutrition
(which severely aﬀects host defense) and the other was wasting due to
the catabolism induced by the acute phase response. The causes of
undernutrition in patients with active TB could be anorexia, impaired
absorption of nutrients, or increased catabolism associated with the
inﬂammatory and immune response [24,44]. Our study identiﬁed un-
dernutrition and sex as signiﬁcant determinants of active TB.
The dietary intake assessment revealed that the mean DDS was 3.56,
and above 80% of TB patients and the controls had below the average
DDS. These results were in accordance with the previous study done in
the same area [26]. A diet of at least 4 DDS was valid as nutritionally
adequate, but below 4 DDS represented a poor dietary diversity
[26,47]. This suggested that both TB patients and controls had poor
dietary diversity. The intakes of energy and vitamin A rich food items
were also poor. More than 85% of TB patients could not fulﬁl even half
of their daily requirements of energy and vitamin A. Poor dietary intake
of vitamin A rich food is an important predictor of vitamin A deﬁciency
[16].
Although the intakes of protein and zinc looked better, the main
dietary sources were cereal based. The previous study in the same area
also indicated a high reliance on the consumption of cereals, vegetables
and legumes with less animal source foods [26]. As our body does not
store zinc, it requires a constant dietary intake. Most plant-based diets
are not good sources of zinc owing to the presence of phytate, a com-
ponent of plants that chelates zinc and prevents its absorption [48]. The
low content of zinc in Ethiopian soil could be another factor for the
inadequate intake of zinc [15]. Hence, plant- based diets with low an-
imal source proteins were accounted for the high deﬁciency of zinc in
both TB patients and controls.
Limitation
Although this study had the strength of dealing with the serum vi-
tamin A and zinc concentrations in TB patients together with CRP,
nutritional status and dietary intakes, it was a facility- based study and
the participants could not represent the general population. In addition,
the 24-h recall method, which was used to assess the dietary intake,
could probably miss some of the feeding behaviours particularly in the
case of altered dietary patterns.
Conclusion
In conclusion, vitamin A and zinc deﬁciencies are severe problems
among TB patients and non-TB controls. The cause-eﬀect relationship
between undernutrition and TB is just like the puzzle of the hen or the
egg, of the two which comes ﬁrst. Our study underlines that under-
nutrition determines the development of TB. Most TB patients have
DDS below average and, very poor dietary intakes of vitamin A, zinc,
protein, and energy. During the duration of anti-TB treatment, the
concentrations of vitamin A and zinc improve but not to the extent of
curbing their deﬁciencies. Therefore, to claim success, TB management
program needs to give emphasis on addressing the problems of vitamin
A and zinc deﬁciencies together with protein-energy malnutrition. In
the future, we recommend further community- based studies to be
conducted at diﬀerent parts of Ethiopia to substantiate our ﬁndings.
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a b s t r a c t
The aim of this study was to explore the existence of vitamin D deﬁciency (VDD) in tuberculosis
(TB) patients living in Africa and to identify its predictor variables. PRISMA guidelines and
checklists were used. The sources of the data were Medline/PubMed, Web of Science, Scopus, and
Google Scholar databases. We identiﬁed 23 articles, of which 15 reported the status of vitamin D in
TB with TB. The deﬁnition of serum vitamin D status was summarized as severe, deﬁcient, and
insufﬁcient when the concentration of 25-hydroxyvitamin (OH)-D 25, 50, and 75 nmol/L,
respectively. The reports showed that up to 88.9% and 96.3% of patients with TB tested by radio-
immunoassay had VDD and vitamin D insufﬁciency, respectively. Statistically signiﬁcant variables
such as lack of sun exposure, inadequate dietary intake, season, clothing, comorbidities, low body
mass index, age, skin pigmentation, use of antiretroviral therapy and anti-TB drugs, and socio-
economic status were identiﬁed as the main predictor variables of vitamin D status. VDD and
vitamin D insufﬁciency were highly prevalent in TB patients in Africa. Further case–control studies
are warranted to clarify the cause–effect relationship between vitamin D and TB and thereby,
design valuable strategies to manage VDD among TB patients in Africa.
 2015 Elsevier Inc. All rights reserved.
Introduction
Sun exposure as a therapeutic approach to treat tuberculosis
(TB) was used more than 100 y ago, before the identiﬁcation of
Mycobacterium tuberculosis as the causative agent for TB [1].
Exposure of children suffering from rickets and TB to artiﬁcial
ultraviolet (UV) light resulted in a positive effect on both
diseases. The use of sanatoria was also based on the belief that
fresh air and sun exposure led to a positive outcome in the
treatment of TB [2]. Vitamin D is a known immunemodulator [3]
that can improve cell-mediated immunity [4] and the phagocytic
capacity of macrophages [5]. It also increases the production of
antimicrobial peptides such as cathelicidin [5], which is part of
the innate immune system that plays a critical role in the ﬁght
against TB. Recent research highlighted the production of
cathelicidin through toll-like receptor pathway [6].
Vitamin D is unique among hormones as it can bemade in the
skin from sun exposure [7]. Most (90%) vitamin D is synthesized
in the skin under the inﬂuence of UV sunlight, and only 10% is
obtained from food, mainly salmon and cod ﬁsh, and dairy
products [8]. Although sunshine is abundant, TB is one of the
most pernicious infectious diseases in Africa. Sub-Saharan Africa
carries the greatest proportion of new cases per population, with
>255 cases per 100 000 population in 2012 [9]. Almost 30% of TB
cases and 34% of TB-related deaths occur in Africa [10].
Few community- and facility-based studies have been
conducted with different population groups in Africa to
assess the distribution of vitamin D deﬁciency (VDD) in pa-
tients with TB and their cause–effect relationship. These
studies have provided insight into the status of vitamin D in
patients with TB. However, four questions still need to be
addressed:
1. Is VDD common in TB patients living in Africa?
2. If yes, which level of deﬁciency is highly predominant?
3. What are the reasons for VDD in TB patients?
4. What are the predictors of VDD?
* Corresponding author Tel.: þ49 152 1132 3555; fax: þ49 711 4592 3822.
E-mail address: tibebe.fscuhoh@gmail.com (T. S. Keﬂie).
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Therefore, the present study was designed to address these
four questions through a comprehensive systematic review of all
articles published in peer-reviewed journals.
Materials and methods
Data sources and search strategy
PRISMA guidelines and checklists were used to conduct this systematic
review [11]. Data were collected from published articles without time restriction.
Electronic searches of Medline/PubMed, Web of Science, Scopus, and Google
Scholars were done through May 25, 2014. Details of the search criteria for each
database were as follow:
 Medline/PubMed: (“vitamin d deﬁciency”[MeSH Terms] OR “vitamin
d deﬁciency”[All Fields]) AND (“tuberculosis”[MeSH Terms] OR “tuber-
culosis”[All Fields]) AND (“patients”[MeSH Terms] OR “patients”[All Fields])
AND (“africa”[MeSH Terms] OR “africa”[All Fields])
 Web of Science: (“vitamin d deﬁciency” OR “cholecaciferol” OR “ergo-
calciferol”) AND (“tuberculosis” OR “tuberculosis patients”) AND (“africa”)
 Scopus: “vitamin d deﬁciency” AND “tuberculosis patients” AND “Africa”
 Google Scholars: “vitamin D deﬁciency” OR “cholecalciferol” OR
“ergocalciferol” OR “calcidiol” OR “calcitriol” AND “tuberculosis” AND
“Africa”
Eligibility criteria
Eligibility for inclusion focused on studies reporting VDD among TB patients
in Africa without restricting for age, sex, or ethnicity. We included all original
articles in English published in peer-reviewed journals. However, reviews,
commentaries, letters, and theses were excluded. We also excluded articles on
African immigrants, as we only focused on TB patients living in Africa.
Deﬁnitions
The cutoff values of serum 25-hydroxyvitamin (OH)-D 75, 50, and
25 nmol/L were used to deﬁne insufﬁciency (VDI), deﬁciency, and severe
vitamin deﬁciency (sVDD), respectively [12,13]. To convert values of 25-OH-D
concentration from conventional (ng/mL) to the International System of Unit
(nmol/L), we multiplied by factor 2.496 [14].
Data extraction and processing
The following data were extracted from each selected study: author(s);
publication year; country/city; latitude; study type; sample size; TB cases; age;
laboratory test; predictor variables; percentages of males and females; and
serum 25-OH-D 75, 50, and 25 nmol/L. Detailed descriptions of the
extracted data can be found in Table 1. Factors that have statistically signiﬁcant
differences in each article were considered predictor variables.
Results
Search results
The literature search and selection process are schemati-
cally indicated in Figure 1. Initially, the search in Medline/
PubMed, Web of Science, Scopus, and Google Scholars yielded
2919 articles. After looking through their titles and abstracts,
80 potential studies were identiﬁed; however, only 23 were
included in the systematic review analysis. Fifty-seven studies
were excluded because of they were duplicates (44); reviews
(3); or commentaries, letters, or thesis (1 each); they
included African immigrants (3) or they did not measure 25-
OH-D (4).
Study characteristics
Table 1 summarizes the characteristics of each study. Of
the 23 studies, 11 were conducted in eastern Africa (latitude
06500S/10N), 5 in southern Africa (latitude 13300S/33S), 4 in
western Africa (latitude 06250N/12N) and 3 in northern Africa
(latitude 26340N/36430N). Most of the studies were cross-
sectional and prospective. Considering all studies reviewed, 15
reported the vitamin D status in TB patients.
In general, all the studies were heterogeneous in reporting
age and vitamin D status. Age was reported either as mean  SD
or median (range or interquartile range). Similarly, in some ar-
ticles, vitamin D levels were described by ng/mL but this unit was
converted into nmol/L by multiplying by factor 2.496 [14].
Additionally, there differences were observed in the laboratory
tests used to measure the level of vitamin D in the blood of
patients with TB, as indicated in Table 2. Formeasuring vitamin D
in both TB and non-TB cases, eight studies used immunoassay
[8,15–21], ﬁve used high-performance liquid chromatography
[22–26], four used liquid chromatography-tandem mass spec-
trometry [12,27–29], and six used other tests [17,31–35]
(Table 1).
Vitamin D deﬁciency
There were inconsistencies in the threshold levels of
25-OH-D concentration when deﬁning sVDD, VDD, and VDI, as
described in Table 3. Half of the studies deﬁned sVDD as
25 nmol/L; 77.3% (17 of 22) deﬁned VDD as 50 nmol/L, and
60% (12 of 20) deﬁned VDI as 75 nmol/L. Based on these results
and those of another study [13], we summarized the deﬁnition
of serum vitamin D status as follow: SVDD 25 nmol/L; VDD
50 nmol/L, and VDI 75 nmol/L. Subsequently, we used these
deﬁnitions to determine the extent of deﬁciencies in TB patients
living in Africa.
The prevalence of sVDD was reported in up to 45.7% of
patients using radioimmunoassay in TB and non-TB cases.
Twenty-two studies in non-TB cases and 15 studies in TB cases
reported the prevalence of VDD in the range of 1.2% to 88.9%. The
minimum prevalence of VDD was measured using a Cobas E601
Analyser and the maximum was measured using radioimmu-
noassay. Likewise, the prevalence of VDI was reported using
different laboratory tests by 20 studies in non-TB cases and 13 in
TB cases in the range of 15% and 96.3% (Table 1). However, 16
studies did not report the prevalence of sVDD in TB patients.
Considering the regions, the highest prevalence of VDI (74.5%–
96.3%) and VDD (42%–88.9%) in patients with TB was reported in
southern Africa.
What are the reasons for VDD in TB patients?
There is paucity of data that explain the reasons for VDD in
patients with TB. TB causes weight loss and micronutrient
deﬁciencies by increasing nutritional requirements, changing
metabolic processes, or decreasing appetite and causing a
reduction in food intake [36]. Vitamin D is required for immune
modulation and infection withMycobacterium tuberculosis binds
to toll-like receptors (TLR 2/1) on macrophages, leading to
upregulation of 1-a-hydroxylase gene expression to promote
greater conversion of 25-OH-D to 1,25-(OH)2-D. This phenom-
enon accounts for the drop in 25-OH-D, an indicator for
VDD [24].
TB may lead to changes in dietary vitamin D intake and sun
exposure through a reduction in appetite and by restricting
outdoor physical activities. Patients with TB who have very little
adipose tissue are unable to store vitamin D, so they have no
reserves when external sources are lacking [20]. TB and its
treatment also may have direct biological effects on the
T. S. Keﬂie et al. / Nutrition 31 (2015) 1204–1212 1205
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Table 1
Summary of reviewed studies
Author (s), year
[ref. No.]
Country, city Latitude Study type Sample
size
TB
cases
Sex Age (y) Laboratory test Serum concentration of 25-OH-D
(nmol/L or ng/mL  2.5)
Predictor (s)
Male
(%)
Female
(%) Non-TB cases TB cases
25
(%)
50
(%)
75
(%)
25
(%)
50
(%)
75
(%)
Kibirige
et al. 2013 [19]
Uganda,
Kampala
00200N Cross-sectional 260 260 56.2 43.8 Mean: 34.7  9.5 ECLIA NA NA NA 13.5 44.2 85.4 Inadequate diet, age,
BMI
Banda et al.
2011 [20]
Malawi,
Blantyre
13300S* Cross-sectional 161 161 50.9 49.1 Median: 30–50 EIA NA NA NA 20.4 42 74.5 Not identiﬁed
Mahmoud and
Ali 2014 [12]
Egypt, Sohag 26340N* Case–control 65 40 44 21 Mean:
35  8y
36  6z
ELISA kit NA 0 0 NA 50 72.5 Dietary, sun exposure,
genetic
Conesa-Botella
et al. 2012 [34]
Uganda,
Kampala
00200N* Prospective 162 119 53.1 46.9 Median: 34
(28–39)
CL NA 11.63 51.16 NA 24.37 40.34 Comorbidities: TB, HIV
Tostmann et al.
2010 [35]
Tanzania,
Sanya Juu
310060S Prospective 81 81 79 21 Median: 31
(26–41)
Cobas E601
Analyser
NA NA NA NA 1.23 17.28 Diet, sun exposure
Wejse et al.
2007 [16]
Guinea-Bissau,
Bissau
12N Case–control 856 362 53.7 46.3 Mean: 37.4  13.7y;
37.3  12.9z
ID-LC-MS/MS
on API 3000 MS
4.9 13.15 39.07 0.28 8.56 46.13 Sex, ethnicity, season,
sun exposure
Mehta et al.
2013 [31]
Tanzania, Dar
es Salaam
06500S Cohort 677 677 67.9 32.1 Mean: 32.3  8.9 LC-MS NA NA NA NA 15.66 61.74 Season, money spent on
food, comorbidities: TB
and HIV
Conesa-Botella
et al. 2012 [21]
South Africa,
Cape Town
33550S* Longitudinal 81 81 40.7 59.3 Median: 33.5
(27–43)
RIA NA NA NA 45.7 88.9 96.3 Use of ART and anti-TB
therapy
Sudfeld
et al. 2012 [26]
Tanzania, Dar
es Salaam
06500S* Cohort 1103 43 31.2 68.8 Median: 30–40 HPLC-MS using
API-5000
NA 9.2 52.8 NA NA NA Comorbidities: HIV,
wasting
Sudfeld et al.
2013 [27]
Tanzania, Dar
es Salaam
06500S* Prospective
cohort
1103 43 31.2 68.8 Median: 30–40 HPLC-MS using
API-5000
NA 9.2 52.8 NA NA NA Use of ART,
comorbidities: oral
thrush, wasting,
Friis et al.
2008 [22]
Tanzania,
Mwanza
2.28 S Cross-sectional 653 508 58.7 41.3 Median: 25–35 RIA NA NA NA 0.8 10.6 41.2 Comorbidities: TB,
season, marital status,
dietary intake,
Mastala
et al. 2013 [23]
Malawi,
Blantyre
13 300 S* Cross-sectional 157 161 52.9 47.1 Mean: 38.9
(18–80)
EIA 0 16.6 47.8 11.2 42.2 74.5 Lower BMI, dietary
intake, use of ART,
comorbidities: heart
failure, TB
Friis et al.
2013 [24]
Tanzania,
Mwanza
2.28 S Cross-sectional 1570 1250 58.1 41.9 Median: 25–35 CLIA NA 4.3 39.6 NA 2.5 15 BMI, season, sun
exposure, dietary
intake, comorbidity:
HIV
Nansera et al.
2011 [28]
Uganda,
Mbarara
0.6132 S Cross-sectional 150 50 51.3 48.7 Mean: 33  9 SPE –RE-HPLC 0 20 NA 12 38 NA Weight loss,
comorbidity: HIV
Steenhoff et al.
2012 [36]
Botswan,
Gaborone
22 000S* Case-control 38 19 36.8 63.2 Median:
34 (31–38)
Diasorin Liaison
assay
NA 78 NA NA 78 NA None
Martineau et al.
2011 [32]
South Africa,
Cape Town
33S Cross-sectional 370 370 44.6 55.4 Median: 31.7
(25.8–42.3)
ID-LC-MS/MS NA NA NA 14.05 62.7 88.1 Season, comorbidities:
TB, HIV, lower BMI
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Wejse et al.
2009 [33]
Guinea-Bissau,
Bandim
1150060N* RCT 365 365 60.8 39.2 Mean: 37  14 ID-LC-MS/MS
on API 3000 MS
NA NA NA NA 8.2 44.7 Not identiﬁed
Glew et al.
2010 [29]
Nigeria,
Gombe
1017022N* Prospective 51 NA 43.1 56.9 Mean: 51.5  10.8 UPLC-MS NA 21.7 66.7 NA NA NA Sex, sun exposure,
clothing, BMI, dietary
intake
Allali et al.
2009 [37]
Morocco,
Rabat
34020N* Cross-sectional 415 NA – 100 Mean: 50  9.3 CL 4 43 91 NA NA NA Age, clothing, time
spent outdoors, dietary
intake
Feleke et al.
1999 [30]
Ethiopia,
Addis Ababa
10N Prospective 61 NA 39.3 60.7 Median: 21
(20–22)x;
25 (22–28)k
HPLC NA 97 77 NA NA NA Clothing, dietary intake,
skin color
Oduwole et al.
2010 [25]
Nigeria, Lagos 06250N* Case–control 34 NA 70.6 29.4 Mean: 1.7
(0.5–2.5);
1.75 (0.5–2.5)
RIA NA 5.88 47.06 NA NA NA Comorbidity:
pneumonia, clothing,
sun exposure
Djennane et al.
2014 [38]
Algeria,
Tizi-Ouzou
36430 N Prospective 435 NA 46.7 53.3 Median: 10
(8–13)
ECL-CPB 8.1{
17.4#
29.9{
41.4#
58.4{ 65.2# NA NA NA Season, skin color,
dietary intake, SES, sun
exposure
Mehta et al.
2009 [39]
Tanzania, Dar
es Salaam
06500S* Prospective 884 NA – 100 Mean: 24.6  5 y CL NA NA 39.25 NA NA NA Comorbidity: HIV
API, atmospheric pressure chemical ionization; ART, antiretroviral therapy; BMI, body mass index; CL, chemoluminescence; CLIA, chemilumniscent immunoassay; ECL-CPB, electrochemiluminescence competitive protein-
binding assay; ECLIA, electrochemilumniscence immunoassay; EIA, enzyme immunoassay; ELISA, enzyme-linked immunosorbent assay; HIV, human immunodeﬁciency virus; HPLC-MS, high-performance liquid chro-
matography tandemmass spectrometry; ID-LC-MS/MS, isotope-dilution liquid chromatography-tandemmass spectrometry; NA, not available; RIA, radioimmunoassay; SES, socioeconomic status; SPE-RE-HPLC, solid-phase
extraction reverse-phase high-performance liquid chromatography assay; TB, tuberculosis; UPLC-MS, ultra-performance liquid chromatography coupled with mass spectrometry
* Not indicated in the literature.
y TB case.
z Control.
x Nonpregnant.
k Pregnant.
{ September.
# March.
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metabolism of vitamin D (e.g., isoniazid and rifampicin have
been reported to reduce serum 25-OH-D), which will contribute
to an association between low serum 25-OH-D and TB [20].
However, there further studies are needed on the cause–effect
relationship between VDD and TB.
Predictor variables of vitamin D deﬁciency
In the present study, 22 articles identiﬁed predictor variables
associated with VDD. Based on the location of the studies done,
we summarized the variables into eastern, southern, western
and northern Africa (Table 1). Variables such as season and
inadequate diet intake were identiﬁed in all regions. However,
clothing and sun exposurewere not identiﬁed in southern Africa.
Several studies showed comorbidities and low body mass index
(BMI; <18.5 kg/m2) to be variables in eastern, western, and
southern Africa.
An independent association between VDD and increased age
(>55 y) and dark skin photo-type were reported in eastern and
northern Africa. Studies on the use of antiretroviral therapy
(ART) in eastern and southern Africa and anti-TB drugs in
southern Africa indicated that ART drugs reduce vitamin D status
in the body [17,23]. The interactions of sex, ethnicity, and religion
with vitamin D status and TB were also reported in western
Articles retrieved
N=2919
Articles Screened and 
assessed for eligibility
n=36
Articles 
excluded after 
title and abstract 
assessment
n=2839
23articles selected for the 
systematic review analysis
1commentary, 1letter, 
1thesis, 3reviews, 3studies 
on African immigrants 
and 4not measuring 25-
OH-D 
Duplicates 
removed
n=44
Scopus
n=15
Web of science
n=20 
Google 
scholars
n=2870
Medline/PubMed
n=14
Fig. 1. Search strategy and selection process.
Table 2
Laboratory tests used to measure the level of vitamin D in TB patients
Laboratory test Author(s) year [ref.no] 25 nmol/L 50 nmol/L 75 nmol/L
ECLIA Kibirige et al. 2013 [19] 13.5 44.2 85.4
EIA Banda et al. 2011 [20] 20.4 42 74.5
Mastala et al. 2013 [23] 11.2 42.2 74.5
ELISA Mahmoud and Ali 2014 [12] NA 50 72.5
CL Conesa-Botella et al. 2012 [34] NA 24.37 40.34
Cobas E601 Analyser Tostmann et al. 2010 [35] NA 1.23 17.28
ID-LC-MS/MS on API 3000 MS Wejse et al. 2007 [16] 0.28 8.56 46.13
Martineau et al. 2011 [32] 14.05 62.7 88.1
Wejse et al. 2009 [33] NA 8.2 44.7
LC-MS Mehta et al. 2013 [31] NA 15.66 61.74
RIA Conesa-Botella et al. 2012 [21] 45.7 88.9 96.3
Friis et al. 2008 [22] 0.8 10.6 41.2
CLIA Friis et al. 2013 [24] NA 2.5 15
SPE-RE-HPLC Nansera et al. 2011 [28] 12 38 NA
Diasorin Liaison assay Steenhoff et al. 2012 [36] NA 78 NA
API, atmospheric pressure chemical ionization; CL, chemoluminescence; CLIA, chemilumniscent immunoassay; ECLIA, electrochemilumniscence immunoassay; EIA,
enzyme immunoassay; ELISA, enzyme-linked immunosorbent assay; ID-LC-MS/MS, isotope-dilution liquid chromatography-tandem mass spectrometry; LC-MS, liquid
chromatography tandem mass spectrometry; NA, not available; RIA, radioimmunoassay; SPE-RE-HPLC, solid-phase extraction reverse-phase high-performance liquid
chromatography assay; TB, tuberculosis
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Africa [12]. Other predictor variables such as time spent outdoors
<30 min/d and socioeconomic status (SES) were reported in
northern Africa [33,34] and money spent on food per person per
day was also reported in eastern Africa [27]. Compared with TB
patients whowere married, single patients had 10.4 nmol/L (95%
conﬁdence interval [CI], 4.0–16.9) lower concentrations [18].
Discussion
The relationship between vitamin D and TB may be mediated
through the mechanisms of increased cathelicidin production
and enhancement of the capacity of macrophages [8]. Vitamin D
is essential for an interferon-g–mediated pathway in macro-
phages that leads to autophagy, phagosomal maturation, and
other antimicrobial activities against M. tuberculosis [22].
Vitamin D deﬁciency
We have systematically reviewed all publications in peer-
reviewed journals. Some variability was observed in the deﬁni-
tion of VDD. More than half of the studies agreed on serum
25-OH-D concentration 25 nmol/L as an indicator of sVDD;
50 nmol/L as an indicator of VDD; and 75 nmol/L as an
indicator of VDI. In fact, this deﬁnition is in agreement with a
previously described deﬁnition [13].
Our systematic review also identiﬁed that VDD is common
in TB patients living in Africa. The highest prevalence of VDD
(42%–88.9%) and VDI (74.5%–96.3%) were reported in southern
Africa [16,17,19,28,32]. All the studies reported the prevalence
of VDD 88.9%. In relation, 86.7% (13 of 15) of the studies
showed a prevalence of VDI that reached 96.3%. These ﬁnd-
ings imply that VDD and VDI are very common among patients
with TB in Africa. In contrast, few studies reported the prev-
alence of sVDD in patients with TB, ranging from 0.2% to 45.7%.
This is very low compared with the prevalence of VDD
and VDI.
Predictors of vitamin D deﬁciency
The deﬁciency of sunshine-derived vitamin in the sunny
continent was not expected. However, VDD and VDI were iden-
tiﬁed as a common problem among patients with TB in Africa.
But what are the predictors of these deﬁciencies in Africa? The
present study summarized the major predictors as discussed
hereafter.
Lack of sun exposure and inadequate diet intake
Almost all eligible studies reported lack of sun exposure and
inadequate diet intake as predictors of VDD among patients with
TB in Africa. The major source of vitamin D for most humans
comes from sun exposure, typically between 1000 and 1500 h in
spring, summer, and fall [7]. However, data on duration of sun
exposure in Africa were missed. During sun exposure,
the UVB (290–315 nm) portion of sunlight photolyzes
7-dehydrocholesterol (7-DHC) in the epidermis to previtamin D3
[37]. Once formed, previtamin D3 undergoes thermal isomeri-
zation to form vitamin D3.
The amount of solar UVB radiation reaching the biosphere is a
function of the solar zenith angle and depends on latitude,
season, and time of the day [38]. Only brief daily sun exposure is
required to produce adequate vitamin D, and excess sun expo-
sure converts cholecalciferol to inactive metabolites [18]. Other
predictor variables affect vitamin D status through impeding the
intensity of sun exposure and affecting dietary intake. It was
initially thought that both vitamin D2 and vitamin D3 follow the
same metabolic pathway. However, minor differences in the
chemistry of side chains between the two forms of vitamin D
result in differences in the site of hydroxylation and leads to the
production of unique biologically active metabolites. Supple-
mentation of vitamin D2 produces appreciable amounts of serum
25-OH-D2, which has a lower afﬁnity for vitamin D–binding
protein and results in a shorter circulating half-life than that of
25-OH-D3 [39].
Few foods naturally contain vitamin D, including oily ﬁsh
such as salmon, mackerel, and herring; and oils from ﬁsh,
including cod liver oil [13]. Sufﬁcient amounts of vitamin D are
obtained from wild ﬁsh compared with those that are culti-
vated [38]. This may be due to the ergosterol (previtamin D2)
and 7-DHC (previtamin D3) content of plankton and
zooplankton in the biomass. Sundried mushroom is rich in
ergocalcipherol (vitamin D2) [7] and small amounts of chole-
calciferol (vitamin D3) can be obtained from liver, meat, egg
yolk, and dairy products [40], which are rarely consumed by
people in Africa [2].
Season
Although seasonal variation in vitamin D status in Africa is
not expected, the present systematic review identiﬁed season as
the major predictor variables of VDD. A study done in Tanzania
showedmean vitamin D concentration of 74.8 nmol/L for January
through February, and 66.3 nmol/L for July through October [27].
Similarly, another study showed VDI is very common in Moroc-
can women during the summer season [34]. In Guinea Bissau,
more cases of hypovitaminosis D were found during the rainy
season [12].
An 8-y period study in South Africa showed the highest
concentration of serum 25-OH-D from January through March
and lowest from July through September (56.8 versus
30.7 nmol/L, respectively; P < 0.001) [28]. A study conducted on
reciprocal seasonal variation in TB notiﬁcations also indicated
the highest number of TB cases from October through
December (4222 versus 5080; P < 0.001) and the lowest from
April through June [28]. These ﬁndings imply that seasonal and
year-to-year variations reﬂect true differences in vitamin D
status over time, due to variation in sun exposure and dietary
intake [20].
Table 3
Threshold levels
Categories of
vitamin D
deﬁciency
Reported
threshold values
Studies
reporting these
values (n)
References
ng/mL nmol/L
Severe deﬁciency 5 12.5 2 19,37
<8 <20 1 25
<10 <25 6 16,19–23
<11 <27.5 1 32
<12 <30 2 30,38
Deﬁciency 10–20 25–50 2 20,22
11–16 27.5–40 1 25
12–19 30–47.5 1 28
<15 37.5 1 37
<20 <50 17 12,16,19,21,23,24,
26,27,29–36,38
Insufﬁciency <30 <75 12 12,16,21,23,24,29,
31–34, 37,38
11–28 27.5v70 1 25
20–30 50–75 5 20,22,26,27,35
21–29 52.5–72.5 1 19
<32 <80 1 39
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Clothing, comorbidities, and low BMI
Studies conducted in eastern, western, and northern Africa
identiﬁed clothing as a predictor of VDD [25,26,33]. Findings of
low vitamin D status in Addis Abeba, Ethiopia were explained by
clothing habits, leaving little skin open to sun exposure [26]. A
study done in Nigeria revealed that pregnant women using veils
for religious reasons had signiﬁcantly lower s-calcidiol levels
compared with nonveiled women [41]. Similarly, clothing was
identiﬁed as the most important factor inﬂuencing hypovitami-
nosis D in Morocco [34]. Muslim custom dictates females to
cover most of their skin surface in the public. One study
described that because they are Muslim, the women do not
derive much beneﬁt from sunlight [25]. Likewise, the associa-
tions between ethnicity, clothing, and hypovitaminosis D were
also reported in western Africa [12].
Although the cause–effect relationship has not yet been ruled
out, comorbidities with TB [18–20,28,32], HIV [17,20,22,24,27,28,
35], pneumonia [21], oral thrush [23], and heart failure [19] were
identiﬁed as predictors of VDI in eastern, western, and southern
Africa. These infectious and noninfectious diseases may attribute
to VDD and VDI by a reduction in appetite and by restricting
outdoor physical activities.
In line with this, a positive relationship between BMI
(<18.5 kg/m2) and VDD was identiﬁed in Africa [15,16,18–20,
22–25,28]. In fact, BMI is usually a measure of underweight in
developing countries. A lack of adipose tissues in underweight
patients leaves them unable to store vitamin D, meaning these
patients have no reserves when external sources are lacking.
Use of ART and anti-TB drugs
A cross-sectional study conducted in Malawi identiﬁed the
use of ART as signiﬁcant predictor variable of VDD [19]. Another
longitudinal study done in South Africa demonstrated that the
use of nucleoside reverse transcriptase inhibitors decreases
25-OH-D concentration [17]. Additionally, VDD during ART
initiation had signiﬁcantly increased the risk for pulmonary TB
and oral thrush infections [23]. It was previously reported that
the use of anti-TB drugs can attribute to decreases in serum
25-OH-D levels [30].
In contrast, it has been shown that 25-OH-D concentrations
increased during the ﬁrst 2 mo of TB treatment [31]. The
association between the use of drugs and 25-OH-D concen-
tration is ascribed to the pharmacology of the drugs [42]. Two
of the standard ﬁrst-line anti-TB drugs, isoniazid (INH) and
rifampicin (RMP), are known for inhibiting and inducing
cytochrome P450 (CYP) activity, respectively, and can affect
vitamin D metabolism. INH reduces 25-OH-D and 1,25-(OH)
2-D concentrations by the inhibition of 25-hydroxylase, as has
been shown in in vitro and animal studies and in humans
[43–46].
RMP is a strong inducer of CYP3A4 [47], which is a vitamin D
24- and 25- hydroxylase [48]. Induction of these enzymes in-
creases the enzymatic conversion of 25-OH-D to the inactive
metabolite 24,25-(OH)2-D and results in decreased 25-OH-D and
1,25(OH)2 D concentrations, as shown in studies in humans [46].
Combined use of INH and RMP reduces 25-OH-D and 1,25-(OH)2-
D concentrations in healthy individuals and patients with
TB [31].
Age, sex, and marital status
The mean and median ages of the majority of study partici-
pants were>30 y. Studies done in Uganda [15] and Morocco [33]
revealed that increasing age was independently associated with
VDD. Additionally, it has been noted half of the population of
Europe >60 y of age have VDD [49]. This is justiﬁed by the in-
verse relationship between age and previtamin D3 concentration
in the epidermis [50]. Moreover, older individuals are not
frequently exposed to sunlight.
The difference between sex and vitamin D status was also
observed in western Africa. Most (83%) Fulani women have poor
25-OH-D concentration [25]. This was explained by the differ-
ence in skin exposure between men and women in the tribe. Sex
was also identiﬁed as a signiﬁcant risk factor of VDD in the
Middle East and North African [51]. A study conducted in eastern
Africa reported that unmarried patients have lower serum 25-
OH-D concentration compared with married patients, possibly
due to behavioral variations leading to work-related differences
in sun exposure [18].
Skin pigmentation, SES, time spent outdoors, and money spent on
food
This systematic review encompassed solely studies done in
Africa and hence almost all participants had pigmented skin.
The production of previtamin D3 is dependent on the concen-
tration of 7-DHC and melanin pigmentation [50]. To synthesize
the same amount of vitamin D, dark-skinned individuals require
three to four times longer sun exposure than light-skinned
persons because melanin efﬁciently absorbs UVB radiation
[52]. In relation, two studies reported skin pigmentation as a
signiﬁcant predictor of VDD in eastern and northern Africa,
respectively [26,34].
A study conducted in northern Africa showed a signiﬁcant
association between poor SES and VDD [34]. Hypovitaminosis D
was also associated with the time spent outdoors <30 min/
d (odds ratio, 2.8; 95% CI, 1.4–5.7; P ¼ 0.003) [33]. One study
indicated that a 10-min exposure of the head and uncovered
arms three times per week would be sufﬁcient to prevent VDI
[33]. Similarly, money spent on food per person per day has an
interaction with low 25-OH-D concentrations [27].
Limitations of the analysis
The ﬁrst limitation of this systematic review was the lack of
representative studies from central Africa. Four databases were
searched to retrieve all published articles but we could not ﬁnd
any studied from central Africa. Second, there was heterogeneity
in study designs, sample sizes, and laboratory tests. Although
four studies used case–control study design, three did not report
vitamin D status in detail. The remaining study was also
unmatched, thus making it difﬁcult to draw conclusions about
the direction of a potential cause–effect relationship between
VDD and TB. In some studies, the sample size was small and the
probability of detecting small differences would be very low.
Selection bias was also observed in volunteers and hospital-
based studies as most studies focused on smear-positive TB
patients and rarely on smear-negative TB patients. In relation,
there could be some variation in measurements as many studies
used different laboratory tests.
Conclusion
VDD and VDI were highly prevalent among TB patients in
Africa. These were attributed to the existence of predictors such
as a lack of sun exposure, inadequate dietary intake, season,
clothing, comorbidities, age, low BMI, skin pigmentation, use of
ARTand anti-TB drugs, SES, time spent outdoors, money spent on
food, sex, and marital status. Understanding the problems with
their predictors enable us to further question the association
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between vitamin D status and TB and what should be done to
address the problem. In fact, the options are vitamin D supple-
mentation, food fortiﬁcation, and biofortiﬁcation, but these are
economically less feasible. Could we suggest sun exposure for
free to lessen the burden of VDD and TB? Therefore, further case–
control studies are warranted to clarify the cause–effect
relationship between vitamin D and TB to understand the
interaction between vitamin D status and disease progression,
and thereby, to design valuable strategies tomanage VDD among
TB patients in Africa.
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a b s t r a c t
Vitamin D deficiency is a pandemic problem. Non-animal source of vitamin D is obtained from edible
mushrooms. Oyster mushroom (Pleurotus ostreatus) was sliced into the size of 1 cm3, 4 cm3 and 9 cm3,
and treated with the sun as a natural resource of UVB under subtropical settings in Ethiopia. The content
of vitamin D was measured by using high-performance liquid chromatography (HPLC). After sun treat-
ment, there was a significant increment in the content of vitamin D2 from nil to 67.4 ± 28.0 mg/g dry
weight (DW). Based on the results of the overall pairwise comparisons, 1 cm3 size of slice group had
the highest content of vitamin D2. Duration of sun exposure, sizes of mushroom slices and moisture con-
tent were identified as determining factors for vitamin D2 synthesis. Exposing slices of oyster mushroom
to the sunlight for <30 min provides the amount that satisfies the current recommended dietary allow-
ance (RDA) of vitamin D without any visible change in color and texture. Thus, sun treatment of oyster
mushroom is an effective and economically cheap strategy in the fight against vitamin D deficiency.
 2018 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Vitamin D deficiency is a pandemic and an ever-increasing
problem in human nutrition and health. It is estimated that
30–50% of individuals in Europe and the U.S. have insufficient
levels of vitamin D (Battault et al., 2013; Holick, 2009; Mansoor
et al., 2010). In Africa, more than 80% of the people are prone to
vitamin D deficiency (Keflie et al., 2015).
Oyster and other edible mushrooms have been recognized as a
source for vitamin D since 1994 (Mattila et al., 1994). Mushrooms
are the only non-animal food source that contains vitamin D
(Valverde et al., 2015). Ergosterol is the principal sterol and precur-
sor for vitamin D2 in mushrooms. It is converted via absorption of
ultra violet B (UVB) light energy (290–320 nm). The absorption of
light causes the isomerization of the molecule and bond cleavage
between carbons 9 and 10, resulting in unstable intermediate
‘‘pre-vitamin D2”. The conversion of pre-vitamin D2 to vitamin D2
then follows via a thermally catalysed process (Chen et al., 2010;
Simon et al., 2011; Keegan et al., 2013).
The formation of ergocalciferol starts without delay after expo-
sure to UVB light. As UVB light is not able to penetrate deeply into
the fruiting body, the reaction rate must cease when the superficial
ergosterol is used up. The yields of ergocalciferol are thus limited,
but at the same time the risk of accumulating extreme doses is low
(Krings and Berger, 2014). Prolonged exposure in the sun-exposed
samples can significantly produce irreversible, over-exposed prod-
ucts by dimerization and ring cleavage of pre-vitamin D2 and
tachysterol (Keegan et al., 2013; Urbain et al., 2016).
Besides of the wavelength of UV irradiation, the efficiency of
vitamin D2 synthesis in mushrooms can be influenced by multiple
parameters such as ambient temperature, exposure time and irra-
diation intensity. It is not known whether the effects of these fac-
tors are independent or interactive (Wu and Ahn, 2014).
So far, very few studies conducted until recent time focused on
the natural resource of UVB irradiation for the synthesis of vitamin
https://doi.org/10.1016/j.sjbs.2018.07.014
1319-562X/ 2018 Production and hosting by Elsevier B.V. on behalf of King Saud University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abbreviations: AI, adequate intake; DRI, dietary reference intake; IU,
international unit; RDA, recommended dietary allowance; UVB, ultra violet ray B.
⇑ Corresponding author at: Institute of Biological Chemistry and Nutrition (140a),
70593 Stuttgart, Germany.
E-mail addresses: Tibebeselassie_Keflie@uni-hohenheim.de (T.S. Keflie),
noelle@uni-hohenheim.de (N. Nölle), christine.lambert@uni-hohenheim.de
(C. Lambert), donatus.nohr@uni-hohenheim.de (D. Nohr), biesal@uni-hohenheim.
de (H.K. Biesalski).
Peer review under responsibility of King Saud University.
Production and hosting by Elsevier
Saudi Journal of Biological Sciences xxx (2018) xxx–xxx
Contents lists available at ScienceDirect
Saudi Journal of Biological Sciences
journal homepage: www.sciencedirect .com
Please cite this article in press as: Keflie, T.S., et al. Impact of the natural resource of UVB on the content of vitamin D2 in oyster mushroom (Pleurotus
ostreatus) under subtropical settings. Saudi Journal of Biological Sciences (2018), https://doi.org/10.1016/j.sjbs.2018.07.014
50
D2 (Simon et al., 2011; Urbain and Jakobsen, 2015; Urbain et al.,
2016; Nölle et al., 2017). Of these studies, none of them addressed
the potential effects of the sun on vitamin D2 production under
tropical and subtropical settings. There is also a scarce information
on the content of vitamin D2 in oyster mushroom. Nowadays, cul-
tivated oyster mushroom is available in the markets of some areas
in Ethiopia. Therefore, this study was designed to assess the impact
of the natural resource of UVB irradiation on the content of vitamin
D2 in oyster mushroom under subtropical settings.
2. Material and methods
2.1. Chemicals
The internal standard (vitamin D3) and external standard (vita-
min D2) were purchased from ENZO Life Sciences (Germany),
whereas potassium hydroxide was purchased from Merck and
ascorbic acid from AppliChem GmbH (Germany).
2.2. Experimental design
The experiment was undertaken on oyster mushroom. The sam-
ples of oyster mushrooms were categorized into sun treated and
non-treated groups. Non-treated group was used as a control
group of the experiment. The third group was added for further
comparisons and irradiated with artificial UVB irradiation.
2.3. Mushrooms
Samples of oyster mushrooms for sun treatment and control
groups were purchased from the local super market in Addis
Abeba, Ethiopia on September 24, 2016. Those samples under the
group of sun treatment were immediately processed and were
either left whole or sliced manually using a knife and ruler into
1 cm3 (1 cm  1 cm  1 cm), 4 cm3 (2 cm  2 cm  1 cm) and
9 cm3 (3 cm  3 cm  1 cm) size of slice groups. The control group
was placed into black plastic bag, knotted tightly, labelled and
stored at minus 80 C. The mean ± standard deviation (SD) of single
mushroom stock was 32.7 ± 4.1 g with cap diameter of 8.2 ± 0.9 cm
and stem length of 10.4 ± 0.5 cm (n = 12).
2.4. Sun treatment
Sun treatment was conducted between 8:00 am and 4:00 pm on
24 and 25 September 2016 at Aleltu town. This town is situated at
9 110 47 N, 39 90 12 E, and 2350 m above sea level in the
north-eastern part of Addis Abeba, the capital city of Ethiopia.
The minimum and maximum temperatures during the process of
sun treatment were 21 C and 34 C, respectively. On both days,
the sky was cloudless. Samples were divided into the above-
mentioned size groups. Each of the samples was positioned
horizontally and exposed to the sun light for the durations of either
30 min, 1 h, 3 h, 8 h or 16 h. In every 15 min for the first 1 h and in
every 30 min later, the samples were turned around to expose all
parts equally to the sun light. Changes in color and texture were
checked every time during the process of turning. Like control
group, the samples were placed into black plastic bags, knotted
tightly, labelled and stored at minus 80 C immediately after their
treatment period was over.
2.5. Samples transportation
The samples were packed into an insulated plastic bags
together with dry ice and transported to University of Hohenheim,
Stuttgart, Germany where further laboratory analyses were
performed. Immediately after arrival, the samples were stored at
minus 80 C.
2.6. UVB irradiation
Samples for artificial UVB irradiation were purchased from a
local supermarket in Stuttgart, Germany. Like the groups for sun
treatment, the samples were divided into four groups: 1 cm3,
4 cm3, 9 cm3 size slices and whole size. All the samples including
a sample of lyophilized powder were horizontally placed on
the shelf of irradiation chamber equipped with UVB-lamps
(Dr. Groebel, GmbH, Ettlingen, Germany). Each side of the samples
was irradiated up to a UVB dose of 1.5 J/cm2 at 22 C.
2.7. Lyophilisation, pulverization and moisture content determination
All treated and non-treated samples were lyophilized with a
Telstar LyoQuest freeze drier (Azbil Telstar Technologies SLU,
LyoQuest-85 year 2014, Spain) and then, pulverized and homoge-
nised into fine powder using a grinding mill (TH. Geyer, Germany)
at Institute of Biological Chemistry and Nutrition, University of
Hohenheim. The powders were kept in an airtight plastic bag
and stored at minus 20 C until used for laboratory analyses. The
moisture content was determined using oven drying method at
the Institute of Agricultural Engineering, University of Hohenheim.
2.8. Vitamin D extraction
Triplicate samples were taken from each group for the measure-
ment of vitamin D2. The extraction of vitamin D2 was carried out
based on the method of Nölle et al. (2017) with some modifica-
tions. Samples of pulverized and homogenized powder (1 g) were
mixed with 19 mL of ethanol (with a chemical purity of 99.7%),
4 mL of 50% potassium hydroxide (500 g KOH in 1 L of H2O),
1.333 mL of sodium ascorbate (1.75 g solved in 10 mL of 1 M
sodium hydroxide) and 1 mL of vitamin D3 (100 mg/L) as internal
standard in a 50 mL falcon tube. The mixture was vortex mixed
and subsequently saponified for 1 h in a water bath at 80 C. The
mixture was then cooled to ambient temperature in ice water. To
promote a better separation of the layers, 10 mL of saturated
sodium chloride solution was added. Subsequently, 15 mL of
n-hexane was added, vortex mixed and centrifuged for 8 min at
4500g (Heraeus, Hanau, Germany). The n-hexane layer was trans-
ferred into a new falcon tube and the extraction processes were
repeated twice, one time with 15 mL of n-hexane and later with
10 mL of n-hexane. The pooled organic layers were washed three
times with deionised water until neutralized. The organic layer
was then transferred into a 100 mL round bottom flask and rotary
evaporated to dryness. The flask was rinsed with 6 mL of n-hexane
and transferred into 10 mL of round bottom flask and, rotary
evaporated again. Once evaporated to dryness, the sample was
immediately re-dissolved in 1 mL of tetrahydrofuran and vortex
mixed. Thereafter, the samples were centrifuged for 5 min at
1600g at 20 C to remove impurities and then used for subsequent
analyses by HPLC.
2.9. HPLC analysis
A system of HPLC (Shimadzu technologies) equipped with a
DGU-20A3R degassing Unit, two LC-20AT pumps, a SIL-20ACHT
auto sampler and a CBM-20A communication bus module (Shi-
madzu GmbH, Duisburg, Germany) was used to measure vitamin
D2 content at the Institute of Biological Chemistry and Nutrition.
The column used was a Reprosil 80 ODS-2 analytical column,
4.6  250 mm, 3 mm particle size (Dr. Maisch GmbH, Ammerbuch,
Germany). The mobile phase was composed of acetonitrile (77%),
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deionized water (14%) and tetrahydrofuran (9%) at a flow rate of
2 mL/min with a total run time of 42min. The injection volume
was 10 ml and detection was carried out by diode array detector at
a wavelength of 265 nm. A set of six calibration standards of vitamin
D2 and D3 were prepared with the contents of 10, 20, 100, 200, 300
and 400 mg/mL, respectively. The Lab Solution software was used for
HPLC control as well as acquisition and quantification of data.
2.10. Statistical analyses
Statistical analyses were performed using IBM SPSS statistics
version 23. The normality of the data distribution was checked
by Shapiro-Wilk’s normality test. Graphs were generated with
Microsoft Excel. The content of each analyte was described as
mean ± standard deviation (SD). Pre-and post-treatment compar-
isons were analysed by paired two sample t-test for means. The
effects of two independent variables on the continuous dependent
variable were examined using two-way of analysis of variance
(two-way ANOVA) and the estimated marginal means were com-
pared with least significant difference (LSD) post hoc test. A
p < 0.05 was considered as statistically significant.
3. Results and discussion
3.1. Moisture content, color and texture changes
In the present study, the overall moisture content of oyster
mushroom was 92.5%. During the process of sun treatment,
changes in colour, texture and moisture content were observed
on the samples. Fig. 1 demonstrates the differences before and
after sun treatment. The description in Table 1 shows the percent-
age of the loss of moisture and the extent to which the color and
texture changed. In 1 cm3 size group, more than 67% of moisture
content was lost within 3 h of sun exposure, followed by brown
coloration and shrivelled texture. Within the same duration of
sun exposure, the whole size group lost about 35% of moisture con-
tent with minor change in color and texture. In 9 cm3 size group,
about 12% of the moisture content was lost within 30 min of sun
exposure without any observable change in color and texture. With
equal durations of sun exposure, about 19% of the moisture content
was lost in 1 cm3 size group. This shows that increasing the surface
area to volume ratio for sun exposure increases the loss of mois-
ture with rapid change in color and texture.
The loss of moisture and shrivelled texture were due to evapo-
ration of the moisture, whereas the color change was as the results
of enzymatic reaction in the tissue of the mushroom. Kalac (2013)
described that the color changes are usually caused by the pres-
ence of tyrosinase enzyme. This enzyme catalyses tyrosin to be oxi-
dized to o-dihydroxyphenylalanine (DOPA), then to brown
quinonic pigments and eventually to melanins (Kalac, 2013). The
reported tissue discoloration could affect the aesthetic value of
mushrooms for consumption.
3.2. Vitamin D2 as the result of sun exposure
The chromatograms in Fig. 2 shows the content of vitamin D2 in
non-treated and sun treated oyster mushrooms. The content of
vitamin D2 increased from nil to considerable levels with different
slice sizes and durations of sun exposure. The maximum content of
vitamin D2 was produced in 1 cm3 size of slice group (67.4 ± 28.0
mg/g dw). Shapiro-Wilk’s test with Liliefors significance correction
(p > 0.05) indicated that the contents of vitamin D2 were normally
distributed in 1 cm3, 4 cm3 and 9 cm3 size of slice groups. For all
vitamin D2 measurements, the coefficient of variation was <13.5%.
For further comparisons, the mean content of vitamin D2 in 1
cm3 size of slice group was used. The mean of vitamin D2 in 1
cm3 size in the present study was higher than the reports of
Jasinghe and Perera (2005) on oyster mushrooms (45.1 ± 3.1 mg/g
dw); Nölle et al. (2017) on brown button mushrooms (36 mg/g
dw); and Simon et al. (2011) on white button mushrooms
(3.7 ± 0.9 mg/g dw). These variations may arise from the type of
mushrooms used for experiments, the differences in the duration
and intensity of sun exposure, and the place of cultivation. Fig. 3
depicts the content of vitamin D2 across the durations of sun expo-
sure and slice sizes of oyster mushrooms. The figure shows that the
contents of vitamin D2 were increased with the durations of sun
exposure.
The mean ± SD of vitamin D2 contents produced in 30 min,
1 h and 3 h of sun exposure were 28.5 ± 8.5, 36.6 ± 8.7 and
73.7 ± 12.9 mg/g dw, respectively. In 1 h of sun exposure, Urbain
and Jakobsen (2015) obtained 3.9 mg/g dw of vitamin D2 from
white button mushroom in Germany. But, Simon et al. (2011)
obtained 3.8 mg/g dw of vitamin D2 from white button mushroom
exposed to the sun for 2.5 h in United States of America. These
two results were by far lower than the present findings. Possible
explanations for the discrepancies in vitamin D2 contents are the
differences in the latitude and altitude of the locations, cultivars/
types, sizes of the mushroom preparations, moisture contents
and temperature as well as duration and intensity of sun exposure.
Latitude and season affect both the quantity and quality of solar
radiation reaching the surface of the earth which in turn have an
influence on the synthesis of vitamin D (Webb et al., 1988).
During the first 3 h of sun exposure, vitamin D2 contents were
rapidly increased in all size groups and the maximum content
was found in 1 cm3 size of slice group with mean ± SD of
88.1 ± 3.1 mg/g dw. Some fluctuations in the distribution of vitamin
D2 were observed along with the durations of sun exposure. From
3 h to 8 h of sun exposures, the content of vitamin D2 in 1 cm3 size
Fig. 1. Oyster mushroom before (A) and after (B) sun treatment.
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Table 1
Percentage of moisture loss and changes in color and texture of sun treated oyster mushroom.
Size Duration of sun exposure (hour) Loss of moisture (%) Minimum Temp. (C) Maximum Temp. (C) Color change Texture change
1 cm3 0.5 19.3 21 23 Not observable None
1.0 31.4 21 27 Very light brown Very slight shrinking
3.0 67.0 21 32 Brown Shrank
8.0 91.0 21 34 Dark brown Totally shrank
16.0 90.2 21 34 Dark brown Totally shrank
4 cm3 0.5 11.4 21 23 Not observable None
1.0 27.4 21 27 Very light brown Very slight shrinking
3.0 59.7 21 32 Light brown Shrank
8.0 89.7 21 34 Dark brown Totally shrank
16.0 90.9 21 34 Dark brown Totally shrank
9 cm3 0.5 12.0 21 23 Not observable None
1.0 23.4 21 27 Not observable Not observable
3.0 62.2 21 32 Brown Shrank
8.0 90.2 21 34 Dark brown Totally shrank
16.0 90.7 21 34 Dark brown Totally shrank
Whole 0.5 0.5 21 23 Not observable None
1.0 7.6 21 27 Not observable None
3.0 35.0 21 32 Very light brown Very slight shrinking
8.0 74.6 21 34 Brown Shrank
16.0 90.8 21 34 Dark brown Totally shrank
Fig. 2. HPLC chromatograms of vitamin D2 analysis in non-treated oyster mushroom (A) and sun treated oyster mushroom (B). Vitamin D3 was used as internal standard.
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of slice group was decreased but from 8 h to 16 h of sun exposure
its content was increased again. Per the results of the overall pair-
wise comparisons, 1 cm3 size of slice group had significantly higher
content of vitamin D2 than 4 cm3, 9 cm3 and whole size groups in
1 h, 3 h and 16 h of sun exposures (p < 0.05).
There were statistically significant differences in vitamin D2
contents among different size groups (p < 0.05). The contributions
of durations of sun exposure, size of slice groups and the interac-
tion of the two were also statistically significant on the content
of vitamin D2 in oyster mushroom (p < 0.05). The overall distribu-
tions of vitamin D2 indicated that the smaller the mushroom sliced,
the higher the content of vitamin D2. These results were corrobo-
rated with the findings of Urbain and Jakobsen (2015), and
Urbain et al. (2016). Nölle et al. (2017) also observed the highest
conversion of ergosterol to vitamin D2 in sliced fruit bodies in
2016.
The effects of durations of sun exposure on the content of vita-
min D2 were also statistically analysed. More than 93% of the vari-
ations in vitamin D2 contents amongst 1 cm3, 4 cm3, 9 cm3 and
whole size groups were accounted for by the duration of sun expo-
sure. As compared to durations of sun exposure, the size of slices in
the group had smaller effects on the content of vitamin D2. After 8
h of sun exposure, there was no statistically significant difference
in the contents of vitamin D2 across all size groups (p > 0.05). How-
ever, in 16 h of sun exposure, the difference in the contents of vita-
min D2 became significant. This showed the variabilities in the
contents of vitamin D2 in extended periods of sun exposure. One
of the factors that account for such variabilities is the intensity of
UVA irradiation. The longer wavelength UVA present in sunlight
could potentially photodegrade vitamin D (Chen et al., 2010).
Vitamin D2 may also be subjected to the action of tissue mono-
oxygenases that reduce the overall conversion of ergosterol to vita-
min D2 (Jasinghe and Perera, 2005). However, in the presence of
ergosterol, the conversion processes might eventually resume
and elevate the concentration of vitamin D2 as the case of 16 h of
sun exposure in our findings. The efficacy of ergosterol to vitamin
D2 conversion was positively dependent on the irradiation inten-
sity. The content of vitamin D2 dramatically increases when the
irradiation intensity increases (Wu and Ahn, 2014).
3.3. Vitamin D2 as the result of UVB irradiation
An experiment on artificial UVB irradiation was conducted for
the sake of comparisons. The bar graphs clearly depicted the
differences of the contents of vitamin D2 across the size of
slice groups (Fig. 4). The maximum content of vitamin D2 was
814.1 ± 21.9 mg/g dw which was measured in 1 cm3 size of slice
group. This amount was more than 9 folds higher than the one
produced with 3 h of sun exposure in the same size group. In
agreement with this, Urbain and Jakobsen (2015) noted that the
content of vitamin D2 produced with artificial UVB irradiation
was more than 10 folds higher than the one produced with solar
radiation during the process of drying.
Wu and Ahn (2014) obtained 239 ± 4.5 mg/g dw of vitamin D2
content in oyster mushroom with operational conditions of
28.2 C, 94.28min and 1.14W/m2. This value was lower than the pre-
sent finding in the whole size oyster mushroom (316.0 ± 5.1 mg/g
dw). Urbain et al. (2016) reported the highest vitamin D2 content
after the largest UVB dose of 2.01 J/cm2 and consisted of
101.5 ± 4.3 mg/g dw. However, this finding was nearly 8 times lower
than our finding in 1 cm3 size of slice group (814.1 ± 21.9 mg/g dw).
This difference could be emanated from the difference in moisture
content, types and sizes of mushroom slices as well as the doses of
UVB irradiation.
With the same operational condition, Wu and Ahn (2014) found
498.1 mg/g dw of vitamin D2 content in lyophilized powder. How-
ever, this finding was higher than our finding in lyophilized pow-
der (314.5 ± 8.2 mg/g dw). With equal dose of UVB irradiation, the
content of vitamin D2 in lyophilized sample was 2.6 times lower
than the one in 1 cm3 size of slice group. One of the reasons for
such a difference could be moisture content. Lyophilized powder
contained very little moisture content as compared to 1 cm3 size
of slice group. This in turn ascertained the essentiality of the mois-
ture content which is important for the dilution of ergosterol in the
photochemical reaction and its conversion to vitamin D2. Perera
et al. (2003) reported that the conversion of ergosterol to vitamin
D2 was affected by the moisture content of the mushrooms.
Further comparison was made on lyophilized powder. One
group of lyophilized powder was exposed to the sun for 20 min
and compared with the one irradiated with artificial UVB. The con-
tent of vitamin D2 produced in the former was about 31 times
lower than in the latter. These results clearly showed how the dif-
ference in the doses of UVB irradiation influences the production of
vitamin D2 in oyster mushroom.
3.4. Contribution of sun treated oyster mushroom
In general, vitamin D2 is effectively produced in oyster mush-
room under sun treatment. Vitamin D2 has similarity with vitamin
D3 in physiological responses such as regulation of calcium and
phosphate homeostasis and, cell proliferation and differentiation
(Jones et al., 1998; Jurutka et al., 2001). Although there is a slight
Fig. 3. Contents of vitamin D2 across different sizes groups and duration of sun exposure.
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difference in the chemical structure at the side chains, recent
reports confirmed that vitamin D2 is as effective as vitamin D3 in
maintaining the contents of 25-hydroxy vitamin D in the blood
(Biancuzzo et al., 2010; Urbain et al., 2011; Keegan et al., 2013).
Hence, its importance in the fight against vitamin D deficiency is
worth noting particularly in tropical and subtropical areas.
The analyses done based on the dietary reference intakes (DRI)
revealed that sun treated oyster mushroom contained a large
amount of vitamin D2. For instance, a group of 9 cm3 size slices
of oyster mushroom which was treated with sun for 30 min pro-
duced vitamin D2 to the levels equivalent to 40.9 ± 5.1 mg/g dw.
This was comparable to the content of vitamin D3 in cod liver oil
(40.3 mg per 1 tablespoon) (Bueno and Czepielewski, 2008).
A regular 100 g serving of such mushrooms could provide vita-
min D2 more than 20 times of the current recommended dietary
allowance (RDA) of 15 mg (600 IU) for all ages between 1 and 70
years as indicated in Table 2 (IOM, 2010; Simon, et al. 2011;
EFSA, 2016). In other words, 5 g fresh weight of such mushrooms
are sufficient to satisfy the RDA of vitamin D.
3.5. Limitations
In the present study, no measurements were taken on the UVB
doses of different durations of sun exposure. In addition, data on
the contents of other UV sensitive substances in the oyster mush-
rooms like vitamin C or b-carotenes were not included in this
study. However, food composition tables show that oyster mush-
rooms do not provide notable amount of such substances.
4. Conclusion
In conclusion, sun-treated oyster mushroom is an excellent
resource of vitamin D2 which is comparable to the content of vita-
min D3 in cod liver oil. Increasing the surface areas of sun exposure
maximizes the synthesis of vitamin D2 in oyster mushroom. Our
findings also indicated that duration of sun exposure, sizes of
mushroom slices and their moisture content at the time of sun
exposure are the factors that determine the synthesis of vitamin
D2. Exposing slices of oyster mushroom to the sun light for a brief
period (30 min) provide the amount that satisfies the current
RDA of vitamin D2 without any visible change in color and texture.
Thus, sun treatment of oyster mushroom is an effective and eco-
nomically cheap strategy in the fight against vitamin D deficiency
particularly in tropical and subtropical areas where there is a year-
round sun shine. In the future, further researches are warranted to
precisely understand the clinical importance of vitamin D2 and the
changes in the chemical compositions of oyster mushrooms as
imparted by sun-treatment.
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Abstract 
Background: Despite the availability of effective antimicrobials, tuberculosis (TB) remains as 
a public health threat globally. There is a need for simple and inexpensive strategies to improve 
the treatment outcomes of TB. Due to its immunomodulatory and antimicrobial properties, 
vitamin D could be one of the potential candidates.   
Objective: To deal with the potential use of vitamin D2 derived from sun-exposed oyster 
mushroom as adjunctive therapy to standard anti-TB treatment.  
Methods: Randomized controlled trial was conducted on 64 pulmonary TB patients (32 
assigned to intervention and 32 assigned to control) in North Shewa, Ethiopia. Intervention 
group was provided with a sandwich bread prepared from sun-exposed oyster mushroom 
containing 146 µg (5840 IU) vitamin D2 continuously from Monday to Friday during the first 
16 weeks of anti-TB treatment. Blood and sputum specimens were taken at the beginning and 
end of the study. The primary outcomes were changes in vitamin D status, clinical 
improvements (assessed by TB score and Karnofsky performance status scale) and 
immunologic responses. Sputum smear and culture conversion were evaluated as secondary 
outcomes. P<0.05 was considered as statistically significant.  
Results: Vitamin D2 intervention brought significant difference of 8.1 ± 6.2 ng/mL (95% CI: 
5.9 to 10.3 ng/mL) in the serum 25-hydroxy vitamin D (25(OH)D) level and corrected vitamin 
D deficiency in more than 35% of TB patients. After intervention, 96.9% vs 21.5% of TB 
patients found in TB score Severity Class (SC)-I and had mean ± SD of Karnofsky performance 
status scale of 80.3 ± 6.9% vs 64.7 ± 5.7% in the intervention group vs control group, 
respectively. Interferon (IFN)- and cathelicidin LL-37 levels were showed significant 
improvement solely in the intervention group. But, the changes in the levels of Interleukin (IL)-
4 and IL-10 as well as sputum smear culture conversion were not significant in both groups.  
Conclusion: Vitamin D2 derived from sun-exposed oyster mushroom was effective in 
improving vitamin D status, clinical outcomes and immune responses. And hence, it could 
serve as potential, safe, easily available and cost-effective adjunctive therapy for TB.  
 
 
Key words: Vitamin D2, sun-exposure, oyster mushroom, TB, adjunctive treatment 
 
Abbreviations: 25(OH)D, 25-Hydroxy Vitamin D; AFB, Acid Fast Bacilli; ALERT, All Africa Leprosy 
Rehabilitation and Training; AHRI, Armauer Hansen Research Institute; BMI, Body Mass Index; CRP, C-
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Reactive Protein; DOTS, Directly Observed Treatment Short Course; ELISA, Enzyme Linked Immunosorbent 
Assay; FFQ, Food Frequency Questionnaire; HPLC, High Performance Liquid Chromatography; IFN-, 
Interferon-; IL, Interleukin; IQR, Inter Quartile Range; MUAC, Mid Upper Arm Circumference; T regs, 
Regulatory T cells; sVDD, Severe Vitamin D Deficiency; SC-I, Severity Class; VDS, Vitamin D Sufficiency; TB, 
Tuberculosis; UVB, Ultra Violet B; VDD, Vitamin D Deficiency; VDR, vitamin D Receptors. 
 
Introduction 
Despite the availability of effective antimicrobials, tuberculosis (TB) remains as a public health 
threat globally. The treatment requires multiple drugs with longer durations that often have 
mild to severe side effects 1. Thus, there is a need for simple and inexpensive strategies to 
improve treatment outcomes. Vitamin D, a fat soluble secosteroid, has immunomodulatory and 
antimicrobial properties which make it as a candidate adjunctive immunotherapy in TB 2. In 
pre-antibiotic era, vitamin D rich resources such as sun-exposure and cod liver oil together with 
TB sanatorium were commonly used to treat patients infected with TB 3.  
 
Vitamin D moderates cell growth and differentiation, and regulates gene transcription by 
binding to vitamin D receptors (VDR) 4. T cells, monocytes and macrophages are known to 
express VDR 5,6. The interaction of T-cells with infected macrophages depends on the 
interplay of cytokines released and, is crucial for eliciting protective immunity against TB 7. 
 
Vitamin D deficiency (VDD) is common in active TB 8. Susceptibility to TB and risk of 
progression from infection to disease, tends to occur more often in patients with low 25-
hydroxy vitamin D (25(OH)D) levels 9. Several studies have been conducted on the role of 
vitamin D supplementation in modifying the treatment progress of TB, however, the results are 
still a matter of debate. Experimental data have shown that Th1 cells through production of 
Interferon (IFN)- are crucial for the release of cathelicidine by macrophages, bacterial killing, 
and containment of M. tuberculosis in granulomas 10. On contrary, other groups have shown 
that vitamin D inhibits the generation of Th1 responses and the production of IFN- by 
promoting the generation of regulatory T cells (T regs) 11. 
 
To look into such paradoxical effects of vitamin D on TB and determine whether provision of 
vitamin D has roles on clinical recovery, immune response and vitamin D status, we designed 
the current study that deals with the impact of vitamin D2 (Ergocalceferol) derived from sun-
exposed oyster mushroom on the treatment outcomes of TB. Our recent study revealed that 
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sun-exposed oyster mushroom has excess amount of vitamin D2 12. The bioavailability of 
vitamin D2 from Ultra Violet B (UVB) light treated mushroom is almost comparable with that 
of the supplement 13. To the best of our knowledge, this is the first study in dealing with the 
use of vitamin D2 derived from sun-exposed oyster mushroom as an adjunctive therapy to 
standard anti-TB treatment. 
 
Materials and methods 
Study site and design 
This randomized two-arms interventional trial was conducted between December 2014 and 
June 2015 at Debre Birhan Referral Hospital and 5 different health centres in North Shewa 
Zone of Amhara Regional State, Central Ethiopia.  
 
Patients  
Patients were recruited from TB clinics of all health facilities. Newly diagnosed, smear 
positive, active pulmonary TB patients who showed commitment to participate for the duration 
of the study were included. Smear positive pulmonary TB, as per the diagnostic algorithm, is 
defined by at least two initial sputum smear examinations positive for acid fast bacilli (AFB), 
or one initial smear examination positive for AFB and culture positive, or one initial smear 
examination positive for AFB and radiographic abnormalities consistent with active TB as 
determined by a clinician 14,15. On the other hand, patients with clinical history of 
pregnancy, breastfeeding, extra pulmonary TB, multi drug resistant TB, HIV infection, 
diabetes mellitus, liver cirrhosis, renal failure and other chronic diseases, and who were taking 
any corticosteroids, immunosuppressive drugs, thiazide diuretics or vitamin D supplementation 
were excluded from the study.  
 
Randomization and follow up  
Eligible patients were randomly assigned into two equal groups. Group I (vitamin D2 
intervention group) consisted of those patients who were provided with sandwich bread which 
was prepared from sun-exposed oyster mushroom (containing 146 µg or 5840 IU vitamin D2) 
for five days in the week for the first 16 weeks of 6 months anti-TB treatment. Group II (the 
control group) included patients who received the first line anti-TB chemotherapy only. As per 
the national treatment guidelines of Ethiopia, the standard first line anti-TB treatment consists 
of a combination of isoniazid, rifampicin, pyrazinamide and ethambutol for 2 months (intensive 
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phase treatment) followed by isoniazid and rifampicin for 4 months (continuous phase 
treatment) 16. Adherence to the DOTS (Directly Observed Treatment Short Course) 
programme and consumption of mushroom sandwich bread were supervised by the clinical 
nurses. Every week, patients were checked for any kind of complaints and undergone physical 
examination. Follow-up of each patient continued for 4 months.  
 
Data collection  
Sociodemographic data were collected using pre-tested and structured questionnaire which is 
translated to Amharic (local language). Medical records were also used to collect clinical 
characteristics. Vitamin D intake was assessed using a modified food frequency questionnaire 
(FFQ). The questionnaire included the availability of vitamin D rich foods, monthly income, 
money spent for foods, duration of sun-exposure, working hours in the sun, clothing style and 
use of sun protection. The types of all market and traditional foods were completely listed and, 
self-administered supplementary vitamin D intake was also considered in the assessment of 
dietary intake. 
 
Sun-exposure of oyster mushroom 
Fresh Oyster mushrooms (Pleurotus ostreatus) were procured from BioEnguday Production 
and Sale Micro-enterprise (Debre Birhan, Ethiopia) with the moisture content of 92.5% as 
determined by oven drying method. To facilitate the production of vitamin D2, mushrooms 
were chopped down to the volume of 9cm3 (3cm x 3cm x 1cm) and exposed to the sun for 3 
hours. Immediately after sun-exposure, mushrooms were put into plastic bag and kept at - 20oC. 
The detailed process of sun-exposure was described in our previous work 12. 
 
Sandwich bread preparation and vitamin D2 analysis 
Sandwich breads were prepared every day morning using ingredients of sun-exposed oyster 
mushroom, wheat bread, olive oil, onion and salt.  We used 27g of sun-exposed oyster 
mushroom (containing 146 µg of VD2) to prepare one sandwich bread. Samples were taken, 
packed into an insulated plastic bags together with dry ice and transported to University of 
Hohenheim (Stuttgart, Germany) where further analysis of vitamin D2 was done. The 
extraction of vitamin D2 was performed based on the method indicated in Keflie et al. 12. A 
system of High Performance Liquid Chromatography (HPLC) (Shimadzu technologies) 
equipped with a DGU-20A3R degassing Unit, two LC-20AT pumps, a SIL-20ACHT auto 
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sampler and a CBM-20A communication bus module (Shimadzu GmbH, Duisburg, Germany) 
as well as Reprosil 80 ODS-2 analytical column, 4.6 × 250 mm, 3 µm particle size (Dr. Maisch 
GmbH, Ammerbuch, Germany) was used to measure vitamin D2 at Institute of Biological 
Chemistry and Nutrition. Our pre-test experiment on the effect of cooking temperature 
indicated that vitamin D2 was almost stable during the process of cooking (Data not shown).  
 
Samples collection 
Blood and sputum samples were taken at the beginning (Day 0) and end of the study (4th 
month). After overnight fasting, 10 mL of venous blood was withdrawn from antecubital fossa 
vein into a non-heparinized vacutainer tube between 8:00 and 10:00 am at all health facilities. 
Blood samples were allowed to clot for about 1 h in the dark and subjected to centrifugation at 
2504xg for 10 min at room temperature. Samples with visible haemolysis were discarded. The 
sera were separated immediately into aliquots of sterile Eppendorf tubes by means of sterile 
pasteur pipettes and stored at -20 °C.  Later, the sera were transported in the ice-box to Armauer 
Hansen Research Institute (AHRI) in Addis Abeba, Ethiopia, where they were stored at −80 
°C until the time of analyses. We used the sera for the analyses of 25(OH)D, cytokines, 
cathelicidin (LL-37) and C-Reactive Protein (CRP).  Similarly, overnight sputum specimens 
were collected in sterile plastic cap for AFB smear examination and mycobacterial culture. 
Sputum specimens were stored at -20 oC and later transported in the ice-box to AHRI. 
 
Measurements 
Assays of 25(OH)D, cytokines, LL-37 and CRP were performed in duplicate at AHRI using 
Enzyme Linked Immunosorbent Assay (ELISA) technique.  
 
25 Hydroxy (OH) Vitamin D 
Serum 25(OH)D (vitamin D2 plus D3) levels were assayed using ELISA kit purchased from 
Enzo Life Sciences, GmbH (Lörrach, Germany). The assay was done as per the manufacturer’s 
instructions. The kit had 1.98 ng/mL detection limit with 0.5 to 1010 ng/mL assay range. 
Measurements were categorized as severe vitamin D deficiency (sVDD) ( 10 ng/mL), 
deficiency (VDD) ( 20 ng/mL), insufficiency (VDI) ( 30 ng/mL) and sufficiency (adequate 
level) (VDS) (> 30 ng/mL) 17, 18. 
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Cytokines, Cathelicidin (LL-37) and C-Reactive Protein (CRP) 
Levels of IFN-, Interleukin-4 (IL-4), IL-10, LL-37 and CRP in the serum were measured using 
ELISA kits. The kits for IFN- and IL-4 were purchased from Sigma-Aldrich (Saint Louis, 
MO63103 USA) with detection limits of 15 pg/mL and 5 pg/mL, respectively. The kit for IL-
10 was purchased from Enzo Life Sciences, GmbH (Lörrach, Germany). This kit had detection 
limit of <7.81 pg/mL. Likewise, the kits of LL-37 and CRP were purchased from Hycult GmbH 
(Beutelsbach, Germany) and their detection limits were 0.1 ng/mL and <5 ng/mL, respectively. 
Mean value of CRP ≥10 µg/mL was considered as positive indicator of infection or 
inflammation. The assays were carried out as per the manufacturer’s instructions.  
 
Mycobacteriology  
Duplicated sputum specimens were collected from each patient. AFB smears were prepared 
using Ziehl-Neelsen staining technique as previously described by Keflie and Ameni 15 at 
all health facilities.  AFB smears were denoted as +1, +2, +3 and +4 whenever 1-9 AFB in 100 
high-powered fields, 1-9 AFB in 10 high-powered fields, 1-9 AFB in 1 high powered field or 
> 9 AFB in 100 high powered fields were observed, respectively 8. Sputum specimens were 
decontaminated with 4% sterile NaOH solutions and culture was performed at AHRI with the 
use of Löwenstein-Jensen solid media as previously reported by Keflie et al. 15.  Bacterial 
cultures were monitored for 6 to 8 weeks until colonies were detected.  
 
Anthropometry 
Anthropometric measurements such as body weight, height, and mid upper arm circumference 
(MUAC) were obtained using standardized procedures. All patients were weighed while 
wearing light clothes using an electronic platform weighing scale to the nearest 0.1 kg. Height 
was measured to the nearest 0.1 cm by means of a seca stadiometer. Body mass index (BMI) 
was calculated as body weight (kg) divided by height (m) squared (kg/m2). BMI values of 18.5, 
17.0, and 16.0 kg/m2 were used as the cut-off values below which patients were classified as 
having mild, moderate, or severe malnutrition, respectively 19. MUAC was measured half 
way between the olecranon and acromion processes of the left arm using a flexible non-stretch 
measuring tape to the nearest 0.1 cm while the arm is hanging relaxed, without compressing 
the tissues. MUAC less than 23 cm for male and 22 cm for female is used to define 
undernutrition as per FANTA III 20.  
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Outcomes  
The primary outcomes were changes in vitamin D status, clinical improvements and 
immunologic responses.  Clinical outcomes were assessed using TB score and Karnofsky 
performance status scale. TB score measures change in the clinical status of TB patients and 
its components include self-reported symptoms (cough, dyspnea, night sweat, chest pain, 
haemoptysis), clinical signs (tachycardia, pallor, fever, auscultatory findings), BMI (Low BMI: 
 18.5 kg/m2, <16 kg/m2) and MUAC (<23 cm for male or < 22 cm for female, < 20 cm). Each 
variable contributed 1 point and the total score varies from 0 to 13 points.  The score was 
grouped as mild (Severity Classes (SC)-I: 0-5 points), moderate (SC-II: 6-7 points) or severe 
(SC-III: 8 points and more). Low TB score correlates with favourable outcomes, cure, and 
completed treatment 21. Likewise, Karnofsky performance status scale corelates purely to 
physical ability and covers 11 points, each scored as a percentage from normal health to death 
(100 to 0%) 22. Sputum smear conversion and culture negativity were evaluated as secondary 
outcome.  
 
Adverse effects 
Patients were interviewed for the occurrence of adverse events related to hypercalcemia such 
as nausea, vomiting, excessive thirst, anorexia, symptoms of kidney stones, and confusion. In 
addition, the occurrence of itching, arthralgia, jaundice, headache, malaise, dyspepsia and 
others were asked.  
 
Ethics 
This study was undertaken in accordance with Helsinki declaration and approved by Ethics 
Review Committee of AHRI-ALERT (All Africa Leprosy Rehabilitation and Training Centre) 
as part of the project entitled ‘’ Effect of micronutrients on the treatment outcomes of TB’’ 
(Project Reg. No. P057/14). All concerned health bureau of North Shewa Zone of Amhara 
Regional State gave us supports by facilitating the processes of the study. After explaining the 
aim and purpose of the study, written informed consent was obtained from each of the 
participating patients.  
 
Statistical analysis 
Sample size estimation was done based on the previous findings of TB Score reduction after 2 
months of anti-TB treatment with the mean ± SD of 3.2 ± 2.3 21. With the assumption of 
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36% more reduction in the primary clinical TB score after vitamin D2 intervention at 5% level 
of significance, 80% power and 20% dropout rate, the sample size was calculated to be 75 for 
each group with total of 150 patients. The study was analysed using IBM SPSS version 23 
statistical program and data were summarized as mean± SD or median with IQR (Inter Quartile 
Range) for continuous variables and frequencies with percentages for categorical variables. 
Means were compared using a two-tailed paired t-test or Wilcoxon signed rank sum test 
depending on the results of Shapiro-Wilk test for normality of distribution. The differences in 
the proportions were analysed using Chi-square (X2) or Fisher’s exact test (when more than 
20% of the cells have expected count less than 5). Kruskal-Wallis test was applied to assess 
the changes in the serum 25(OH)D levels across different categorical variables.  Pearson’s and 
Spearman correlation tests were used to identify the associations between parametric and non-
parametric variables, respectively. Variables with p-value less than 0.25 in bivariate analysis 
were entered into multiple linear regression model in order to evaluate the relationship between 
the changes in the serum 25(OH)D levels and the clinical outcomes by adjusting independent 
factors. A p-value less than 0.05 was considered statistically significant.  
 
Results 
Description of recruitment 
A total of 155 TB patients were assessed for eligibility. Of these, 35 patients failed to meet the 
inclusion criteria and 20 patients refused to provide their consents. One hundred patients were 
recruited and assigned into vitamin D2 intervention group and control group. Due to various 
reasons, 36 patients were lost and the remaining 64 patients (32 patients in vitamin D2 group 
and 32 patients in control group) completed the study. The flow of participants is illustrated in 
detail in Figure 1. 
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   155 TB patients screened for 
eligibility     
       
      35 TB patients failed to 
meet the inclusion 
criteria 
      
      
   120 TB patients 
recruited 
   
      
20 TB patients refused 
to provide their consent 
      
     
 100 TB patients 
assigned randomly 
   
      
        
 50 allocated to Vit D2 
intervention group 
  50 allocated to the 
control group 
 
   
         
         
18 lost to follow up 
n=6 refused 
participation 
n=7 transferred 
n=5 defaulted before 
completion 
     18 lost to follow up 
n=12 refused 
participation 
n= 2 transferred 
n=4 defaulted before 
completion 
     
     
     
     
     
         
 32 completed the study   32 completed the study 
   
       
Figure 1: Study recruitment, inclusion and completion profile of TB patients   
  
 
Basic Characteristics 
Basic characteristics were compared between vitamin D2 intervention group and the control 
group. As it is indicated in Table 1, the two groups had almost similar baseline characteristics. 
The median age with IQR was 28 (14) years in the intervention group and 26 (8.5) years in the 
control group. 
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Sun-exposed oyster mushroom  
The content of vitamin D2 in fresh oyster mushroom was almost nil. However, large amount 
of vitamin D2 was produced after sun-exposure and we obtained concentrations of 540.9 µg/ 
100 g fresh weight.  
 
Vitamin D 
Table 1: Basic Characteristics of TB patients assigned in vit D2 intervention group and 
control group 
 
 
Variables Vit D2 Intervention Control P-value 
Age (years) median (IQR) Age  28 (14) 26 (8.5) 0.90 
Sex n (%) Male 18 (56.3) 16 (50.0) 0.62 
Location n (%) Urban  21 (65.6) 20 (62.5) 0.79 
Educational Status n (%) Illiterate  2 (6.3) 3 (9.4) 0.43 
Primary Education  11 (34.4) 15 (46.9) 
Secondary Education  14 (43.7) 13 (40.6) 
Tertiary Education  3 (9.4) 1 (3.1) 
Religious Education  2 (6.2) 0 (0.0) 
Occupation n (%) Student  7 (21.9) 6 (18.7) 0.79 
Farmer 6 (18.7) 6 (18.7) 
Working for the government  6 (18.8) 10 (31.3) 
Working for NGO*  9 (28.1) 6 (18.8) 
House Wife  4 (12.5) 4 (12.5) 
Marital Status n (%) Single  17 (53.1) 11(34.4) 0.13 
Married  15 (46.9) 21 (65.6) 
Family Size n (%) 1 to 4  12 (37.5) 5 (15.6) 0.12 
5 to 8  15 (46.9) 22 (68.8) 
> 8  5 (15.6) 5 (15.6) 
Monthly Income n (%)  1000 ETB*  3 (9.4) 10 (31.3) 0.11 
1001 to 3000 ETB*  20 (62.5) 12 (37.5) 
3001 to 5000 ETB*  6 (18.7) 6 (18.7) 
> 5000 ETB*  3 (9.4) 4 (12.5) 
Money spent for food n (%) 30 to 40% of monthly income   16 (50.0) 7 (21.9) 0.072  
40.1 to 50% of monthly income   7 (21.9) 14 (43.7)  
50.1 to 60% of monthly income   5 (15.6) 4 (12.5)  
> 60% of monthly income   4 (12.5) 7 (21.9) 
Working in the Sun for 1hour/day n 
(%) 
No   12 (37.5) 18 (56.3) 0.13 
Yes   20 (62.5) 14 (43.7) 
Clothing style (covering the body) n 
(%) 
No   5 (15.6) 10 (31.3) 0.14 
Yes   27 (84.4) 22 (68.7) 
Use of sun protection n (%) No   7 (21.9) 10 (31.3) 0.39 
Yes   25 (78.1) 22 (68.7) 
Vitamin D rich food consumption 
(E.g. Oily Fish) n (%) 
No   24 (75.0) 25 (78.1) 0.77 
Yes   8 (25.0) 7 (21.9) 
AFB Smear Examination n (%) AFB Smear  +3  24 (75.0) 31 (96.9) 0.012 
BMI mean (SD) BMI 17.5 (2.4) 18.7 (3.8) 0.13 
MUAC median (IQR) MUAC 21 (5) 20 (3) 0.93 
*NGO-Non-Governmental Organization; 1USD  27.96 ETB (Ethiopian Birr)     
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More than 65% of the study participants spent 30 to 50% of their monthly income on food. 
But, less than 26% of them tried to include vitamin D rich foods like oily fish in their diet. The 
correlation between the serum 25(OH)D level and vitamin D rich food intake, working in the 
sun for 1 hour per a day, use of sun protection and clothing style was not significant. Although 
more than 40% of TB patients were working in the sun for about 1 hour per day, their skin did 
not directly expose to the sun as most of them (>68%) cover their body by clothes and using 
sun protection (Table 1).  
 
The mean ± SD of serum 25(OH)D level at baseline was 29.1 ± 12.3 ng/mL versus 30.6 ± 16.8 
ng/mL in the intervention group and control group, respectively.  In the intervention group, the 
proportions of VDD and VDI at baseline were nearly 42% and 58%. Whereas, these values in 
the control group were about 41% and 59%, respectively (Table 2).  
 
Table 2: Serum 25(OH) vitamin D level in VD2 intervention group and the control group of TB patients 
25(OH)Vitamin D Level VD2 Intervention Group 
 
Control Group 
 
       
 
Before  
n (%) 
After  
n (%) 
P - 
value 
Before  
n (%) 
After  
n (%) 
P - 
value 
sVDD‡ (10ng/mL) - - 0.0012 1 (3.4) 1 (3.4) 0.73 
VDD§ (20ng/mL) 13 (41.9) 2 (6.4) 12 (41.4) 7(24.1) 
VDI† (30ng/mL) 18 (58.1) 8 (25.8) 17 (58.6) 15 (51.7) 
Sufficient VD (>30ng/mL) 13 (41.9) 23 (74.2) 12 (41.4) 14 (48.3) 
‡sVDD - Severe Vitamin D Deficiency; §VDD - Vitamin D Deficiency, †VDI - Vitamin D Insufficiency, and 
Sufficient VD 
 
After 4 months of VD2 intervention, the mean ± SD of the serum 25(OH)D level was higher in 
the intervention group than the control group (37.2 ± 10.9 vs 34.4 ± 17.6). The intervention 
induced 27.8% increase in the mean of serum 25(OH)D level in the intervention group (for the 
difference: mean ± SD of 8.1 ± 6.2 ng/mL; 95% CI of 5.9 to 10.3 ng/mL, p < 0.001) (Figure 
2). In addition, the proportions of VDD and VDI were significantly reduced in the intervention 
group by 35.5% and 32.3%, respectively. Although not statistically significant, the 
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corresponding values for the control group were 17.3% and 6.9% (Table 2). The changes in 
the serum 25(OH)D level were not different across sex and age categories.  
 
Figure 2: The changes of 25(OH)D level in the serum of TB patients before and after 
intervention. Significant change was observed in intervention group (A) but not in the control 
group (B). 
 
Clinical outcomes 
At baseline, the mean ± SD of TB score was 6.1 ± 3.2 points for intervention group and 6.9 ± 
2.1 points for the control group. About 34% of TB patients in the intervention group and 38% 
in the control group were found in the TB score SC-III. After intervention, progressive change 
was observed in TB score of the intervention group (mean ± SD of 2.6 ± 1.8; 95% CI of 1.95 
to 3.17; p<0.001) as compared to the control group (mean ± SD of 6.7 ± 1.8; 95% CI of 6.13 
to 7.37; p= 0.211). The number of TB patients with TB score SC-I was significantly improved 
by 56.3% in the intervention group, but this improvement was very small in the control group 
(only 3.1%) (Table 3). Holding location, occupation and family size constant, there was an 
inverse relationship between TB score and the serum 25(OH)D level in the intervention group 
(=-0.630, p <0.001). About 33% of the variability of TB score in the intervention group was 
accounted for by the change in the serum 25(OH)D level. However, the contribution of the 
change in 25(OH)D for such variability in the control group was 22%.  
 
TB score had statistically significant inverse correlation with Karnofsky performance status 
scale (r=-0.554, p=<0.001), body weight (r=-0.393, p=0.001), BMI (r=-0.498, p<0.001), and 
MUAC (r=-0.515, p<0.001). The mean ± SD of Karnofsky performance status scale before and 
P-value= <0.0001 
 
P-value= 0.16 
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after intervention were 61.9 ± 6.9% and 80.3 ± 6.9% in the intervention group, and 64.7 ±5.7% 
and 66.2 ± 5.5% in the control group, respectively. The change in the Karnofsky performance 
status scale was statistically significant in the intervention group (p < 0.001), but not in the 
control group (p=0.52) (Table 3). There was strong correlation between BMI and MUAC 
(r=0.71, p<0.001). After intervention, the group of intervention had significant improvements 
in BMI (by 0.91 kg/m2) and MUAC (by 1.16 cm). However, these improvements were not 
statistically significant in the control group (BMI by -0.01 kg/m2 and MUAC by -0.1 cm).  
 
Table 3: Clinical and mycobacteriological findings in TB patients before and after intervention 
Variables Vitamin D2 Intervention Control 
 
Before         
n (%)  
After       
n (%) 
P-value 
Before     
n (%) 
After         
n (%)   
P-value 
TB Score Severity Class (SC)       
SC-I (0 to 5 Points) 13 (40.6) 31 (96.9) <0.001 8 (25.0) 7 (21.9) 0.88 
SC-II (6 to 7 Points) 8 (25.0) 1 (3.1) 
 
12 (37.5) 14 (43.7) 
 
SC- III ( 8 Points) 11 (34.4) 0 (0.0) 
 
12 (37.5) 11 (34.4) 
 
Karnofsky performance status scale 
  
  
 
50 Points 5 (15.6) 0 (0) <0.001 1 (3.1) 0 (0.0) 0.52 
60 Points 16 (50.0) 0 (0) 
 
15 (46.9) 13 (40.6) 
 
70 Points 11(34.4) 7 (21.9) 
 
16 (50.0) 18 (56.3) 
 
  Points 0(0.0) 25 (78.1) 
 
0 (0.0) 1 (3.1) 
 
Acid Fast Bacilli (AFB)† 
   
  
 
Smear +1, n (%) 0 (0) 10 (31.3) <0.001 0 (0.0) 14 (43.7) <0.001 
Smear +2, n (%) 8 (25.0) 14 (43.7) 
 
1 (3.1) 15 (46.9) 
 
Smear +3, n (%) 16 (50.0) 5 (15.6) 
 
21 (65.6) 1 (3.1) 
 
Smear +4, n (%) 8 (25.0) 3 (9.4) 
 
10 (31.3) 2 (6.3) 
 
Culture Positive n (%) 32 (100) 29 (90.6) 0.076 31 (96.87) 29 (90.6) 0.302 
† AFB Smear +1: 1 - 9 AFB Observed/ 100 high powered fields; +2: 1 - 9 AFB Observed/ 10 high powered fields; +3: 1 - 
9 AFB Observed/ high powered fields); and +4: > 9 AFB Observed/ 100 high powered fields. 
 
Mycobacteriological outcomes 
AFB smear examinations and bacterial culture were performed to analyse the changes in the 
bacterial load. After intervention, there were significant changes in AFB load in both 
intervention and control groups (p<0.001), in which more than 30% of TB patients had AFB 
smear examination level +1 (1 to 9 AFB observed/ 100 high powered fields). Despite the 
changes in the bacterial load, AFB smear negativity could not be achieved and nearly 91% of 
the patients were culture positive after intervention. In both intervention and control groups, 
the changes in the culture conversion were not statistically significant (Table 3). 
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Immunological outcomes and anti-microbial peptides 
Figure 3 illustrates the changes in the levels of cytokines and cathelicidin (LL-37) before and 
after intervention. At baseline, the mean ± SD of cytokines were 14.9 ± 12.2 vs 13.8 ± 7.0 
pg/mL (IFN-), 4.6 ± 3.4 vs 9.8 ± 10.4 pg/mL (IL-4), 15.2 ± 5.8 vs 20.3 ± 8.8 pg/mL (IL-10) 
and that of LL-37 was 192.7 ± 65.2 vs 165.9 ± 92.7 ng/mL in the intervention group versus the 
control group. After intervention, the corresponding values became 59.5 ± 39.8 vs 14.8 ± 8.7 
pg/mL (IFN-), 6.5 ± 5.0 vs 9.0 ± 8.2 pg/mL (IL-4), 17.8 ± 5.9 vs 14.6 ± 5.6 pg/mL (IL-10) 
and 245.3 ± 99.3 vs 174.8 ± 90.1 ng/mL (LL-37). In both groups, there was no significant 
difference in CRP level. 
 
While comparing the means, we observed significant changes in the levels of IFN- and LL-
37 (p<0.05) in the intervention group. However, such changes were not observed in the control 
group. IFN- had significant positive correlation with 25(OH)D (r=0.426, p= 0.017). Moreover, 
there were statistically significant relationship between 25(OH)D level and the levels of IFN- 
(= 0.349, p=0.039) and LL-37 (=0.366, p=0.0.028) holding location, occupation and family 
size constant.  
 
 
P-value= 0.01 
P-value= 0.69 
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Figure 3: The serum level of different cytokines and antimicrobial peptides before and after intervention. A, C, 
E and G in the intervention group and B, D, F and H in the control group represent the serum level of 
IFN-, IL-4, IL-10 and Cathelicidin (LL-37), respectively. P-value <0.05 shows significant difference between 
before and after intervention. 
P -value= 0.73 
Your 
P-value=0.44 
P-value= 0.34 
P-value= 0.26 
P-value=0.02 
 
P-value=0.21 
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Discussion 
Our study demonstrated for the first time the effects of sun-exposed oyster mushroom on the 
treatment outcomes of TB. A high proportion ( 40%) of VDD was found in this study; and it 
was directly related to factors such as lack of sun exposure and inadequate intake of vitamin D 
rich diets. These two factors were identified together with others in our previous systematic 
review as the main predictor variables of vitamin D status among TB patients in Africa 18. 
Despite its high content of ergosterol, oyster mushroom contains vitamin D2 to the level close 
to nil. However, sun-exposure increases the amount of vitamin D2 in oyster mushroom 12.  
 
Intervention with sun-exposed oyster mushroom; containing 146 µg (5840 IU) vitamin D2 daily 
for 5 days in the week for the first 16 weeks; brought a significant difference of 8.1 ng/mL in 
the mean 25(OH)D level; and corrected deficiency in more than 35% of TB patients without 
showing any adverse effects. Comparable to this, in 3 consecutive days of UVB exposure to 
Asian immigrants in the UK, Yesudian et al. 23 found 9.16 ng/mL increase in the mean 
25(OH)D level from a baseline of 11.23 ng/mL. Tukvadze et al. 8 in Georgia also showed 
that adjunctive high-dose oral vitamin D3 was safe and led to a substantial increase in plasma 
25(OH)D concentrations over 16 weeks. Similarly, Urbain et al. 13 demonstrated that 
intervention with vitamin D2-enhanced button mushrooms via UV-B irradiation was effective 
in improving vitamin D status. 
 
A previous study revealed that oral vitamin D supplementation was associated with significant 
suppression of the concentrations of circulating inflammatory markers, like CRP 24. In the 
present study, however, there was no significant change in the level of CRP. In the same line, 
Wu et al. 1 confirmed that there was no evidence on the improvement of CRP after the 
intervention. Our previous work underscored that CRP was not the best option to control the 
change in the acute phase response of vitamin D and other micronutrient’s levels in the serum 
of TB patients 25.  
 
Intriguingly, our intervention ameliorated the clinical outcomes and immune responses of TB 
patients, but not sputum culture conversion. Clinical outcomes were assessed by TB score and 
the Karnofsky performance status scale. Wejse et al. 21 found that TB score declined for 96% 
of the surviving patients from initiation to end of treatment. At the end of standard 
chemotherapy at 6 months, most patients had a TB score below 1 26.  
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In this study, a progressive change was observed during 4 months of intervention. Most patients 
(96.9%) found in TB score SC-I, having more than 55% improvement from baseline. During 
the same duration of treatment, about 22% of patients in the control group was found in TB 
score SC-I with less than 5% improvement. There was a significant inverse relationship 
between TB score and serum 25(OH)D level. The variability of TB score in more than one-
third of TB patients was attributed to the change in the serum 25(OH)D level. In line with this, 
a study done in Iran indicated a reduction of TB score in patients who took a single oral dose 
of 450,000 IU cholecalciferol after 2 and 3 months of treatment 27. Another study done in 
Egypt showed better healing after 1000 IUs of oral vitamin D supplementation 28. More 
recently, Bekele and his colleagues 26 reported that an additional 25% reduction in the TB 
score in the intervention group was considered as a significant effect.   
 
TB score was inversely associated with the Karnofsky performance status scale. In this study, 
there was a significant change in the Karnofsky performance status scale of the intervention 
group having a mean of 80.3% as compared to 66.2% in the control group. Similarly, there was 
a significant change in nutritional status as assessed by BMI and MUAC. BMI had a strong 
relationship with MUAC. We observed the improvements of BMI (by 0.91kg/m2) and MUAC 
(by 1.16 cm) solely in the intervention group. In agreement with this, Salahuddin et al. 9 
showed that 2 doses of 600,000 IU vitamin D administered intramuscularly resulted in a greater 
weight gain by 1.14 kg and improvement in BMI.  Two small randomized studies 28, 29 have 
also suggested the beneficial effects of vitamin D on weight gain. These implied that the 
improvement in the level of vitamin D has a contribution to the improvement of the nutritional 
status of TB patients.  
 
Although there were significant changes in bacterial load as assessed by AFB smear 
examination, we could not find a whole AFB smear negativity and sputum culture conversion. 
Comparable to this, several studies done elsewhere 9, 26, 30, 31 demonstrated that vitamin 
D supplementation did not affect time to sputum smear and culture conversion. However, there 
were some contrasting reports.  Studies done by Nursyam et al. 29 and Coussens et al. 32 
indicated that vitamin D supplementation accelerated sputum smear conversion. Martineau et 
al. 33 also showed that administration of four doses of 2.5 mg vitamin D3 had a faster effect 
on sputum smear conversion in patients with the tt genotype of the TaqI VDR polymorphism. 
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Therefore, the reasons for such inconsistencies could be the presence of the variants of VDR 
polymorphisms, variability in vitamin D dosages or different phases of baseline serum 
25(OH)D level as indicated in Farazi et al. 27. 
 
It’s well established that vitamin D intervention can modify the balance between Th1 and Th2 
responses 34. We found a significant increment in IFN- level, the classical cytokine of Th1 
response in the intervention group. Whereas, non-significant changes were observed in the 
levels of Th2 cytokines such as IL-4 and IL-10. These implied that vitamin D intervention 
skewed the balance of cytokines towards Th1 response. In contrary, several studies reported 
that vitamin D intervention inhibits the level of IFN-, but enhances the production of IL-4 and 
IL-10 7, 10, 35. However, in agreement with the present study, Salahuddin et al. 9 showed 
that vitamin D administration brought significant change in IFN- production in TB patients 
with VDD at baseline.  Fabri et al. 36 also reported that in vitro supplementation of vitamin 
D deficient serum with 25(OH)D3 restored IFN-γ. These recapped that the difference in the 
effects of vitamin D intervention on Th1 and Th2 cytokines was mainly dependent on VDD at 
baseline.  
 
In the present study, there was a significant change in the level of cathelicidin LL-37.  This 
was supported by several studies done elsewhere 7,8, 10, 37. We found a direct relationship 
between LL-37, IFN- and 25(OH)D level in the intervention group. This indicated that better 
status of vitamin D increases the level of IFN- mediated cathelicidin LL-37. According to 
different studies, vitamin D promotes mycobacterial killing 37 or reduced intracellular 
viability of M. tuberculosis 24 in macrophages through the production of cathelicidin LL-37, 
after activation of macrophages via either toll-like receptor 38 or IFN- pathways 36.   
 
Limitation 
The first limitation of this study was the inability to separately measure 25(OH)D2. ELISA kits 
detect 25(OH)D which is the summation of 25(OH)D2 and 25(OH)D3. Secondly, data on the 
genotypes of VDR polymorphisms were not included as we could not have access to measure 
the genes of VDR polymorphisms at the time of the study. VDR polymorphisms are, however, 
expected to influence the effects of vitamin D intervention.  
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Conclusion 
In conclusion, vitamin D2 intervention from a sandwich bread prepared with sun-exposed 
oyster mushroom effectively corrected VDD in TB patients taking the standard anti-TB 
treatment without showing any adverse reaction. The accelerated improvements on the clinical 
and immunological outcomes although not on sputum smear conversion give us a clue that sun-
exposed oyster mushroom could serve as a potential, safe, easily available and cost- effective 
adjunctive treatment of TB. As this is the first study, further investigations on the interactions 
of vitamin D2, sputum smear conversion and immunological responses on the large size and 
diverse groups of TB patients are warranted.  
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4.1. Discussion 
      
     Nutrition plays significant roles in treating TB 1. Before the advent of anti-TB 
chemotherapy, a diet rich in calories, proteins, fats, minerals and vitamins was considered in 
the treatment of TB 2. The introduction of anti-TB drugs; however, led to reduced emphasis 
on the importance of nutritional support in the management of TB patients 3. TB patients 
with strains susceptible to first line anti-TB drugs are treated only with standardized first line 
treatment regimen 4. 
 
4.1.1. Dietary and nutritional assessment 
 
     In dietary and nutritional assessment, we identified a big nutritional gap in the central part 
of Ethiopia. The main dietary pattern of the population included cereals (teff, wheat and 
barley), vegetables (onion, green pepper, tomato and cabbage), legumes (peas, faba bean and 
lentils), oils (cooking oil) and spices (salt). All these food items are the ingredients of injera, 
and thick stew made from flour of roasted legumes (‘shiro wot’).  In agreement with our study, 
Workicho et al. 5, Kefiyalew and Eshetu 6, Steyn et al 7 and Mekuria et al. 8 reported 
that cereals, followed by legumes and, root and tubers are the most commonly consumed food 
groups. These staples dominate the national food basket in Ethiopia, supplying more than 70% 
of calories 9. Animal source foods (ASF) were consumed by about one-third of the 
population. Despite the large livestock population in Ethiopia, consumption of animal products 
is limited 10 because of decreased access, relatively high price, lack of cooling devices and 
monotonous food habit 5, 6. 
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     Healthy food intake is associated with food variety and diet quality of individuals 11. Food 
variety score (FVS) and diet diversity score (DDS) are the proxy indicators of the quality of 
diets in which more than three-fourth of the population in our study had poor FVS (10-19 
varieties of foods per week) and DDS (below 4 out of 9 DDS). This implied that most people 
had poor nutrient adequacy and dietary quality. The median meal frequency per day was 3 with 
the minimum of 1. Meaning that there were some portion of the population who were eating 
only one time. Consumption of monotonous diets for longer time lacks essential nutrients and 
subsequently contributes to the burden of malnutrition and micronutrient deficiencies 12. In 
our study, malnutrition was the common problem in the population. Given its commonness in 
the people with and without TB, it is more likely that malnutrition is paving the way for TB 
infection and disease advancement. More than half of the population in our study had the risk 
of micronutrient deficiencies. Deficiency of single or multiple nutrients can reduce an 
individual’s resistance to infection 13. 
 
4.1.2. Vitamin A and zinc deficiencies 
 
     The burden of vitamin A and zinc deficiencies in TB patients was very high. Our case-
control study revealed that more than half of TB patients had deficiencies of vitamin A and 
zinc. In line with this, studies done elsewhere reported that TB patients had high proportion of 
vitamin A (60%) 14 and zinc (47.1%) 15 deficiencies. The low zinc level reported in TB 
patients was in concert with several studies done in different places 15. Zinc deficiency 
impairs the synthesis of vitamin A binding proteins and reduces plasma vitamin A 
concentration 13. 
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     Vitamin A deficiency usually occurs in the places where the people consume a monotonous 
cereal-legume diet 16. Traditional staple foods, such as cereals, legumes, and tubers, contain 
zinc, but the presence of phytate, fibre, and lignin reduces its bioavailability. Cow’s milk, 
because of its high concentrations of calcium and casein, and soymilk, because of its phytate 
content, may further reduce the absorption of zinc from the diet. The tannin content in tea and 
coffee can potentially inhibit zinc absorption. The soil where the plants are growing has also 
an influence on the availability of zinc concentration 17. 
 
4.1.3. Protein-Energy malnutrition 
 
     While analysing the intake of nutrients, we found that more than three-fourth of TB patients 
had below half of the energy fulfilment. In patients with active TB, the energy requirement is 
likely to increase 18 as the result of increasing basal metabolic rate or resting energy 
expenditure 19. At the same time, energy intakes are likely to decline as a result of illness-
associated anorexia 19. On the other hand, the protein intake in our study was above the 
average fulfilment albeit cereal-based diets. Patients with TB used a larger proportion of 
proteins from oral feeding for oxidation and hence for energy production. Such failure to 
channel food protein into endogenous protein synthesis is anabolic block which represents one 
of the mechanisms for wasting in TB patients 19.  
 
     Several studies reported that patients with active TB are more likely to be wasted or have a 
lower body mass index (BMI = kg/m
2
) than healthy controls 15. Our study revealed that about  
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one-third of TB patients had BMI less than 18.5 kg/m2. This finding was, in fact, less than the 
reports of Workineh et al. 20 (71.4%), Kant et al. 13 (66%), Zachariah et al. 21 (57%) and  
Amare et al. 14 (65.4%), but it was higher than the report of Onwubalili 22 (13%). As 
defined by mid-upper arm circumference (MUAC), close to half of TB patients in our study 
were undernourished. The possible reasons for such undernourishment could be protein-energy 
malnutrition, micronutrient deficiencies and impaired metabolism. Undernutrition is associated 
with increased risk of mortality and poor treatment outcomes. Although nutritional status is 
improved by effective TB treatment, the most improvements are limited to increase in fat mass 
with little effect on muscle tissue. The evidence suggests that adequate nutritional intake during 
TB care and recovery is needed to fully restore nutritional status during and following TB 
treatment and microbial cure 18. 
 
4.1.4. Vitamin D deficiency 
 
     TB has strong relationship with vitamin D 23, 24. Vitamin D, popularly referred to as 
sunshine vitamin’’ plays significant role in metabolic and immunologic processes 25. It is 
mainly obtained endogenously after sun-exposure, and from dietary supplements and food 
sources 25. Populations from temperate regions, where exposure to sun is limited, especially 
during winter season are expected to have vitamin D deficiencies (VDD) unless they rely on 
dietary intakes 26. Astoundingly, there were some studies that showed the presence of VDD 
in the people living in Africa. This caught our attention and posed a question why TB patients 
in Africa face the challenges of VDD, while sunshine is available in the continent throughout 
the year.  
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     Based on this question, we undertook a systematic review and found that above three-fourth 
of TB patients had VDD and insufficiencies (VDI). Noteworthy to mention, use of sun  
protection (lack of sun-exposure), inadequate dietary intake, low BMI, skin pigmentation, use 
of drugs (anti-retroviral or anti-TB), socioeconomic status, season, clothing, comorbidities and 
age were identified as the main predictor variables that hampered the status of vitamin D. VDD 
increases the susceptibility to TB infection 27 and encourages the development of advanced 
TB by causing low macrophage activation and reduced production of antimicrobial factors 3. 
 
4.1.5. Mushroom-derived vitamin D2 
 
     Mushroom is a potential non-animal source of vitamin D 28. Owing to its nutritional and 
medicinal properties 29, consumption of mushroom has increased worldwide for the past four 
decades 28. Considering its cost, availability and accessibility, we undertook a study on 
mushroom under subtropical settings. In this study, the impact of sun-exposure on the content 
of vitamin D2 in oyster mushroom was assessed. The content of vitamin D2 was almost nil, but 
significantly increased after sun-exposure. This was supported by the studies of Phillips and 
Rasor  30. The difference in the content of vitamin D2 before and after sun-exposure is 
attributed to the presence of sterol, mainly ergosterol in the fruiting body of mushroom 29.  
 
     Upon exposure to UVB radiation, pro-vitamin D2 (ergosterol) was converted to pre-vitamin 
D2, which then thermally isomerized to vitamin D2 31. The process of vitamin D2 synthesis 
is affected by many factors. Our study indicated that duration of sun-exposure, sizes of  
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mushroom slices and their moisture content at the time of sun-exposure determined the 
synthesis of vitamin D2. This was corroborated with the work of Jasinghe et al. 32. Cardwell  
et al. 28 also described that time of exposure, temperature, and exposure of UVB radiation 
can influence the production of vitamin D2. Increasing the surface area of sun-exposure 
increases the production of vitamin D2. The maximum content of vitamin D2 was produced in 
1cm3 size of slice group (67.4 ± 28.0 µg/g dry weight (dw)), which was closer to the report of 
Huang et al. 33 (69.00 μg/g dw).  
 
     While increasing the duration of sun-exposure, the content of vitamin D2 increased; 
however, there was a change in colour and texture. The change in colour brought discolouration 
which deterred the consumption of mushroom 28. Our study showed that the change in the 
colour and texture could be minimized by shortening the duration of exposure. For instance, 
exposing a group of 9 cm3 size of slices for 30 minutes produced about 41 μg/g dw of vitamin 
D2 without any visible change in colour and texture. This amount of vitamin D2 was 
comparable to the amount of vitamin D3 in cod liver oil (40.3 μg per 1 tablespoon) 34. Thus, 
exposing slices of oyster mushroom to the sun for brief period ( 30 minutes) produces enough 
vitamin D that can satisfy the current recommended dietary allowance (RDA) of vitamin D. 
Our study confirmed that sun-exposed oyster mushroom is the potential alternative source of 
vitamin D, especially for vegetarians, vegans and for persons who are fasting ASF during 
religious fasting time.  
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4.1.6. Role of mushroom-derived vitamin D2 on the treatment outcomes of TB 
 
     Mushroom-derived vitamin D2 is bioavailable and relatively stable during storage and 
cooking 28. Vitamin D2 is as effective at increasing and maintaining total serum 25 hydroxy 
(OH) vitamin D level as vitamin D3 29, 35, 36. In fact, vitamin D2 and D3 are structurally 
very similar. The only exceptions are that vitamin D2 has double bond between carbon 22 and 
23 and a methyl group on carbon 24 31. In pre-antibiotic era, vitamin D3 derived from cod  
liver oil and direct sun-exposure was once part of regular therapy for TB 15, 24, 37. Given 
the implication of VDD and risk for TB, several studies have been performed so far to re-
introduce vitamin D3 as a supplementary therapy to the anti-TB treatment 23. Dietary source 
of vitamin D in the form of supplement or fortified foods may represent a new strategy for the 
TB prevention and shortening of TB treatment in the face of growing drug resistance 24. 
 
     To the best of our knowledge, we demonstrated for the first time the role of mushroom-
derived vitamin D2 on treatment outcomes of TB.  Intervention with 27 g sun-exposed oyster 
mushroom in sandwich bread; containing 146 µg (5840 IU) vitamin D2 daily for 5 days per 
week for the first 16 weeks; brought an improvement of about 8 ng/mL in the serum 25(OH)D 
level; and corrected VDD in more than one-third of TB patients without showing any adverse 
effects. Likewise, Martineau et al. 38 corrected the profound VDD in TB patients by 
providing a single oral dose of 2.5 mg vitamin D. Hassanein et al. 39 also observed the change 
in the serum 25(OH)D level in TB patients provided with vitamin D supplementation.  
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     Our intervention ameliorated the clinical outcomes and immune response of TB patients, 
but not sputum smear and culture conversion. Clinical outcomes were described in terms of TB 
score severity class and Karnofsky performance status scale. Different studies done elsewhere 
reported that the addition of vitamin D supplementation to the standard anti-TB drug regimen 
leads to the improvement of clinical outcomes in TB patients 24, 37, 40.  More than three-
fourth of TB patients were found in the low severity class of TB score (class I) having about  
80% Karnofsky performance status scale after intervention. About one-third of the variability 
of TB score in the intervention group was accounted for by the change in the serum 25(OH)D 
level. Likewise, Farazi et al. 40 reported that TB patients in the vitamin D supplementation 
group had lesser TB score than the control group after two to three months.   Salahuddin et al. 
41 also found that vitamin D supplementation improved TB score. Weight gain is usually an 
outpatient marker of betterment in TB 40. The improvements of BMI and MUAC were solely 
observed in the intervention group. Similarly, Salahuddin et al. 41 and Farazi et al. 40 
demonstrated that vitamin D supplementation improved the mean weight gain during anti-TB 
therapy.  
 
     Vitamin D mediates the activation of innate and cell mediated immunity against TB 
infection 40. Upon M. tuberculosis detection, toll-like receptors (TLR) on the macrophage 
membrane are activated to induce transcriptional up-regulation of the vitamin D receptor 
(VDR) and enhance CYP27B1 expression, leading to the increased synthesis of 1, 25(OH)2D 
and VDR, two essential components responsible for the VDR-dependent regulation of a variety 
of genes including the up-regulation of cathelicidin expression 24, 37. Cathelicidin LL-37 
peptide has both antimicrobial and immunoregulatory activities, such as direct killing of  
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bacteria via osmotic lysis, but also induction of autophagy, regulation of chemokine production 
and chemokine receptor expression, modulation of cytokine secretion and chemotactic effects 
on immune cells 42. 
 
     In monocytes and macrophages, IFN- can induce CYP27B1-hydroxylase 43 and up-
regulates TLR2/1L – induced antimicrobial peptide expression 44. In our study, there were 
significant improvements in IFN- and cathelicidin LL-37 levels, but not in the levels of 
interleukin (IL)-4 and IL-10. In agreement with this, Fabri et al. 45 described that the in vitro 
supplementation of vitamin D – deficient serum with 25(OH)D restored IFN- induced 
antimicrobial peptide expression, autophagy, phagosome-lysosome fusion, and antimicrobial 
activity. The high IFN- level together with the low level of IL-4 and IL-10 implied that our 
intervention skewed the balance of cytokines towards TH1 responses. Likewise, Fabri et al. 
45 confirmed that the capacity of T cell clones to induce monocyte production of cathelicidine 
LL-37 peptides correlated with the amounts of IFN-, but inversely correlated with the amount 
of IL-4.  
 
     Our intervention could not bring a total sputum and culture negativity. In fact, this finding 
was supported by different studies done elsewhere 41, 46.  On the contrary, there were several 
studies that reported a total sputum smear and culture conversion in patients provided with 
vitamin D supplementation 47, 48. The reasons for such inconsistencies could be the variants 
of VDR polymorphisms, variability in vitamin D dosages or differing phases of baseline serum 
vitamin D level 40. 
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4.2. Conclusion 
 
     In conclusion, the cereal-vegetable-legume based dietary pattern has led to poor dietary 
quality and nutrient adequacy. Micronutrient deficiencies and protein-energy malnutrition are 
the predominant nutritional problem in TB patients, and hence this calls for giving attention to 
nutrition in the management of TB. While sun-exposed oyster mushroom is the potential 
resource of vitamin D2, the provision of such mushroom effectively corrects VDD and 
improves the clinical outcomes and immunological responses in TB patients. To get more 
effects on the treatment outcomes of TB, there is a need to incorporate nutrients enriched with 
mushroom-derived vitamin D2 in its management. Well-designed nutrition programme is more 
helpful to support the first line anti-TB drugs, increase the cure rate and reduce the 
infectiousness of TB. The control of TB substantially contributes to the control of poverty and 
food insecurity as they are the causes and consequences of TB. Therefore, nutrition programme 
needs to be parts and parcels of the national TB control programme in Ethiopia. Further 
research is warranted to design nutrition formulation for various age and sex groups of TB 
patients and to determine the interaction of vitamin D2, VDR polymorphism and TB treatment 
outcomes.  
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Figure adapted from: 
https://commons.wikimedia.org/wiki/Atlas_of_Ethiopia. 
The circle at the middle showed our study site in 
North Shewa Zone of Amhara Regional State, 
Central Ethiopia.  
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